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ABSTRACT 
The objectives of the experiments presented in Section I were: to determine embryo 
mortality (EM) around the period of maternal recognition of pregnancy and identify alterations 
in ovarian dynamics in cows that suffered EM, and evaluate resynchronization programs based 
on ovarian structures present at nonpregnancy diagnosis (NPD) to maximize reproductive 
efficiency of lactating dairy cows. The objectives of the experiments presented in Section II were 
to test the feasibility of inducing luteal regression and an LH surge after intravaginal (IVG) 
administration of PGF2α and GnRH, respectively.  
The first experiment of Section I demonstrated that combining data for mRNA expression 
of interferon stimulated genes in white blood cells and circulating concentration of pregnancy 
specific protein B is a useful method to identify cows undergoing EM. In addition, we observed 
that only cows undergoing EM after Day 24 of gestation had extended luteal phases and EM did 
not cause major alterations to the follicular wave dynamics after the onset of luteolysis. The 
other experiments presented in Section I demonstrated that a resynchronization of ovulation 
program (Short-Resynch) without the first GnRH treatment 25 ± 3 days after AI and in which 
cows were differentially treated based on the ovarian structures present at NPD (32 ± 3 days after 
AI) resulted in a greater proportion of cows re-inseminated at estrus without negatively affecting 
overall pregnancy per AI when compared with the Ovsynch protocol initiated 25 ± 3 days after 
 AI. In another experiment, Short-Resynch increased hazard of pregnancy after first service when 
compared to blanket use of the Ovsynch protocol initiated 32 ± 3 days after AI.  
Experiments presented in Section II demonstrated that two IVG treatments of PGF2α 12 
hours apart caused a decline in progesterone concentration similar to that observed after a single 
intramuscular luteolytic dose of PGF2α. Further, we observed that IVG instillation of GnRH 
analogues in combination with citric acid as an absorption enhancer elicited an LH surge of 
similar magnitude than after intramuscular administration of GnRH.  
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SECTION I 
STRATEGIES TO MAXIMIZE REPRODUCTIVE PERFORMANCE OF 
NONPREGNANT PREVIOUSLY INSEMINATED COWS BASED ON OVARIAN 
STATUS AT NONPREGNANCY DIAGNOSIS 
CHAPTER I 
ESTROUS CYCLE IN CATTLE AND SYNCHRONIZATION OF OVULATION IN 
LACTATING DAIRY COWS 
 
1. General Introduction 
 Optimizing reproductive efficiency of dairy cattle is paramount to maximize dairy herd 
profitability (De Vries, 2006; Giordano et al., 2011; Giordano et al., 2012c). Optimizing time to 
pregnancy during lactation maximizes the time cows spend at stages of their lactation at which 
income over feed cost is maximized during their life time. In addition, cows that conceive early 
once eligible to become pregnant are less likely to be removed from the herd (Pinedo et al., 
2010), provide replacement animals to maintain or grow the herd, and require fewer reproductive 
treatments and inseminations. Thus, reproductive success of dairy farms is determined by a 
combination of factors inherent to cow health, nutrition, management, and economic conditions. 
A healthy transition into lactation allows rapid uterine involution and resumption of ovarian 
cyclicity. Thereafter, reproductive success is determined by the rate at which cows are 
inseminated and the success of these inseminations. Therefore, an ideal reproductive 
management program for dairy cattle: (1) minimizes the interval from the end of the voluntary 
waiting period to the first artificial insemination (AI), (2) minimizes the interval between two 
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subsequent inseminations in cows that fail to conceive, and (3) maximizes fertility of all AI 
services (Giordano et al., 2013).  
 In the last decades, a better understanding of the physiological processes governing 
reproductive events in lactating dairy cows led to the development of synchronization of estrus 
and ovulation programs. These programs allowed the dairy industry to dramatically improve 
both insemination and conception risk in dairy herds (Wiltbank and Pursley, 2014). Further, the 
physiological responses to synchronization of ovulation protocols for first AI postpartum have 
been recently optimized leading to major gains in fertility (Moreira et al., 2001; Bello et al., 
2006; Souza et al., 2008). Conversely, optimization of synchronization programs for second and 
greater AI has been more difficult. In part, this is because most resynchronization protocols have 
been developed based on assumptions about the reproductive physiology of non-inseminated 
cattle when in fact, they are used to synchronize ovulation in previously inseminated 
nonpregnant cows. These cows may present different ovarian dynamics than non-inseminated 
cows. For example, it is well known that embryo mortality during the period of embryonic 
development (i.e., up to 42 d after insemination) is prevalent in lactating dairy cows. During this 
period, the embryo produces and secretes factors into the uterine lumen to prevent luteal 
regression and therefore puts a transitory end to cyclicity, which needs to resume after embryo 
demise. In this regard, the effect of embryo mortality on ovarian dynamics and the response to 
resynchronization of ovulation programs is poorly understood. 
 This chapter aims to describe basic principles of estrous cycle physiology in cattle, 
current knowledge about embryo mortality in cattle, and synchronization of ovulation programs 
for lactating dairy cows. 
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2. Estrous cycle in cattle 
2.1. Hormonal regulation 
The estrous cycle is the combination of physiological, histological, and behavioral 
changes that take place from one estrus event to the next. These cyclic changes are controlled by 
finely tuned interactions among the main hormones and factors released by the hypothalamus, 
pituitary gland, ovaries, and uterus (Goodman and Inskeep, 2006). The estrous cycle can be 
divided into four stages: proestrus, estrus, metestrus, and diestrus. The endocrine environment 
during the first two is characterized by high concentration of estradiol (E2) produced by the pre-
ovulatory follicle and low concentration of progesterone (P4), whereas P4 produced by the 
corpus luteum (CL) is the predominant ovarian steroid during metestrus and diestrus.  
Luteinizing hormone (LH) and follicle stimulating hormone (FSH) are critical for the 
regulation of the estrous cycle. These hormones are synthesized and secreted by the gonadotropic 
cells of the pituitary gland in response to gonadotropin releasing hormone (GnRH) produced by 
the hypothalamus (Crowe, 1999). The latter is secreted in pulses and in response to each pulse, a 
pulse of LH is released (Welt et al., 2002). On the other hand, the predominant pattern of FSH 
secretion is not pulsatile but rather basal and mostly regulated by circulating concentrations of 
E2 and inhibin rather than by GnRH pattern of secretion (Padmanabhan et al., 2002). Although 
P4 secretion by the CL in cattle is mostly constitutive, LH may also play a role in normal 
development and function of the CL (Niswender et al., 2000). During the different phases of the 
estrous cycle E2 and P4 modulate GnRH and gonadotropin secretion through a complex 
feedback loop system which involves different neuronal nuclei and neuropeptides.  
During proestrus and estrus, when P4 concentration is low, E2 produced by the dominant 
follicle establishes a positive feedback on LH. As a result, LH secreted in a small amplitude and 
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high frequency pulse pattern. This positive feedback loop concludes with an E2 surge which 
induces estrous behavior and triggers a surge of LH which, in turn, induces ovulation. 
Conversely, due to the elevated circulating concentration of P4 during diestrus, E2 and P4 
combined reduce LH pulsatility which results in high amplitude and low frequency pulses of LH 
(Goodman and Inskeep, 2006). Follicle stimulating hormone secretion is downregulated by E2 
and Inhibin secreted by the dominant follicle. After ovulation or atresia of the dominant follicle, 
E2 and inhibin concentrations decrease due to disappearance of the dominant follicle allowing 
FSH circulating concentration to rise and stimulate the beginning of a new follicular wave within 
24 to 36 hours of ovulation (Goodman and Inskeep, 2006). On the other hand, luteal regression is 
regulated by prostaglandin F2α (PGF2α) secreted by the endometrium and oxytocin secreted by 
the anterior pituitary gland and the CL itself (Mccracken et al., 1999). Luteolysis is discussed in 
detail later in this chapter. 
   
2.2. Follicular dynamics 
Follicular development occurs during the estrous cycle in cattle and is characterized by a 
wave like pattern of growth and regression of follicles (Rajakoski, 1960). The introduction of 
transrectal ultrasonography (TUS) to monitor growth and regression of individual antral follicles 
allowed the validation of the initial hypothesis of a wave-like pattern of growth and regression of 
ovarian follicles (Sirois and Fortune, 1988; Ginther et al., 1996). The number of follicular waves 
per cycle varies with a predominance of two waves per cycle in lactating Holstein cows and 
predominance of three waves per cycle in non-lactating heifers (Sartori et al., 2004). The first 
follicular wave emerges 1 to 2 days after ovulation (Day = 0). In two wave cycles, emergence of 
the second wave occurs around Day 9 or 10. In three wave cycles, the second wave emerges 
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around Day 8 or 9 and the third wave around Day 15 or 16 (Adams et al., 2008). Each wave of 
follicular growth can be divided into three phases: recruitment, selection, and dominance. 
Recruitment is characterized by escape from undergoing atresia of a group of small antral 
follicles (3 to 4 mm) in response to an increase in FSH concentration (Fortune, 1994). After 
emergence, follicles grow at a similar rate for approximately two days until the time of selection, 
which is defined as the time at which the future dominant follicle reaches the maximum 
difference in growth rate with the largest subordinate follicle. At this point, the future dominant 
follicle is approximately 6.5 to 8 mm in diameter (Ginther et al., 1996). The ensuing period of 
dominance is characterized by continuous growth of the dominant follicle at a higher rate than 
subordinate follicles until ovulation or atresia (Ginther et al., 1996). In lactating dairy cows, the 
dominant follicle of a non-ovulatory wave usually grows until it reaches approximately 15 to 17 
mm in diameter. Average size of the ovulatory follicle in lactating cows is 16 to 18 mm (Sartori 
et al., 2004). After ovulation or atresia of the dominant follicle, the circulating concentration of 
E2 decreases dramatically allowing the occurrence of a surge of FSH, and thereby the emergence 
of a new follicular wave (Ginther et al., 1996). 
At approximately the time of deviation in follicle growth, FSH secretion is suppressed by 
E2 and inhibin produced predominantly by the dominant follicle. Because subordinate follicles 
are still FSH dependent, lower circulating levels of FSH result in follicle regression and atresia 
(Aerts and Bols, 2010). In contrast, granulosa cells of the dominant follicle express LH receptors 
allowing continuous growth in a low FSH environment (Ginther et al., 1996). Biochemical 
differences between dominant and subordinate follicles arise as early as the recruitment stage. 
For example, it has been documented that the dominant follicle has lower abundance of IGF-1 
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binding proteins in the follicular fluid, thus greater abundance of free IGF-1 has been proposed 
as the cause of greater growth rate (Fortune et al., 2004).  
During follicular waves in which a dominant follicle develops to pre-ovulatory size in the 
presence of elevated P4 concentrations and increased E2 secretion, the hormonal environment 
prevents the occurrence of an LH surge thereby preventing ovulation. In addition, reduced LH 
pulsatility will lead to atresia of the dominant follicle and emergence of a new follicular wave 
due to lack of inhibition of FSH release (Ireland et al., 2000). Conversely, the positive feedback 
loop on the hypothalamus and pituitary generated by the combination of reduced circulating P4 
and elevated E2 concentrations in circulation after CL regression leads to increasing GnRH and 
LH pulsatility, which will ultimately cause a surge of LH triggering ovulation and the formation 
of a new CL (Jeong and Kaiser, 2006). 
 
2.3. Corpus luteum formation, growth, and regression   
 The CL is a transitory gland formed from granulosa and theca cells of the ovulatory 
follicle. The main function of this gland is to secrete P4. After ovulation, cells from the theca and 
granulosa of the ovulatory follicle reorganize to form the CL which reaches it maximum volume 
approximately 10 to 14 days after ovulation (Sartori et al., 2004). Progesterone concentration 
increases gradually after ovulation reaching 1 ng/mL approximately three to four days after 
ovulation and maximum levels (~7 ng/mL in heifers and 5 ng/mL in lactating dairy cows) around 
12 to 14 days after ovulation (Sartori et al., 2004). 
 In the absence of pregnancy luteal regression is usually triggered ~16 to 19 days after the 
previous ovulation. The mechanism of luteolysis is governed by finely tuned interactions among 
the pituitary gland, ovaries, and uterus which will ultimately derive in endometrial (luminal and 
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glandular epithelium) secretion of the luteolysin PGF2α (Mccracken et al., 1999). Prostaglandin 
F2α secretion in the endometrium is stimulated by oxytocin [OT; (Roberts et al., 1976)] which is 
secreted in a pulsatile manner by the neurohypophysis, and by the CL in response to PGF2α. 
Whether PGF2α secretion is triggered by OT coming from the neurohypophysis or from the CL 
is still a matter of controversy. Regardless, once OT stimulates PGF2α secretion in the 
endometrium, each pulse of PGF2α is usually followed by an OT pulse from the CL establishing 
a positive feedback loop (Flint et al., 1990). Four to six pulses of PGF2α within 24 hours are 
necessary to effectively induce complete CL regression. Progesterone concentration drops below 
1 ng/mL within 24 to 48 hours after the onset of luteolysis (Ginther et al., 2009). It has been 
hypothesized that the pulsatile secretion pattern of PGF2α is required because prolonged 
exposure to elevated concentrations of PGF2α desensitizes luteal cells to PGF2α making them 
refractory to the luteolytic signal (Skarzynski and Okuda, 1999).  
Almost 99% of the PGF2α that reaches the systemic circulation is metabolized during 
first passage through the lungs (Davis et al., 1980). Thus, to overcome the limitation of PGF2α 
reaching the ovary through the systemic circulation, ruminants developed a specialized counter 
current transport mechanism of PGF2α from the uterine vein to the ovarian artery through the 
utero-ovarian plexus (Lee et al., 2010). This mechanism is mediated by a transmembrane 
transporter located in the three layers (tunica intima, tunica media, and tunica adventitia) of the 
uterine vein and ovarian artery which allows PGF2α to reach the ovary by diffusion from the 
uterine vein into the ovarian artery (Lee et al., 2010).  
The process of luteal regression can be divided into functional luteolysis (cessation of P4 
synthesis and secretion), and structural luteolysis [loss of cells that form the CL structure; 
(Niswender et al., 2000)]. The immediate decrease in circulating P4 concentration after exposure 
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to pulses of PGF2α has been attributed to a reduction in luteal blood flow, mainly in response to 
an increase in the levels of the potent vasoconstrictor endothelin-1 (Niswender et al., 2000). 
Further, during luteolysis P4 secretion is reduced due to downregulation of steroidogenic acute 
regulatory protein [StAR; (Tsai et al., 2001)]. Downregulation of StAR limits cholesterol 
transport to the inner mitochondrial membrane, which is the first rate limiting step in steroid 
hormone synthesis (Stocco and Clark, 1996). On the other hand, structural regression is mediated 
through apoptosis and immune infiltration (Brännström and Norman, 1993).  
The CL contributes to the regulation of its own lifespan because P4 produced by the CL 
regulates endometrial expression of the P4 receptor (PR), E2 receptor (ER), and oxytocin 
receptor (OXTR). After ovulation and CL formation, exposure to P4 progressively 
downregulates OXTR and ER, in the endometrium (Mccracken et al., 1999). Thus, during the 
first 5 to 7 days after ovulation ER (Kimmins and Maclaren, 2001; Robinson et al., 2001) and 
OXTR (Wathes and Hamon, 1993; Mann and Lamming, 1994; Robinson et al., 2001) are 
downregulated in the endometrial luminal epithelium and superficial glandular epithelium, 
preventing the pulsatile secretion of PGF2α. After 15 to 18 days of exposure to P4, the 
endometrium becomes refractory to P4 through downregulation of PR (Boos et al., 1996; 
Kimmins and Maclaren, 2001; Robinson et al., 2001). As a result, OXTR is upregulated in the 
endometrium (Wathes and Hamon, 1993; Mann and Lamming, 1994; Robinson et al., 2001) 
facilitating the luteolytic mechanism. Further, upregulation of OXTR mediated by E2 has been 
demonstrated in sheep (Wathes and Lamming, 1994). In cattle, E2 appears to have a positive 
effect on OXTR expression; however, it remains to be determined if E2 stimulation is necessary 
for OXTR upregulation (Leung and Wathes, 2000).  
 
  
9 
 
3. Maternal recognition of pregnancy 
 If conception takes place, the luteolytic process must be abrogated to maintain pregnancy. 
In this regard, the process by which the embryo signals the cow to prevent luteolysis is known as 
maternal recognition of pregnancy (MRP). In cattle, the embryo reaches the uterus by 
approximately Day 4 to 6 after ovulation and hatches from the zona pellucida by Day 9 to 10. 
Thereafter the conceptus begins to elongate growing from ~2 mm on Day 12 to approximately 
20 cm by Day 19 (Hue et al., 2007). Beginning approximately on Day 12 to 14 after ovulation, 
mononuclear cells of the trophoblast portion of the elongating conceptus start to produce and 
secrete substantial amounts of interferon-τ [IFNT; (Farin et al., 1990)]. Interferon-τ is a type I 
interferon, homologous to IFN-α and IFN-ß with secretion limited to the placenta of ungulates 
(Roberts et al., 2008). Interferon-τ is believed to be the first signal to abrogate luteolysis and 
maintain pregnancy acting in a paracrine manner on the endometrium of the gravid uterine horn 
(Lamming et al., 1995). The ability of IFNT to prevent luteolysis has been demonstrated in 
several studies where intrauterine administration of IFNT extended luteal lifespan in cattle 
(Knickerbocker et al., 1986; Meyer et al., 1995) and sheep (Godkin et al., 1984; Ott et al., 1993). 
The proposed mechanism by which IFNT seems to mediate maternal recognition of 
pregnancy is through down regulation of OXTR expression in the luminal and glandular 
epithelium of the endometrium. In sheep, it has been shown that IFNT exerts its effect on OXTR 
expression through downregulation of the ER (Spencer et al., 1995; Bazer et al., 1997). 
Conversely, there is controversial data regarding the role of E2 and ER in the regulation of the 
luteolytic mechanism in cattle. Some experiments have shown that ER remains unchanged 
during early pregnancy and therefore may not have a role in the down regulation of OXTR 
(Robinson et al., 1999), whereas others have shown downregulation of the ER on Days 16 and 
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18 of pregnancy (Robinson et al., 2001). More recently, Araujo et al. (2009) showed that 
maintaining low concentration of circulating E2 through follicular ablation delayed the onset of 
luteolysis in heifers, suggesting that E2 plays a role in luteolysis in cattle. Nonetheless, luteolysis 
could not be prevented through prolonged ablation either because E2 concentration was not 
reduced sufficiently or because E2 is not completely necessary in the luteolytic cascade. 
By the time the endometrium desensitizes to P4 due to loss of PR, IFNT acting through a 
paracrine manner prevents the expression of OXTR and as a consequence pulsatile release of 
PGF2α thus, preventing the luteolytic cascade. The exact duration of the period of substantial 
IFNT secretion in cattle has not been clearly determined. Whereas it has been documented that 
substantial IFNT secretion begins around Day 16 of pregnancy (Mann and Lamming, 2001; 
Robinson et al., 2006), there is limited research regarding the end of IFNT secretion. Godkin et 
al. (1988) and Geisert et al. (1988) suggested that IFNT secretion can continue for as long as Day 
30 of pregnancy, however, assays used in these experiments could not discriminate between 
IFNT and other similar conceptus secreted proteins. Most experiments documented greatest 
IFNT secretion from 16 to 19 d after conception (Robinson et al., 2006; Forde et al., 2014). 
Although there is evidence that IFNT reaches the systemic circulation (Han et al., 2006; Gifford 
et al., 2007; Green et al., 2010), a limitation to study the pattern of IFNT secretion dynamics in 
vivo is that circulating concentrations are very low which has limited assay sensitivity. To the 
best of my knowledge there is not an accurate method to measure circulating concentration of 
IFNT at the moment.  
In summary, most research studies have shown greatest secretion of IFNT from ~14 to 19 
days after conception. To the best of my knowledge there is not conclusive data regarding the 
duration of IFNT secretion and the extent of exposure to IFNT required to prevent luteolysis or 
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aid in pregnancy maintenance. In addition, the exact process or molecules involved in preventing 
luteal regression after the initial period of CL maintenance through effects mediated by IFNT 
remains unknown. 
 
4. Embryonic mortality in lactating dairy cows 
 4.1. Fertilization rates in lactating dairy cows 
 Pregnancy wastage due to embryo mortality in dairy cattle has been recognized as a 
major cause of economic losses (De Vries, 2006; Diskin and Morris, 2008) and has been subject 
of study for more than 40 years (Ayalon, 1978). Embryo mortality refers to death of the embryo 
between fertilization and the completion of organogenesis, which occurs approximately 42 days 
after conception in cattle (Hubbert, 1972). Traditionally, early embryonic mortality referred to 
those occurring before the initiation of maternal recognition of pregnancy (~ Days 14 to 19 after 
AI), whereas late embryonic mortality referred to those occurring between the time of MRP and 
Day 42 of pregnancy (Humblot, 2001; Whitlock and Maxwell, 2008). Recent experiments have 
shown that fertilization rates in lactating dairy cows range from 55 to 85% depending on 
lactation status and season of insemination (Sartori et al., 2002; Cerri et al., 2009a; Cerri et al., 
2009b). Therefore, when contrasted to the ~ 30 to 50% conception risk that is usually expected at 
the time of nonpregnancy diagnosis (NPD) 30 to 60 days after AI (Ferguson and Skidmore, 
2013; Wiltbank and Pursley, 2014; Borchardt et al., 2017), it can be assumed that a substantial 
number of pregnancies are lost from the time of AI to NPD. Estimates of embryo loss from 
fertilization to Day 7, determined through the percentage of nonviable embryos recovered after 
uterine flushing, have ranged from 11 to 21 percentage points (Cerri et al., 2009a; Cerri et al., 
2009b). Embryo losses before MRP have been attributed to deleterious genes, chromosome 
  
12 
 
aberrations, and poor oocyte quality (Hansen, 2002). Because these losses occur before, or right 
after the embryo enters the uterus, they are not expected to have any effect on the subsequent 
estrous cycle, and there is no known diagnostic method to detect these losses other than embryo 
recovery through uterine lavage. 
 
 4.2. Detection of embryo mortality and impact on the estrous cycle 
 It is commonly accepted that embryo demise around the period of MRP (14 to 19 days 
after AI) in cattle delays luteal regression (Humblot, 2001; Santos et al., 2004), thus, altering the 
normal pattern of return to estrus and ovulation which can be detrimental to estrus detection 
efficiency and the response of cows to resynchronization of ovulation protocols for timed AI 
(TAI). The greatest limitation to determine the effect of embryo loss on the estrous cycle has 
been lack of reliable methods to accurately estimate embryo mortality before 26 to 28 days after 
AI when the presence of an embryo can be detected by TUS (Pieterse et al., 1990; Filteau and 
Descôteaux, 1998). A caveat of the research that studied the effect of embryo mortality on 
ovarian function is that most studies estimated the occurrence of embryo mortality based on the 
inter-estrus intervals or P4 concentration dynamics. For example, Humblot (2001) suggested that 
cows undergoing embryo mortality before Day 16 would not have their estrous cycle extended, 
whereas cows undergoing embryo loss after Day 16 would have extended luteal phases (>24 
days). The use of P4 concentration or delayed return to estrus as sole indicators of embryo 
mortality overestimates embryo losses because extended luteal phases can be a consequence of 
other phenomena such as variability among individuals or uterine infections. Also, return to 
estrus is not reliable because of limitations with estrus detection and the potential occurrence of 
ovulation without estrus expression (Valenza et al., 2012; Stevenson et al., 2014).  
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 Alternative methods to provide an indication of the presence and subsequent demise of an 
embryo may be more accurate to determine embryo losses. In this regard, pregnancy associated 
glycoproteins (PAG) are a family of glycoproteins produced by the binucleate cells of the 
placenta (Butler et al., 1982; Xie et al., 1997; Klisch et al., 2006). These glycoproteins are 
produced and stored in granules within binucleate cells of the placenta, and released into the 
dam’s blood stream after binucleate cells migrate and fuse with epithelial cells of the 
endometrium (Wooding, 1982). Currently, there is evidence of at least 22 members of this family 
of glycoproteins which are differentially expressed during gestation (Xie et al., 1991; Green et 
al., 2000; Patel et al., 2004). Although some of the available laboratory assays to detect PAG can 
identify specific members of the family (Zoli et al., 1992), other laboratory tests do not target a 
specific molecule, but rather recognize a group of them referred to as pregnancy specific protein 
B [PSPB; (Sasser et al., 1988)]. The fact that PAG are exclusively produced by the placenta 
makes them an accurate marker of pregnancy in cattle. In this regard, experiments conducted to 
validate the use of PAG as a method of pregnancy diagnosis showed high level of agreement 
between PAG concentrations and TUS to detect the presence of an embryo 27 to 35 days after AI 
(Szenci et al., 1998; Silva et al., 2007; Romano and Larson, 2010). Although PAG testing has 
been adopted as method for pregnancy testing in cattle, the methodology has some limitations. 
For example, the long half-life of PAG, which extends for as long as 70 days (Zoli et al., 1992; 
Kiracofe et al., 1993; Mialon et al., 1993) after calving and up to 10 d after embryo mortality 
during the first trimester of pregnancy (Szenci et al., 2000; Giordano et al., 2012b), can generate 
false pregnancy outcomes in the early postpartum period or in cows that undergo pregnancy loss.   
The greatest limitation to the use PAG for determination of embryonic mortality around 
the early stages of the period of maternal recognition of pregnancy is the timing at which PAG 
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can be reliably detected in circulation with current laboratory assays. Although in some cows 
PAG can be detected as early as Day 15 of gestation (Sasser et al., 1986; Green et al., 2005), in 
most pregnant cows PAG cannot be detected until Day 25 (Whitlock and Maxwell, 2008).  
Several studies have reported PAG dynamics after spontaneous (Mialon et al., 1993; Szenci et 
al., 2000), and induced embryo mortality (Szenci et al., 2003; Giordano et al., 2012b), or used 
circulating PAG concentrations as a marker of late embryonic mortality (Humblot, 2001). 
Nevertheless, none of these experiments attempted to determine embryo loss around the early 
stages of the period of MRP. Mialon et al. (1993) measured serum concentrations of PAG in beef 
cows, beef heifers, and dairy cows at ~28, 35, 50 and 90 days after AI. Outcomes based on PAG 
were compared with NPD through TUS performed 50 days after AI and transrectal palpation 
performed 90 days after AI as reference test. In this experiment, they observed different PAG 
concentrations patterns among cows with late embryo loss. For example, a group of heifers had 
PAG concentrations indicative of the presence of an embryo on Day 28 but not on Day 35 
(4/123). On the other hand, another group of heifers did not have elevated PAG concentrations 
on Day 28, but did on Day 35 (3/123). Moreover, among cows diagnosed nonpregnant 50 days 
after AI, a group of cows presented a slight increase (6/210) and another had declining PAG 
concentrations from Day 28 to Day 35 (15/210). Szenci et al., (2000) measured PAG and P4 
concentrations on Day 21 after AI, every other day from 26 or 27 to 44 or 45, and on Day 53 or 
58 in 11 cows that were diagnosed as undergoing embryo mortality using TUS. Data from this 
experiment showed great variation regarding time of luteal regression and disappearance of PAG 
in blood with regard to time of embryo death. Interestingly, in one group of cows the decline in 
PAG concentrations preceded embryo death, whereas in other the opposite was observed. Thus, 
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data from Szenci et al. (2000) suggested that PAG concentrations dynamics is not a reliable tool 
to diagnose timing of embryonic death.  
Collectively, most data support the notion that circulating PAG concentration is a 
valuable marker of embryonic loss after PAG become detectable in circulation which, in most 
cows is not until after the final stages of the period of MRP. On the other hand, return to estrus 
and P4 concentration have been commonly used to estimate embryo mortality around the period 
of MRP. Nevertheless, these methods are not accurate because they are not pregnancy specific 
and are affected by additional physiological factors.  
More recently, it has been demonstrated that a group of genes (interferon stimulated 
genes, ISG) are upregulated in peripheral white blood cells and other tissues in response to IFNT 
secreted by the embryo during the period of maternal recognition of pregnancy (Han et al., 2006; 
Gifford et al., 2007; Green et al., 2010). Gifford et al. (2007) performed an experiment designed 
to test the feasibility of identifying nonpregnant cows as early as Day 18 after AI based on 
mRNA expression of ISG in peripheral blood white cells. Lactating dairy cows (n = 50) received 
TAI and blood samples were collected at 0, 16, 18, and 20 days after AI. Transrectal 
ultrasonography on Day 40 to 45 was used as reference test. White blood cells were harvested 
and ISG mRNA expression was determined using RT-qPCR. Results from this experiment 
showed differential fold change in mRNA expression between pregnant and nonpregnant cows 
for certain ISG starting on Day 16 (myxovirus resistance protein 2, MX2) or 18 (interferon 
stimulated gene 15, ISG15) until Day 20 after AI.  
Similar results were observed by Green et al. (2010) in three experiments performed to 
test different approaches for early NPD using ISG expression in dairy cows and heifers. In the 
first experiment, cows (n = 20) received TAI and white blood cells were obtained at 14, 16, 18, 
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and 20 days after AI to measure ISG expression. Nonpregnancy diagnosis was performed 
through TUS on Day 30 as reference test. Pregnant cows (n = 5) had greater ISG15 and MX2 
mRNA expression (expressed as ratio to housekeeping gene) on Days 18 and 20 after AI. In the 
second experiment, mRNA was isolated from peripheral white blood cells on Day 17 (n = 32) or 
18 (n = 42) after AI and NPD was performed on Day 32 by TUS. On Day 17, 2'-5'-
oligoadenylate synthetase 1 (Oas1) mRNA expression (expressed as the ratio to housekeeping 
gene) was greater in pregnant than nonpregnant cows, whereas both Oas1 and MX2 were 
differentially expressed on Day 18. In addition, on Day 18 authors observed a pregnancy by 
parity interaction whereby pregnant multiparous cows had lower ISG expression levels than 
pregnant primiparous cows. In a third experiment, white blood cells were collected from 
lactating dairy cows (n = 54) and heifers (n = 24) during the luteal phase of the cycle preceding 
AI, and 18 days after AI to determine ISG mRNA expression as the ratio of the second sample to 
the first. For parous cows, there was no pregnancy or parity effect on Oas1 or MX2 mRNA 
expression, and there was a tendency for a pregnancy by parity interaction effect for the MX2 
ratio. On the other hand, ratios of Oas1 and MX2 were greater for pregnant than nonpregnant 
heifers. In these experiments, the authors also intended to establish a cut off value of ISG mRNA 
expression for NPD using ROC curves but they did not find a suitable value with acceptable 
sensitivity and specificity. Collectively, results from Gifford et al. (2007) and Green et al (2010) 
provide evidence that differential ISG mRNA expression in peripheral white blood cells between 
pregnant and nonpregnant cows may be used for early detection of the presence of an embryo. 
Matsuyama et al. (2012) generated more evidence for ISG expression in response to 
IFNT in two experiments designed to evaluate the effect of different doses of intrauterine 
administration of IFNT on ISG mRNA expression in peripheral white blood cells. Moreover, 
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differences in ISG mRNA expression between non-lactating Japanese black cows that received 
AI, embryo transfer, or cyclic controls were explored. In the first experiment, at 16 or 17 days 
after estrus cows received intrauterine treatments of 0, 500 or 1,000 µg of recombinant IFNT. 
There was a treatment by time interaction on mRNA expression for ISG15 and MX2 in 
peripheral white blood cells whereby the greater doses of IFNT induced an increase in mRNA 
expression of greater magnitude and duration than the smallest dose. Interestingly, the 
correlation between dose of IFNT and mRNA expression was high (ISG15: r = 0.88, MX2: r = 
0.83) suggesting that greater amount of IFNT released by embryos may be associated with 
greater mRNA expression of ISG in peripheral white blood cells. For the second experiment, 
blood samples were collected on Days 7, 16, 18, 21, and 25 after detected estrus (cyclic control 
cows; Day = 0), AI, or embryo transfer (ET; Day = 7). Pregnancy diagnosis through TUS 30 to 
50 days after estrus was used as reference test. Cows were classified as pregnant (AI = 13 and 
ET = 16), nonpregnant with extended inter-estrus intervals (≥25 days; AI = 9 and ET = 11), 
nonpregnant with normal inter-estrus intervals (<25 days; AI = 19 and ET = 17), and cyclic 
controls (n = 15). Pregnant cows had greater ISG15 mRNA expression than nonpregnant cows 
and cycling controls 18, 21, and 25 days after estrus. Interestingly, although non-statistically 
significant, ET cows with extended inter-estrus intervals had intermediate ISG15 mRNA 
expression from 18 to 25 days after estrus suggesting that these cows had an embryo present 
around the time of MRP but the embryo did not survive until the time of pregnancy testing. 
Thus, it is possible to speculate that intermediate mRNA expression of ISG15 might have been 
the result of lower IFNT production by a less viable embryo.  
Collectively, results from these experiments provide evidence that differences in ISG 
mRNA expression in peripheral white blood cells between pregnant and nonpregnant cows may 
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be used for early detection of the presence of an embryo. Despite this, in these studies cows were 
retrospectively classified after NPD and none of the studies attempted to truly predict the 
presence of an embryo around the period of MRP.  
Current data regarding embryo mortality around the period of maternal recognition of 
pregnancy and its impact on the ovarian dynamics is not consistent because most research used 
P4 concentration and delayed return to estrus as the diagnostic method. On the other hand, use of 
PAG and TUS as diagnostic methods provided evidence that embryo loss after Day 25 results in 
delayed luteal regression. The availability of new early pregnancy diagnostic methods such as 
ISG mRNA expression provide new tools to elucidate the real impact of embryo mortality before 
Day 25 on the estrous cycle.  
 
5. Synchronization of ovulation in cattle  
Synchronization of ovulation for TAI is one of the most widely applied biotechnologies 
in cattle production around the world (Lamb et al., 2010; Wiltbank and Pursley, 2014). Poor 
estrus detection efficiency due to physiological limitations of high producing dairy cows 
(Sangsritavong et al., 2002) or because of limited access to qualified labor and facilities make 
synchronization of ovulation a valuable tool to ensure timely insemination of cows. Moreover, 
some newly developed protocols may increase fertility to AI services as compared to 
insemination at detected estrus (Borchardt et al., 2016). The aim of synchronization of ovulation 
protocols is to manipulate follicular and luteal dynamics to facilitate the development of a 
dominant follicle in an ideal physiological environment and synchronize ovulation within a 
narrow time frame so that females can be inseminated at a predetermined time without the need 
for estrus detection.  
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The first synchronization of ovulation protocol reported in the literature (Pursley et al., 
1995) consisted of a sequence of GnRH and PGF2α treatments (GnRH-7 days-PGF2α-2 days-
GnRH). The first GnRH treatment given at random stages of the estrous cycle was aimed at 
inducing ovulation and the formation of a new CL. Also, the emergence of a new follicular wave 
is expected to happen 1.5 to 2 days after GnRH treatment (Pursley et al., 1995). Seven days after 
the first GnRH, cows are expected to have a dominant follicle and a mature CL (≥6 days old) 
that can undergo luteolysis in response to a single PGF2α treatment. After luteolysis, the 
dominant follicle is expected to continue growing so that 48 hours after the PGF2α treatment the 
GnRH-induced LH surge after the second GnRH treatment of the protocol induces ovulation 
within 24 to 32 hours in most cows (Pursley et al., 1995; Rantala et al., 2009; Giordano et al., 
2012a). Thus, manipulating timing of ovulation allowed insemination of all cows at a fixed time 
without the need of performing estrus detection and attain similar fertility than that of cows 
inseminated upon estrus detection (Pursley et al., 1997). Following the development of the 
Ovsynch protocol, an overwhelming amount of research has been dedicated to develop and 
validate new synchronization protocols to maximize fertility through optimization of follicular 
development and the endocrine environment before and after insemination. 
 
5.1. Synchronization of ovulation protocols for first AI postpartum 
To maximize reproductive efficiency of dairy herds, cows need to be rapidly detected in 
estrus and inseminated after the end of the voluntary waiting period. In this regard, the adoption 
of synchronization of ovulation protocols ensures that cows are rapidly inseminated after the end 
of the voluntary waiting period without relying exclusively on estrus detection. 
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The main limitation of using the Ovsynch protocol alone to synchronize ovulation in 
dairy cows is that a considerable proportion of cows will not ovulate to the first GnRH treatment 
if the protocol is started at random stages of the estrous cycle (Pursley et al., 1995; Vasconcelos 
et al., 1999; Bello et al., 2006). This can happen because of: (1) absence of a follicle of sufficient 
size and maturity to respond to an LH surge, (2) presence of an already atretic dominant follicle, 
or (3) the occurrence of an LH surge of insufficient magnitude to cause ovulation. If cows fail to 
ovulate and a new follicular wave does not emerge ~1.5 to 2 days later, the dominant follicle 
present at the time of the first GnRH treatment may either ovulate spontaneously (in cows that do 
not have an active CL) or become atretic before the time of PGF2α treatment. In the first 
scenario, the newly formed CL will not be responsive to PGF2α at the time of treatment, and in 
both cases there will probably not be a dominant follicle capable of ovulating at the time of 
second GnRH treatment. Moreover, in some cows the follicular wave giving rise to the ovulatory 
follicle may emerge shortly before the first GnRH treatment. In consequence, these cows would 
ovulate an “old” follicle. This phenomenon has been associated with lower fertility probably due 
to reduced oocyte quality (Revah and Butler, 1996) which leads to reduced embryo quality (Cerri 
et al., 2009b).  Further, cows that ovulate to the first GnRH treatment of Ovsynch-like protocols 
have greater fertility than cows that do not (Chebel et al., 2003; Galvão et al., 2007; Bisinotto et 
al., 2010), probably because of better synchronization of the follicular wave. In this regard, there 
is evidence that initiating the Ovsynch protocol on Days 5 to 9 of the estrous cycle maximizes 
the number of cows that have their follicular wave synchronized (Vasconcelos et al., 1999; Bello 
et al., 2006). Therefore, with the objective of maximizing the proportion of cows that are at an 
optimal stage of the estrous cycle at the time of the first GnRH treatment, presynchronization 
treatments have been developed. 
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 The Presynch-Ovsynch protocol was the first presynchronization treatment described in 
the literature (Moreira et al., 2001). It consisted of two PGF2α treatments 14 days apart, and the 
first GnRH treatment of Ovsynch given 12 days after the second PGF2α. The reasoning behind 
this treatment is that cows bearing a mature CL at the time of first PGF2α treatment would show 
estrus within a seven day period, hence at the time of the second PGF2α treatment they would be 
expected to have a seven day old or older CL which could respond to the second PGF2α 
treatment. Because cows that fail to respond to the first treatment would be probably in metestrus 
or proestrus, they would be expected to be in diestrus at the time of the second PGF2α treatment. 
Thus, most cows would be expected to have a mature CL at the time of second PGF2α treatment, 
and thereby would be expected to undergo luteolysis, display estrus, and ovulate within three to 
seven days after treatment. Because of synchronized estrus and ovulation after the Presynch 
portion of the protocol, most cows would be on Days 5 to 9 of the estrous cycle at the time of 
first GnRH of Ovsynch which increases the response to the GnRH treatment and the rest of the 
protocol. The improvement in synchrony of ovulation for cows that received the 
presynchronization protocol resulted in greater pregnancy per AI (P/AI; 48.5%) than for cows 
that only received the Ovsynch protocol [36.6%, (Moreira et al., 2001)].  
Bello et al. (2006) tested a protocol that included PGF2α and GnRH to presynchronize 
cows for first service postpartum. The Ovsynch protocol without presynchronization was 
compared with a presynchronization treatment that consisted of a PGF2α treatment followed by 
GnRH two days later. The Ovsynch protocol was initiated either four (G4G), five (G5G) or six 
(G6G) days after the GnRH for presynchronization. Initiating Ovsynch 6 d after the 
presynchronization treatment maximized the proportion of cows that ovulated in response to the 
first GnRH of Ovsynch (Ovsynch = 54%, G4G = 56%, G5G = 67%, and G6G = 85%), optimized 
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the response to the PGF2α of Ovsynch (Ovsynch = 69%, G4G = 92%, G5G = 92%, and G6G = 
96%), and resulted in the greatest synchronization rate (Ovsynch = 69%, G4G = 80%, G5G = 
75%, and G6G = 92%). This improved response to the G6G protocol translated into greater P/AI 
than for presynchronized and not presynchronized cows (Ovsynch = 27%, G4G = 24%, G5G = 
39%, and G6G = 50%), thereby it was concluded that G6G could be used to improve the fertility 
of first AI service in lactating dairy cows. 
More recently, Souza et al. (2008) developed the Double-Ovsynch protocol which 
consists of two Ovsynch protocols seven days apart. The first Ovsynch, usually referred to as 
Pre-Ovsynch, not only sets most cows to Day 7 of the estrous cycle at the time of first GnRH of 
Ovsynch but also induces ovulation in most anovular cows (Souza et al., 2008; Herlihy et al., 
2012; Ayres et al., 2013). This is an advantage compared with PGF2α-based protocols such as 
Presynch-Ovsynch because in the latter, anovular cows usually do not respond to the 
presynchronization protocol. In fact, the proportion of cows with P4 concentration indicative of a 
functional CL at the time of first GnRH of Ovsynch was greater for cows that received the 
Double-Ovsynch (90.6%) than the Presynch-Ovsynch protocol [66.6% (Souza et al., 2008)]. 
Further, Double-Ovsynch also increased the proportion of cows with high P4 (≥ 3 ng/mL) at the 
time of PGF2α treatment of Ovsynch. Increased synchrony of ovulation and improved endocrine 
environment before TAI translated into 8 percentage points greater P/AI in cows treated with 
Double-Ovsynch than the Presynch-Ovsynch protocol (Souza et al., 2008). 
These synchronization protocols designed to increase P/AI to first service have been 
widely adopted by the dairy industry in the U.S. (Caraviello et al., 2006; Ferguson and Skidmore, 
2013; Scott, 2016). In combination with improvements in cow genetics and herd management 
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adoption of fertility programs allows high producing dairy herds to achieve first service P/AI of 
up to ~50% (Giordano et al., 2012e; Herlihy et al., 2012; Borchardt et al., 2017).  
 
5.2. Management strategies for second and greater AI services. 
 Even though the combination of synchronization programs for first service and overall 
improvements in herd management allow well-managed farms to achieve P/AI in the range of 40 
to 55% (Souza et al., 2008; Borchardt et al., 2016; Borchardt et al., 2017), there is a substantial 
proportion of nonpregnant cows that needs rapid re-insemination. In this regard, a common 
reproductive management strategy for second and greater AI services consists of the combination 
of insemination after estrus detection and a resynchronization of ovulation protocol for TAI for 
cows not re-inseminated at detected estrus. The most commonly used protocol for 
resynchronization of ovulation and TAI is Ovsynch (Caraviello et al., 2006; Scott, 2016) which, 
when used for resynchronization, is commonly referred to as Resynch.  
The main objective of resynchronizing cows is to minimize time to pregnancy after the 
end of the voluntary waiting period, hence maximizing reproductive efficiency and herd 
profitability (Giordano et al., 2013). Time to pregnancy is determined by the insemination and 
conception risk which can be increased by reducing the interbreeding interval and maximizing 
P/AI, respectively. A potential strategy for minimizing the interbreeding interval is to initiate 
Resynch protocols as early as possible after a previous AI. The possibility of treating pregnant 
cows with GnRH allows to initiate resynchronization of ovulation protocols before NPD, and the 
use of TUS allows to perform NPD as early as 26 days after AI (Pieterse et al., 1990; Filteau and 
Descôteaux, 1998). Therefore, Resynch protocols can be initiated as early as 19 days after AI 
(Fricke et al., 2003). Despite this, other factors such as: (1) the expected physiological response 
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to treatments, (2) impact on estrus detection, and (3) the feasibility of performing an accurate 
NPD must be taken into account when deciding the timing of initiation of a resynchronization 
protocol.  
Fricke et al. (2003) evaluated the impact of initiating resynchronization of ovulation at 
three different intervals after AI on conception risk in lactating dairy cows. Cows were initiated 
in the Cosynch protocol (GnRH-7 d-PGF2α-2 d-GnRH + TAI) 19 (D19), 26 (D26), or 33 (D33) 
days after AI. Pregnancy per AI was greater for cows in the D26 and D33 treatments (34 and 
38% respectively) than for the D19 treatment (23%). Therefore, although the D19 treatment 
minimized the interbreeding interval and increased insemination risk, it did not maximize 
conception risk. It was suggested that the greater proportion of cows expected to be in proestrus 
at the time of the first GnRH treatment in the D19 treatment, may have resulted in an inferior 
ovulatory response and synchronization rate, which in turn, resulted in lower fertility. 
Furthermore, authors observed greater pregnancy loss when NPD was performed 26 days after 
AI (D19 and D26 treatments) than 33 days after AI (D33 treatment). Thus, although the D19 and 
D26 treatments maximized insemination risk, the reduction in fertility and increased pregnancy 
losses may offset the beneficial impact of shorter interbreeding interval on pregnancy rate. Lopes 
et al. (2013) performed another experiment to compare P/AI after initiating resynch 32 ± 3 (R32) 
and 39 ± 3 (R39) days after AI. No difference in P/AI was observed among treatments (R32 = 
33.6% and R39 = 34.3%). In summary, resynchronization of ovulation protocols initiated at 26, 
32, and 39 days after AI result in similar conception risks. 
An important limitation to the experiments described above is that the impact of initiating 
resynch before NPD on estrus expression was not evaluated. Maximizing the proportion of cows 
re-inseminated upon estrus detection reduces the interbreeding interval and treatment costs. In 
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this regard, the proportion of cows re-inseminated at detected estrus before NPD was evaluated 
after initiating Resynch 21 and 28 days after AI (Chebel et al., 2003) or 24 and 31 days after AI 
(Bruno et al., 2014). In both experiments, there was no effect of the day of initiation of Resynch 
on P/AI, however, the proportion of cows re-inseminated upon estrus detection was reduced by 
the early GnRH treatment. Limited estrus expression after GnRH treatment can be attributed to 
the suppression of E2 production by granulosa cells of the dominant follicle in response to the 
GnRH-induced LH surge (Berndtson et al., 1995; Komar et al., 2001; Jo and Fortune, 2003). 
Thus, treatment of cows with GnRH around the time when most cows are expected to express 
estrous behavior after a previous insemination increases the number of cows submitted to TAI, 
increases reproductive treatment costs, and extends the interbreeding interval.  
Presynchronization protocols for first service TAI increase conception risk by 
maximizing the proportion of cows that are at an ideal stage of the estrous cycle at the time of 
the first GnRH of Ovsynch. Likewise, extensive research has been done to improve conception 
risk after resynchronization of ovulation protocols using different presynchronization strategies. 
Giordano et al. (2012d) performed two experiments to evaluate different approaches for 
presynchronization before Resynch. In the first experiment, they compared the Day-25 Resynch 
protocol (D25; Ovsynch initiated 25 days after AI) without presynchronization, the D25 protocol 
with a human chorionic gonadotropin (hCG) treatment on Day 18 after AI (HGPG), and the 
Double-Ovsynch (DO) protocol initiated 22 days after AI. Nonpregnancy diagnosis was 
performed 32 days after AI. Pregnancy per AI 53 days after AI was greater for the HGPG 
(33.4%) and DO (32.5%) groups than for the D25 group (25.4%). This first experiment provided 
evidence that improving synchrony of ovulation and the endocrine environment (mainly P4 
concentration) at the time of the first GnRH of Resynch has a positive impact on fertility.  
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Taken together, most of the available evidence shows that the time of initiation of 
resynchronization of ovulation protocols does not have a substantial impact on conception risk 
after TAI and that using a presynchronization strategy may increase conception risk after TAI. 
Despite this, these experiments were focused on the effect of treatments on P/AI without 
assessing the impact on time to pregnancy, which is the final driver of reproductive efficiency. 
Moreover, protocols initiated prior to NPD negatively affected estrus expression, which in turn 
can negatively affect insemination risk. Further, part of the improvement on P/AI obtained with 
presynchronization protocols for resynchronization of ovulation may be due to forcing cows with 
high fertility to be inseminated at TAI because of estrus suppression. Considering that many 
dairy farms are adopting new technologies to assist with detection of estrus or may have an 
interest in increasing the proportion of cows submitted for AI after a detected estrus, it is 
paramount to develop resynchronization of ovulation protocols that do not interfere with estrus 
expression after a previous insemination while minimizing the interbreeding interval and the 
number of unnecessary treatments. 
 
5.3. Role of progesterone at the time of initiating synchronization of ovulation 
protocols and during follicular development. 
Cows not bearing a CL or with low circulating P4 concentration (< 1 ng/mL) at the time 
of the first GnRH of Ovsynch have reduced conception risk compared with cows with a CL and 
high P4 concentration (Sterry et al., 2006; Herlihy et al., 2012; Bisinotto et al., 2015a). Ovulatory 
response to the GnRH treatment, which is needed for initiation of a new follicular wave, is 
greater when P4 concentration is low at the time of treatment (Giordano et al., 2012a; Stevenson 
and Pulley, 2016). Despite this, fertility seems to be more dependent on high P4 concentration at 
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the time of first GnRH treatment and during follicular development than on ovulatory response 
(Stevenson and Lamb, 2016). This is probably because follicles that develop in a low P4 
environment might have compromised oocyte quality (Rivera et al., 2011) due to prolonged 
exposure to high frequency and low magnitude pulses of LH (Endo et al., 2012) which, in turn, 
can cause asynchrony between oocyte maturation and ovulation (Revah and Butler, 1996; 
Inskeep, 2004). It is also possible that low circulating P4 concentration between the first GnRH 
and the PGF2α treatment of Ovsynch-like protocols is associated with a short estrous cycle after 
insemination due to earlier upregulation of estradiol receptors in the endometrium (Cerri et al., 
2011). Earlier luteolysis might then impair fertility by triggering the luteolytic cascade before 
establishment of MRP.  
The impact of P4 supplementation during Ovsynch-like protocols has been studied 
extensively. A recent meta-analysis from Bisinotto et al. (2015b) reported that P4 
supplementation using controlled intravaginal release devices in cows without a CL at the time 
of the first GnRH of Ovsynch resulted in a 5.8 percentage point increment in P/AI [31.1% (n = 
2,071) vs 36.9 (n = 2,117) for untreated and treated cows, respectively]. Conversely, no major 
benefit was observed for cows bearing a CL at the initiation of the protocol [39.4% (n = 4,808) 
vs 40.9 (n = 4,766) for untreated and treated cows]. 
 
5.4. Progesterone concentration at the time of GnRH treatment before timed AI and 
at the time of timed AI. 
The aim of the GnRH treatment before TAI is to induce an LH surge which, in turn, will 
trigger ovulation within 28 to 32 hours after treatment (Pursley et al., 1995). Lack of complete 
luteal regression by the time of the GnRH treatment before TAI results in elevated circulating P4 
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concentration and an LH surge of lower magnitude (Giordano et al., 2012a; Stevenson and 
Pulley, 2016) which reduces the risk of ovulation around TAI (Stevenson and Pulley, 2016). 
Therefore, minimizing circulating P4 concentration at the time of GnRH treatment before TAI is 
paramount to maximize the number of cows that ovulate within the expected time frame and 
thereby maximize fertility to TAI. Moreover, data from rats suggest that P4 can be detrimental 
for oocyte transport in the oviduct (Fuentealba et al., 1988) which may explain part of the 
detrimental effect of high P4 at the time of AI. 
Data from three field studies support the hypothesis that low P4 concentration (< 0.5 
ng/mL) at the time of AI result in greater conception risk in dairy heifers (De Silva et al., 1981) 
and lactating dairy cows (Waldmann et al., 2001; Ghanem et al., 2006) inseminated at detected 
estrus. Further, similar results were observed in cows synchronized with different Ovsynch-like 
protocols in which P4 concentration at the time of GnRH or TAI below 0.5 ng/mL was 
associated with greater conception risk (Giordano et al., 2012e; Lopes et al., 2013; Stevenson 
and Lamb, 2016). 
Progesterone concentration at TAI in synchronization of ovulation protocols depends on 
the luteolytic response to the PGF2α treatment. Luteal regression after a single PGF2α treatment 
in synchronization of ovulation protocols ranges from 70 to 94% (Moreira et al., 2000; Brusveen 
et al., 2009; Martins et al., 2011). Therefore, 6 to 30% of the cows have P4 concentration above 
the optimal level at the time of TAI and will have compromised fertility. The presence of a 
young CL (≤6 days old) not fully responsive to PGF2α has been proposed as the main reason for 
lack of CL regression (Henricks et al., 1974; Wiltbank et al., 2015). Failure to induce luteal 
regression appears to be more frequent in resynchronization of ovulation protocols than in cows 
synchronized for first AI postpartum (Martins et al., 2011). Further, Giordano et al. (2012e) 
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observed that luteal regression was compromised among cows than did not have a CL at the time 
of initiating Resynch and ovulated in response to GnRH than cows with a functional CL. Only 
35.6% of cows that ovulated after the first GnRH treatment had P4 <0.4 ng/mL 56 h after 
induction of ovulation with PGF2α before TAI.  
Given the importance of minimizing circulating P4 around induction of ovulation for 
TAI, different alternatives have been evaluated to ensure complete luteal regression. For 
example, a second PGF2α treatment 24 h after induction of luteal regression in Ovsynch-like 
protocols has been shown to increase the proportion of cows with complete luteal regression at 
the time of GnRH treatment and TAI (Brusveen et al., 2009; Carvalho et al., 2015; Wiltbank et 
al., 2015). Moreover, Carvalho et al. (2015) observed greater P/AI when using two PGF2α 
treatments 24 hours apart than when using a single treatment (39 vs. 33%).  This increase in P/AI 
was attributed to a greater proportion of cows with complete luteal regression in the group that 
received two PGF2α treatments (98%) than in the group that received a single PGF2α (83%). 
Moreover, Santos et al. (2010) reported greater risk of luteolysis after two PGF2α treatments 24 
hours apart (95.7%) than a single treatment (59.1%) in a five day-Cosynch protocol (GnRH-5 d-
PGF2α-72 h-GnRH + TAI). These results provide evidence that a second PGF2α treatment is 
effective to induce complete luteal regression even for cows with young CLs not fully responsive 
to a single PGF2α treatment.  
 
6. Summary 
This literature review is intended to give an overview of the main physiological 
mechanisms that govern the estrous cycle in the cow and current knowledge of the effect of 
embryonic mortality on ovarian function. Moreover, it summarizes current research regarding 
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synchronization of ovulation protocols and important physiological aspects that determine the 
effectiveness of these protocols. 
Diagnostic methods used to detect embryo mortality in experiments aimed at elucidating 
the effect of this phenomenon on ovarian dynamics did not have the necessary accuracy to detect 
the presence of an embryo prior to Day 24 after AI. Therefore, more research is needed to 
understand the effect of early embryo mortality occurring around the period of MRP on ovarian 
dynamics. In this regard, determination of ISG mRNA expression in peripheral white blood cells 
is a promising tool to detect the presence of an embryo during the period of MRP. Thus, the 
experiment presented in Chapter II of this section had the objective of identifying embryo 
mortality around the period of MRP and determine its impact on ovarian function in lactating 
dairy cows. Thereafter, Chapters III and IV present data from experiments conducted to evaluate 
new programs for resynchronization of ovulation. These programs were aimed at minimizing 
time to pregnancy during lactation reducing the interbreeding interval for TAI services and 
increasing P/AI for cows expected to have low fertility after TAI while not interfering with 
estrus expression after a previous insemination. These programs were designed based on our 
improved understanding of the ovarian dynamics of lactating dairy cows after a previous 
insemination (Chapter II of this section).  
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CHAPTER II 
EMBRYO MORTALITY AROUND THE PERIOD OF MAINTENANCE OF THE 
CORPUS LUTEUM CAUSES ALTERATIONS TO THE OVARIAN FUNCTION OF 
LACTATING DAIRY COWS 
Robert Wijma, Matias L. Stangaferro, Manasi M. Kamat, Sreelakshmi Vasudevan, Troy L. Ott 
and Julio O. Giordano 
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ABSTRACT 
Objectives were to identify cows with embryo mortality (EM) around the period of corpus 
luteum (CL) maintenance by interferon tau (IFNT) and characterize ovarian function in cows 
that underwent EM. Lactating Holstein cows received AI (Day = 0) with semen or extender only. 
From Day 14 to 42 transrectal ultrasonography was performed daily to monitor ovarian 
dynamics and uterine contents whereas blood was collected every 48 h to determine ISG15 and 
MX2 mRNA abundance in blood mononuclear cells (Day 14 to 22 only) and determination of 
hormone concentrations. Cows were classified in the following reproductive status groups: cyclic 
(inseminated with extender; n = 15), pregnant (embryo present on Day 42; n = 23), no-embryo (n 
= 23), and EM (n = 14). Embryo mortality was defined as the presence of an embryo based on 
ISG mRNA abundance and concentrations of pregnancy-specific protein B (PSPB) above 
specific cutoff points but no embryo visualized by ultrasonography. Within the EM group, early 
EM (up to Day 22) was when ISG fold changes were above specific cutoff points from Day 18 to 
22 and PSPB below 0.7 ng/mL on and after Day 24, whereas late EM (after Day 22) was when 
PSPB was above 0.7 ng/mL on or after Day 24 regardless of ISG expression. This experiment 
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provided evidence that the combination of ISG expression patterns and PSPB concentrations is a 
reasonable method to determine EM around the period of CL maintenance by IFNT as cows with 
evidence of EM had patterns of ISG expression more similar to pregnant than cyclic cows or 
cows with no-embryo. Within the EM group, only cows with late EM had delayed luteal 
regression and longer interovulatory intervals. No major alterations in follicular function were 
observed after the onset of luteolysis. Our results suggest that embryo development needs to 
continue beyond 22 days after AI to effectively prevent luteolysis and extend the luteal phase. 
 
INTRODUCTION 
Pregnancy loss during the embryonic period of gestation [up to 42 days after AI; 
(Hubbert, 1972)] is a major cause of poor reproductive performance of lactating dairy cow 
(Santos et al., 2004; Moore et al., 2005). Unquestionably, the greatest detriment to cow 
reproductive performance is embryo loss. Nevertheless, cows that lose their pregnancy may also 
exhibit alterations in ovarian function leading to delayed estrus expression and re-insemination 
(Bartolome et al., 2005; Chebel et al., 2006; Remnant et al., 2015). Pregnancy loss may also be 
responsible, at least in part, for the poor response to synchronization of estrus and ovulation 
treatments used for previously inseminated non-pregnant cows (Giordano et al., 2012b; Lopes et 
al., 2013; Bruno et al., 2014; Giordano et al., 2015). 
Timing of embryo demise is critical because embryo losses before the beginning of the 
period of corpus luteum (CL) maintenance by interferon tau (IFNT; ~14 to 16 days of gestation; 
(Farin et al., 1990; Robinson et al., 2006)) are not expected to affect ovarian function. By 
contrast, cows that experience embryo mortality (EM) during or after the period of CL 
maintenance might present extended luteal phases and interovulatory intervals due to abrogation 
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of the luteolytic mechanism by conceptus-derived IFNT (Knickerbocker et al., 1986; Helmer et 
al., 1989; Meyer et al., 1995). Because of the lack of reliable methods to detect the presence of 
embryos around the period of CL maintenance or simple models to mimic the process in-vivo, 
the complex relationship between the occurrence and timing of EM around the period of CL 
maintenance and ovarian function has not been characterized in detail. Previous studies 
estimated embryo presence and subsequent demise based on the interval from AI to a next estrus, 
circulating concentrations of progesterone (P4), circulating concentrations of pregnancy 
associated glycoproteins (PAG) (Humblot, 2001; Grimard et al., 2006; Gábor et al., 2007; 
Breukelman et al., 2012), or combinations thereof. Although these studies provided useful 
insights into the relationship between EM and ovarian function, embryo losses might have been 
either overestimated or underestimated. For example, return to estrus and circulating 
concentrations of P4 overestimate the occurrence of EM by assuming that lack of estrus or luteal 
regression is exclusively due to the presence of an embryo during the period of CL maintenance. 
By contrast, using PAG to determine the presence of embryos during the period of CL 
maintenance may underestimate pregnancy losses because the first detectable rise in PAG in 
blood with current laboratory assays typically occurs 24 days following AI (Green et al., 2005; 
Giordano et al., 2012a). Experimental models of induction of CL maintenance (Northey and 
French, 1980; Heyman et al., 1984; Meyer et al., 1995) using conceptus-derived proteins (i.e., 
IFNT) and tissues, or removal of the conceptus from the uterus at different stages of pregnancy 
mimic to some extent the effect of EM, however, these models may not fully replicate the 
physiological conditions of naturally occurring EM.  
More recently, changes in the pattern of gene expression in circulating immune cells in 
response to IFNT have been used to determine the presence of an embryo during the period of 
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CL maintenance in cattle (Han et al., 2006; Gifford et al., 2007; Stevenson et al., 2007; Green et 
al., 2010). Cows confirmed pregnant through visualization of a viable embryo (32 to 45 days 
after AI) presented increased expression of interferon stimulated genes (ISG) such as the 
myxovirus resistance proteins 1 and 2 (MX1 and MX2), 2’-5’-oligoadenylate synthetase-1, and 
interferon stimulated gene 15 (ISG15) in peripheral blood leucocytes when compared with non-
pregnant or cyclic cows (Han et al., 2006; Gifford et al., 2007; Stevenson et al., 2007; Green et 
al., 2010; Pugliesi et al., 2014). Expression of ISG was characterized by maximum mRNA 
expression from approximately 18 to 22 days after AI (Han et al., 2006; Pugliesi et al., 2014) 
coincident with a period of known high IFNT release in cattle (Farin et al., 1990; Robinson et al., 
2006). Therefore, this novel approach may be used in combination with other methods such as 
measurement of PAG in circulation as an experimental tool to provide evidence of the presence 
of an embryo during the period of CL maintenance in cattle by IFNT.  
Our hypotheses were that: 1) coupling the determination of ISG expression in peripheral 
blood mononuclear cells (PBMC) and measurement of circulating concentrations of PSPB 
(marker of a suite of PAG) during the period of CL maintenance by IFNT will facilitate the 
identification of cows with EM and 2) EM during or immediately after the period of CL 
maintenance will extend the CL lifespan and affect follicular wave dynamics and ovulation. 
Thus, our first objective was to identify lactating dairy cows that underwent EM through 
determination of changes in ISG expression in PBMC and PSPB concentrations in blood. 
Thereafter, our objective was to characterize in detail the patterns of CL growth and regression 
and follicular dynamics in cows that underwent EM as determined by ISG and PSPB. Defining 
the extent of EM around the period of CL maintenance and its impact on ovarian function is a 
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necessary first step for the development of novel strategies to improve reproductive efficiency of 
lactating dairy cows. 
 
MATERIALS AND METHODS 
This research was conducted from June to December of 2013 at the Dairy Unit of the 
Cornell University Ruminant Center (Harford, NY). All procedures were approved by the 
Animal Care and Use Committee of the College of Agriculture and Life Sciences at Cornell 
University and complied with the Guide for the Care and Use of Agricultural Animals in 
Research and Teaching (McGlone, 2010).  
Cows were housed in freestall barns and were fed a total mixed ration once a day with ad 
libitum access to feed and water. The diet was formulated to meet or exceed nutrient 
requirements for lactating dairy cows producing 45 kg of milk per day (Cornell Net 
Carbohydrate and Protein System). Cows were milked three times per day at approximately 8 h 
intervals and received recombinant bovine somatotropin (500 mg of Sometribove zinc; Posilac, 
Elanco Animal Health, Indianapolis, IN) at 14 days intervals beginning approximately at 60 days 
in milk until dry off. 
Lactating primiparous (n = 37) and multiparous (n = 58) Holstein cows were 
synchronized with the Presynch-Ovsynch protocol [prostaglandin F2α (PGF2α)-14 days-PGF2α-
12 days- gonadotropin releasing hormone (GnRH)-7 days-PGF2α-56 h-GnRH-16 h-AI; (Moreira 
et al., 2001)) starting on average at 33 days in milk (range = 24 to 43 days in milk) to receive 
timed AI (TAI). At TAI, cows were stratified by parity and randomly assigned to be sham 
inseminated with semen extender only or inseminated with regular semen (henceforth referred to 
as semen) from seven bulls of proven fertility in a ratio of approximately 1 sham insemination to 
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4 inseminations with semen. In total, 20 cows were inseminated with extender only and 75 cows 
with semen. Straws for sham inseminations and straws containing sperm were packaged by the 
same laboratory (Genex CRI, Ithaca, NY) and using the same extender used for frozen semen 
preparation. Inseminations were performed by one professional AI technician from Genex. 
Research personnel were blind to treatments during data collection.  
 
Determination of ovarian function and pregnancy status  
Transrectal ultrasonography (TUS) of the ovaries was conducted using a portable 
ultrasound machine (Ibex Pro, Ibex, Loveland, CO). In all enrolled cows, TUS was performed on 
Days 0, 2, and 7 (TAI = 0) to assess the response to the synchronization of ovulation protocol. 
Cows that did not ovulate after TAI were excluded from the experiment. Thereafter, TUS of the 
ovaries was performed daily from Day 14 to 42 (Figure 2.1). 
At each examination, the position and diameter of follicles greater than 4 mm and 
corpora lutea was recorded on an ovarian map. All measurements were performed during each 
examination using the ultrasound machine internal digital calipers. Follicle and CL diameter was 
the average of the two longest perpendicular measurements. Follicle growth was determined by 
dividing the total growth (mm) between two specific time points by the number of days between 
the time points. Ovulation was defined as the disappearance of at least one follicle ≥10 mm 
between two consecutive examinations and confirmed by the presence of a new CL 7 days after 
presumptive ovulation (ovulation was not confirmed 7 days after presumptive ovulation in two 
cows because they ovulated 40 days after AI) on the ovary where the putative ovulatory follicle 
was observed. Changes in steroid hormone concentrations [estradiol (E2) and progesterone (P4)] 
were also used to confirm ovulation.  
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The uterus of each cow was evaluated daily to determine the presence or absence of 
uterine fluid, placental membranes, and an embryo.  
 
Blood sample collection 
Blood was collected into 8-mL heparinized evacuated tubes (Vacutainer, BD, Franklin 
Lakes, NJ) via puncture of the coccygeal vein or artery on Days 0, 2, and 7 to determine 
circulating concentrations of P4. These samples were used to verify the response to the 
synchronization of ovulation protocol. Thereafter, from Day 14 to 42 after TAI, blood collection 
was performed every 48 h to determine circulating concentrations of P4, E2, and PSPB. Samples 
were immediately placed into crushed ice and centrifuged at 1700 x g for 20 minutes at 4°C 
within 2 h of collection. Plasma was harvested and transferred into two different storage tubes 
and stored at -20°C until assays were performed.  
On Days 14, 16, 18, 20, and 22 a blood sample was collected using cell preparation tubes 
(CPT tubes, Vacutainer, BD, Franklin Lakes, NJ) to harvest PBMC (lymphocytes and 
monocytes) for subsequent RNA extraction. Tubes were kept at room temperature and within 1 
to 2 h of collection, samples were centrifuged for 30 minutes at 1500 x g at room temperature. 
Cells were re-suspended in the plasma layer and transferred into 15 mL conical tubes and 
centrifuged for 15 minutes at 500 x g at 4°C. After centrifugation, the supernatant was removed 
and the PBMC pellet was lysed with 200 µl Trizol (Invitrogen, Carlsbad, CA) and frozen at -
80°C until assayed. 
 
Determination of progesterone concentrations  
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Progesterone concentrations in plasma were determined in duplicate using a commercial 
solid-phase, no-extraction RIA (Coat-a-count; Diagnostic Products Corp., Los Angeles, CA). To 
assess precision of the assay, control samples with high (7.4 ng/mL) and low (0.5 ng/mL) 
concentrations of P4 were included at the beginning and end of each assay (n = 15 assays). 
Average detection limit for the P4 assay was 0.03 ng/mL. Average intra-assay CV for the high-
concentration sample for the 15 assays performed was 8%, whereas the inter-assay CV was 11%. 
For the low-concentration sample the average intra-assay CV for the 15 assays was 14%, 
whereas the inter-assay CV was 21%. 
 
Determination of pregnancy-specific protein B concentrations  
Concentrations of PSPB in plasma were determined using a commercially available 
sandwich ELISA assay (BioPRYN, BioTracking LLC, Moscow, ID). Samples were shipped to 
BioTracking LLC and the assay performed in their laboratory. A standard curve was added to the 
commercial assay to determine PSPB concentrations. Six PSPB standards (0.125, 0.25, 0.5, 1.0, 
2.0 and 4.0 ng/mL) and a blank were used for analysis. A curve was fitted to the standards on 
each plate using a linear least squares regression. The resulting standard curve was used to 
determine the concentration of PSPB in each sample. Samples were run in duplicate in two 
separate assays. For assay validation, two control samples (high and low) containing PSPB were 
added to all plates in triplicate to calculate inter- and intra-assay CV. Average intra-assay CV for 
the high-concentration sample was 2.4%, whereas the inter-assay CV was 3.6%. For the low-
concentration sample the intra-assay CV was 2.9% whereas the inter-assay CV was 4.1%. 
Average detection limit for the assay was 0.3 ng/mL. 
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Determination of estradiol concentrations  
Estradiol concentrations in plasma were determined by a double antibody RIA (MaiaZen 
Estradiol R-FA-120, Zen Tech SA, Belgium) after benzene:toluene extraction. Average detection 
limit was 0.3 pg/mL. To assess the precision of the assays (n = 10 assays), a control sample (6.5 
pg/mL) was added in quadruplicate (2 x 100 μL and 2 x 200 μL) at the beginning and end of 
each assay. The average intra-assay CV was 16% and the inter-assay CV was 17%. 
 
RNA extraction and cDNA Synthesis 
After thawing PBMC, RNA was extracted and purified following the manufacturer 
instructions (Trizol, Invitrogen, Carlsbad, CA). Concentration and quality of RNA were assessed 
using a Nanodrop (ND 1000 spectrophotometer, version 3.8.1,Thermoscientific, Wilmington, 
DE, USA) and with an Experion automated electrophoresis system with the Experion RNA 
StdSens kit (Bio-Rad, Hercules, CA) and the Experion software version 3.0 (Agilent 
technologies, Wilmington, DE) following manufacturer’s instructions. Because heparin was used 
during sample collection, heparinase (H2519, Sigma Aldrich, St. Louis, MO) treatment was used 
to avoid interference with the assay. Briefly, samples were incubated with 1 U of heparinase I/μg 
of RNA, 40 U of RNasin (PRN2511, Promega Corporation, Madison, WI) and buffer containing 
5 mM Tris buffer at a pH of 7.5, with 1 mM CaCl2 for 2 h at 25°C. This was followed by DNase 
treatment which was carried out using RQ1 RNase free DNase kit (M6101; Promega 
Corporation, Madison, WI). Briefly, 1 μg of RNA was incubated with 1 μL of RQ1 DNase 10X 
Reaction Buffer and 1 μL of RQ1 RNase-Free DNase in 8 μL total volume at 37°C for 30 min. 
One μL of DNase stop solution was added and incubated for 10 min at 65°C. Complementary 
DNA synthesis was done using a Dynamo cDNA synthesis kit (F470L; Thermo Scientific, 
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Waltham, MA). A master mix made up of 10 μL RT buffer, 1 μL of random hexamer primers, 2 
μL of M-MuLV RNase H+ reverse transcriptase with 1 μg of DNAse treated RNA sample was 
incubated for 10 min at 25°C for primer extension, 30 min incubation at 37°C for cDNA 
synthesis and 5 min at 85 °C for reaction termination. As a negative control for the reaction, four 
reaction master mixes were prepared without M-MuLV RNase H+ reverse transcriptase and 
served as no RT controls for our PCR assays. After cDNA synthesis, samples were stored at -20 
°C.  
 
Quantitative Real Time PCR for ISG15 and MX2 gene expression 
Except for annealing temperature (Table 1), all reactions were completed as follows. Real 
time PCR was done using SensiMix SYBR No-ROX Kit (QT650-05, Bioline USA, Taunton, 
MA). Fifteen microliters of a master mix containing 10 μL of SYBR Green, 0.33 μL (15 μM) of 
reverse primer, 0.33 μL (15 μM) of forward primer and 4.34 μL of nuclease free water was 
added into each well. Five μL of cDNA template (previously diluted 1:5 with nuclease free 
water) was added (each sample was ran in duplicate) and the last two wells were loaded with no 
RT and water only controls. The following run parameters were used: denaturation at 95°C for 5 
min followed by  40 cycles of amplification: denaturation at 95 C for 30 sec,  annealing (see 
Table 2.1 for details about each gene) for 45 sec, extension 72°C for 1 min. This was followed 
by a final extension step of 72°C for 5 min, followed by melting curve analysis. Duplicate 
samples that differed by more than 0.5 CT were re-analyzed.  Standard curves consisting of 12 
log dilutions of PCR amplified template were used to validate the assays. Standard curves 
exhibited Ct values ranging from 5 to 35 and samples with Ct values beyond the range were 
excluded. Standard curves had slopes between -3.2 and -3.3, R2 values of 0.98 or greater and 
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efficiencies between 100 and 105%.  Signal intensity was captured and analyzed using ABI 7500 
Fast real time PCR machine (Applied Biosystems, Life Technologies). Ribosomal protein L19 
(RPL19) was used as a reference gene and ΔCt’s, ΔΔCt’s and fold changes for ISG15 and MX2 
were calculated as described in Livak and Schmittgen (2001) using each cow’s day 14 as 
reference. The reference gene was chosen based on the absence of effects of treatments on the 
abundance of its mRNA and similar cDNA amplification efficiencies between target genes and 
the reference gene calculated here and elsewhere (Ribeiro et al., 2014). 
 
Creation of reproductive status groups 
Cows that received sham insemination were included in the cyclic reproductive status 
group (CY) whereas cows with a viable pregnancy based on TUS examination at the end of the 
study, 42 days after AI, were included in the pregnant reproductive status group (PG). On the 
other hand, cows that received AI with semen and had no evidence of an embryo during the 
experimental period were considered as nonpregnant (NP). Further, NP cows were 
retrospectively classified into a no-embryo (NE) or embryo mortality (EM) group. Cows were 
included in the EM reproductive status group if there was evidence of the presence of an embryo 
as determined by ISG15 and MX2 gene expression in PBMC and/or PSPB concentrations in 
plasma but no viable embryo was observed with TUS during the experimental period. 
Conversely, cows in the NE group did not have evidence of the presence of an embryo based on 
ISG expression and plasma concentrations of PSPB.  
Because specific criteria to determine the presence of an embryo based on ISG 
expression have not been established, we used Receiver Operating Characteristic (ROC) curve 
analysis to determine cutoff values for ISG15 and MX2 fold changes that provided evidence of 
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the presence of an embryo from Day 18 to 22. Cyclic cows were used to provide data for 
negative outcomes because these cows did not have an embryo present any time after AI. Cows 
in the PG group were used to provide data for positive outcomes because all had an embryo 
present from Day 18 to 22. Cows in the NP reproductive status group were not included in the 
ROC analysis because they constituted the group of interest for determination of the presence or 
absence of an embryo from Day 18 to 22 based on ISG. The ROC analysis option of MedCalc 
(version 12.5.0.0; MedCalc Software bvba, Ostend, Belgium) was used to create the ROC 
curves. For each day of interest (i.e., 18, 20, and 22 days after AI) data for fold change 
(compared to Day 14) for CY (negative outcome) and PG (positive outcome) cows were used to 
determine the minimum fold change that indicated with the greatest combined sensitivity and 
specificity the presence of an embryo (positive outcome).  
After a fold change cutoff value for each gene (i.e., ISG15 and MX2) for each day was 
determined, cows with no evidence of a viable embryo based on TUS (i.e., NP reproductive 
status group) were re-classified into the NE or EM reproductive groups as follows. Cows 
assigned to the EM group had a fold change above the cutoff value determined by ROC for 
either ISG15, MX2, or both on Days 18, 20, and 22 (e.g., ISG15 above cutoff on Days 18 and 20 
but not on Day 22 and MX2 above cutoff on Day 22 but not on Days 18 and 20. At least one of 
the two genes was above the cutoff for each one of the days of interest). Evidence of embryo 
presence was also based on circulating concentrations of PSPB ≥ 0.7 ng/mL on or after Day 24. 
The cutoff selected for PSPB was based on the mean PSPB concentration for PG cows on Day 
24 (0.7 ng/mL). Cows in the NE reproductive status group did not have a fold change above the 
cutoff value determined by ROC during any day or no more than two days during the days of 
interest (e.g., no ISG15 or MX2 above the cutoff for any day or ISG15 above the cutoff on Days 
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18 and 20 but both ISG below the cutoff on Day 22) and PSPB concentrations did not reach 0.7 
ng/mL on and after Day 24.  
Further, to explore the effect of EM at different time points on ovarian function, cows in 
the EM group were re-classified based on ISG expression and PSPB concentrations in two 
additional reproductive status groups: 1) Early embryo mortality (EEM): evidence of embryo 
presence based on ISG expression but PSPB concentrations below 0.7 ng/mL on and after Day 
24 and 2) Late embryo mortality (LEM): circulating concentrations of PSPB above 0.7 ng/mL 
for at least one day on or after Day 24. 
 
Statistical analysis 
 This research was conducted as a mix of a completely randomized design (i.e., random 
assignment of cows to insemination with extender only or semen) and a prospective cohort study 
(i.e., determination of EM and ovarian function from 14 to 42 days after AI).   
ISG expression differences between groups: Two separate analyses were conducted to evaluate 
ISG expression differences between reproductive status groups. For the first analysis, 
reproductive status groups (i.e., CY, NP, and PG) created based on the initial TUS diagnosis 
were included. The second analysis included reproductive status groups (CY, NE, EM, and PG) 
created based on ISG expression and PSPB concentrations as described. Differences in ΔΔCts 
for ISG15 and MX2 for the different reproductive status groups were analyzed by ANOVA using 
the MIXED procedure of SAS (Version 9.4; SAS Institute, Cary, NC). Normality of data for 
ΔΔCts was assessed using graphical methods (histogram and Q-Q plot) generated with the 
UNIVARIATE procedure of SAS and the residual option of the MIXED procedure. 
Reproductive status group (either CY, NP, and PG or CY, NE, EM, and PG), day after AI, the 
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reproductive status group by day interaction, and parity were included in the model as fixed 
effects, whereas cow nested within reproductive status group was included as a random effect in 
all models.  
Ovarian dynamics: Two analyses were conducted to evaluate ovarian function. The first analysis 
included cows in the CY, NE, and EM reproductive status groups, whereas the second analysis 
included cows in the CY, NE, EEM, and LEM reproductive status groups. Binomial outcomes 
(proportion of cows with complete luteal regression and proportion of cows ovulating) were 
analyzed using Fisher’s exact test through the FREQ procedure of SAS because some 
reproductive status groups had less than five positive outcomes and for some reproductive status 
groups 100% of the cows had a positive outcome. Mean separation analysis was not conducted 
for binomial outcomes because there was an insufficient number of observations for certain 
subgroups for a meaningful comparison. Continuous variables (days to onset of luteal regression, 
days to complete luteal regression, days to ovulation, days from onset of luteal regression to 
ovulation, days from complete luteal regression to ovulation, maximum ovulatory follicle 
diameter, ovulatory follicle diameter before ovulation, ovulatory follicle growth rate to 
maximum diameter and ovulatory follicle growth rate before ovulation) were analyzed by 
ANOVA using the MIXED procedure of SAS. The day of the onset of luteal regression was 
defined as the day before P4 concentrations dropped 50% below the maximum concentration 
observed and continued decreasing in the subsequent samples. The day of complete luteal 
regression was the day after ovulation at which P4 concentration was below 0.5 ng/mL. For cows 
that underwent complete luteal regression, E2 concentrations were evaluated after normalization 
to the day of the onset of luteal regression and the day of complete luteal regression, whereas for 
cows that presented complete luteal regression and ovulated, E2 concentrations were normalized 
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to the day of ovulation. Because data for E2 concentrations were not normally distributed, values 
were log transformed before conducting the analysis and back transformed for reporting. In all 
cases, models included reproductive status group as a fixed effect, whereas cow nested within 
reproductive status group was included as a random effect. When the effect of a categorical 
explanatory variable was significant, the Least Significant Difference post-hoc mean separation 
test was used to determine differences between means.  
 Survival analysis for time to complete luteal regression and ovulation after AI was 
conducted using Cox’s proportional hazards regression with the PHREG procedure of SAS with 
reproductive status group as fixed effect. Kaplan-Meier survival curves were generated to 
illustrate the hazard of complete luteal regression and ovulation after AI using the Survival 
Analysis option of MedCalc.  
  All values for quantitative outcomes are reported as Least Square Means (± SEM) unless 
otherwise stated whereas for binomial outcomes proportions generated using the FREQ 
procedure of SAS are reported. All explanatory variables and their interactions were considered 
significant if P < 0.05 whereas P-values between 0.05 and 0.10 were considered a tendency.  
 
RESULTS 
Classification of cows into reproductive status groups and incidence of embryo mortality 
Figure 2.2 includes a graphical depiction of the reproductive status groups generated, the 
criteria used to generate the groups, and the number of cows included in the final analysis 
presented herein. Seventeen cows were removed from the study because they failed to ovulate 
after AI (n = 8), presented clinical health disorders (n = 3), or left the herd before completion of 
the study (n = 6). After removal of these cows, data were available from 15 cows that received 
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sham insemination (CY reproductive status group; 7 primiparous and 8 multiparous) and 63 
cows inseminated with semen (27 primiparous and 36 multiparous). Data for ISG was not 
available for one cow in the CY reproductive status group because the RNA sample was lost 
during processing, however, data for this cow were included in the analysis of ovarian function.  
Within the group of cows inseminated with semen and available for analysis, 40 cows 
were considered NP and 23 cows were PG (36.5% pregnancy per AI) based on the initial 
classification through TUS 42 days after AI. Three cows in the NP reproductive status group that 
completed the experimental period presented an embryo with a heartbeat 30 to 35 days after AI 
but the embryo died before Day 42. Including these cows in the PG rather than NP reproductive 
status group would have resulted in 41.3% pregnancy per AI. These three cows were excluded 
from all analyses because their pregnancy reached a further stage of development (embryo with a 
heartbeat visualized by TUS) than in cows classified into the embryo mortality group based on 
ISG expression and concentrations of PSPB only (described below).  
After re-classification of cows based on ISG expression fold changes and plasma PSPB 
concentrations, 23 cows remained in the NE reproductive status group and 14 cows were 
included in the EM reproductive status group. Based on this classification, 62% (37/60) of the 
cows inseminated with semen had evidence of the presence of an embryo. Of these cows, 38% 
(14/37) underwent EM after Day 18 based on the criteria used to define EM in the current study. 
Cut off criteria, sensitivity, specificity and area under the curve for gene expression fold change 
to determine the presence of an embryo on Days 18, 20, and 22 are shown in Table 2.2. Day 18 
was selected as the earliest day to define a criterion because it was the first day after AI when 
mRNA relative abundance was different between CY and PG groups (data presented in 
Interferon Stimulated Genes Expression section). Individual cow ISG fold changes for Days 18, 
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20, and 22, and PSPB concentrations on Days 24 and 26 for cows in the EM reproductive status 
group are shown in Supplementary Table 2.1.  
Furthermore, among cows with evidence of EM, 50% (n = 7) underwent EEM and 50% 
(n = 7) LEM. Figure 2.3 includes individual circulating concentrations for PSPB for cows in the 
LEM group and the mean ± 3 SD for cows in the PG group from 20 to 42 days after AI. Figure 
2.4 includes the relative abundance of mRNA for ISG15 and MX2, and circulating concentrations 
of P4, E2, and PSPB for two representative cows in the EEM (Figure 2.4A and 4B) and two 
cows in the LEM reproductive status group, respectively (Figure 2.4C and 4D).  
 
Interferon Stimulated Genes expression  
The mRNA abundance for ISG15 and MX2 for cows in the CY, PG, and NP groups was 
affected by reproductive status group (P < 0.001) and the reproductive status group by day 
interaction (P < 0.001; Figure 2.5A and 5B). Days after AI tended to affect (P = 0.10) ISG15 
mRNA abundance and affected (P < 0.001) MX2 expression. Based on mean separation analysis, 
PG cows had greater ISG15 and MX2 mRNA abundance than CY and NP cows on Days 18, 20, 
and 22. There was no effect of parity (P > 0.10) on ISG15 or MX2 mRNA abundance. 
When cows in the NP reproductive status group were subdivided in the NE and EM 
groups, mRNA abundance for ISG15 and MX2 were affected by reproductive status group (P < 
0.001), day (ISG15: P = 0.04; MX2: P < 0.001), and the reproductive status group by day 
interaction (P < 0.001; Figure 2.6A and 6B). Cows in the PG and EM groups had greater ISG15 
and MX2 mRNA abundance on Days 18 and 20 than cows in the CY and NE groups. On Day 22, 
cows in the PG group had the greatest ISG mRNA abundance of all reproductive status groups. 
Cows in the EM group had greater ISG15 and MX2 mRNA abundance than cows in the NE and 
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CY groups (Figure 2.6A and 6B). There was no effect of parity (P > 0.1) for ISG15 or MX2 
mRNA abundance.  
 
Ovarian function in cows that underwent embryo mortality  
Luteal regression: The proportion of cows that underwent complete luteal regression by Day 42 
was affected (P < 0.01) by reproductive status group because fewer cows in the EM group 
presented complete luteal regression than cows in the CY and NE groups (Table 2.3). The timing 
of the onset of luteal regression (P < 0.001) and complete luteal regression (P < 0.01) was also 
affected by reproductive status group because cows in the EM group had more days to the onset 
and to complete luteal regression than cows in the CY and NE groups (Table 2.3). The hazard of 
complete luteal regression from Day 14 to 42 was greater (P < 0.01; Figure 2.7A) for cows in the 
CY than the EM group (HR 5.6; 95% CI: 2.1 – 15.8) and for cows in the NE than the EM group 
(HR 3.5; 95% CI: 1.4 – 8.6). Conversely, the hazard of complete luteal regression did not differ 
between the CY and NE groups (HR 1.6; 95% CI: 0.8 – 3.1). 
 
Ovulation and follicular parameters: The proportion of cows ovulating within 42 days after AI 
was less (P = 0.02) for cows in the EM than the CY and NE reproductive status groups (Table 
2.3). Furthermore, days from AI to ovulation were affected by reproductive status group (P = 
0.03) such that cows in the EM and NE groups had more days from AI to ovulation than cows in 
the CY reproductive status group (Table 2.3). Mean days from the onset of luteal regression and 
complete luteal regression to ovulation were not affected by reproductive status group (Table 
2.3). The hazard of ovulation from 14 to 42 days after AI was greater (P < 0.01; Figure 2.7B) for 
cows in the CY (HR 4.6, 95% CI: 1.9 – 11.9) and the NE groups (HR 2.5, 95% CI: 1.1 – 5.7) 
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than for cows in the EM group. Conversely, the hazard of ovulation did not differ for the CY and 
NE reproductive status groups (HR 1.9, 95% CI: 0.9 – 3.7). 
Maximum diameter of the ovulatory follicle, ovulatory follicle diameter before ovulation, 
growth rate to maximum size, and ovulatory follicle growth rate for the last 5 days before 
ovulation (cows that failed to ovulate not included) were not affected by reproductive status 
group (Table 2.3). 
 
Estradiol concentrations: Estradiol concentrations were affected (P < 0.001) by day relative to 
the onset of luteal regression, complete luteal regression, and ovulation. There was no effect (P > 
0.10) of reproductive status group or the reproductive status group by day interaction on E2 
concentrations relative to the onset and to complete luteal regression (Figure 2.8A and 8B). 
Conversely, concentrations of E2 tended (P = 0.05) to differ for cows in the CY, NE, and EM 
reproductive status groups when concentrations were normalized to the day of ovulation (Figure 
2.8C).  
 
Ovarian function in cows with early versus late embryo mortality 
Luteal regression: The proportion of cows undergoing complete luteal regression by 42 days 
after AI was affected by reproductive status group (P < 0.01; Table 2.4). Cows undergoing LEM 
had more days to the onset of luteal regression (P < 0.001) and complete luteal regression (P < 
0.001) than cows in the CY, NE, and EEM reproductive status group (Table 2.4). The hazard of 
complete luteal regression was greater (P < 0.01; Figure 2.9A) for cows in the CY than the LEM 
group (HR = 11.7; 95% CI: 3.2 – 42.7), for cows in the NE than the LEM group (HR = 7.2; 95% 
CI: 2.1 – 25.1), and for cows in the EEM than the LEM group (HR = 4.3; 95% CI: 1.2 – 15.9). 
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The hazard of complete luteal regression was similar for cows in the CY and NE (HR = 1.6; 95% 
CI: 0.8 – 3.1), CY and EEM (HR = 2.7; 95% CI: 0.9 – 7.6), and EEM and NE reproductive status 
groups (HR = 0.6; 95% CI: 0.2 – 1.6). 
 
Ovulation and follicular parameters: The proportion of cows ovulating within 42 days after AI 
was affected by reproductive status group (P < 0.01; Table 2.4) which also affected the timing of 
ovulation after AI (P < 0.001). Cows in the LEM group had the longest interval to ovulation 
whereas cows in the EEM group had similar interval to ovulation than cows in the NE and CY 
groups (Table 2.4). Cows in the NE group had more days to ovulation than cows in the CY 
group. The hazard of ovulation was greater (P < 0.01; Figure 2.9B) for cows in the CY than cows 
in the LEM group (HR = 13.6; 95% CI: 2.9 – 61.9), for cows in the NE than the LEM group (HR 
= 7.2; 95% CI: 1.7 – 31.4), and for cows in the EEM than the LEM group (HR = 7.3; 95% CI: 
1.5 – 36.4). The hazard of ovulation was similar for cows in the CY and NE group (HR = 1.9; 
95% CI: 0.9 – 3.7), CY and EEM (HR = 1.8; 95% CI: 0.7 – 4.9), and for cows in the EEM and 
NE groups (HR = 1.0; 95% CI: 0.4 – 2.5). 
 
Table 2.1. Gene, primer orientation and sequence (5′ to 3′), annealing temperatures and NCBI 
sequences for RPL19, MX2, and ISG15 primers used in quantitative real time PCR. 
Gene Primer Sequence (5′ to 3′) °C1 NCBI sequence 
RPL19 
forward primer ATCGATCGCCACATGTATCA 
60 NM_001040516.1 
reverse primer GCGTGCTTCCTTGGTCTTAG 
MX2 
forward primer CTTCAGAGACGCCTCAGTCG 
57 NM_173941.2 
reverse primer TGAAGCAGCCAGGAATAGTG 
ISG15 
forward primer GGTATCCGAGCTGAAGCAGTT 
60 NM_174366.1 
reverse primer ACCTCCCTGCTGTCAAGGT 
1Annealing temperature 
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Table 2.2. Cut off value (criterion), sensitivity, specificity, and area under the curve with 95% confidence intervals obtained by 
Receiver Operating Characteristic curve analysis for ISG15 and MX2. The criterion for fold change determined by Receiver Operating 
Characteristic curve analysis predicted with the highest combined sensitivity and specificity the presence of an embryo for each day of 
interest.  
   ISG15  MX2 
Day after 
AI 
 
Criterion Se1 (%) Sp2 (%) AUC3 95% CI   Criterion Se1 (%) Sp2 (%) AUC3 95% CI 
18  2.1 73.7 91.7 0.84 0.67 - 0.95   1.5 94.7 94.9 0.90 0.78 - 0.98 
20  2.6 75.0 92.3 0.89 0.74 - 0.97   1.9 95.0 100.0 0.99 0.87 - 1.00 
22  1.6 100.0 76.9 0.90 0.75 - 0.98   1.4 95.0 76.9 0.93 0.78 - 0.99 
1Se = sensitivity 
2Sp = specificity 
3AUC = area under the curve 
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Table 2.3. Ovarian function parameters for cows in the Cyclic, Embryo mortality, and No embryo reproductive status group. 
 Reproductive status group  
  Cyclic No Embryo Embryo mortality P-value 
Complete luteal regression % (n/n) 100 (15/15) 100 (23/23) 71 (10/14) < 0.01 
Days  to onset of luteal regression 18.5 ± 0.5a 19.8 ± 0.5a 27.2 ± 2.8b < 0.001 
Days to complete luteal regression1 20.7 ± 0.6a 22.4 ± 0.5a 26.8 ± 2.7b  < 0.01 
Ovulation % (n/n) 93 (14/15) 91 (21/23) 57 (8/14) 0.02 
Days AI to ovulation 23.1 ± 0.5a 25.7 ± 0.6b 27.5 ± 2.4b 0.03 
Days  from onset of luteal regression to ovulation 4.9 ± 0.5 6.2 ± 0.6 6.4 ± 1.0 0.27 
Days from complete luteal regression to ovulation 2.9 ± 0.4 3.5 ± 0.6 3.5 ± 1.1 0.27 
Maximum diameter ovulatory follicle (mm) 20.5 ± 0.6 19.0 ± 0.6 20.3 ± 1.2 0.20 
Diameter before Ovulation (mm) 20.5 ± 0.6 18.8 ± 0.6 20.3 ± 1.0 0.16 
Growth rate to maximum diameter (mm/d) 1.5 ± 0.2 1.4 ± 0.1 1.3 ± 0.2 0.22 
Growth rate to ovulatory diameter (mm/d) 1.4 ± 0.2 1.3 ± 0.1 1.1 ± 0.2 0.46 
1Two cows in the embryo mortality group initiated luteolysis but P4 did not fall below 0.5 ng/mL by Day 42. 
Different letters in a same row indicates P < 0.05.  
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Table 2.4. Ovarian function parameters for cows in the Cyclic, Early embryo mortality, Late embryo mortality, and No embryo 
reproductive status groups as determined by transrectal ultrasonography, pregnancy-specific protein B, and ISG expression in 
peripheral blood mononuclear cells. 
 Reproductive status group  
  Cyclic No Embryo EEM1 LEM2 P-value 
Cows with complete luteal regression, % (n/n) 100 (15/15) 100 (23/23) 86 (6/7) 57 (4/7) < 0.01 
Days to onset of luteal regression 18.5 ± 0.5a 19.8 ± 0.5a 22.1 ± 3.4a 34.2 ± 2.9b < 0.001 
Days to complete luteal regression3 20.7 ± 0.6a 22.4 ± 0.5a 21.1 ± 1.5a 35.0 ± 3.1b < 0.001 
Cows ovulating, % (n/n) 93 (14/15) 91 (21/23) 86 (6/7) 29 (2/7) < 0.01 
Interval from AI to Ovulation, (d) 23.1 ± 0.5a 25.7 ± 0.6b 24.5 ± 1.6ab 36.5 ± 3.5c < 0.001 
Days  from onset of luteal regression to ovulation 4.9 ± 0.5 6.2 ± 0.6 5.5 ± 1.5  9.0 ± 0 0.13 
Days from complete luteal regression to ovulation 2.9 ± 0.4 3.5 ± 0.6 3.2 ± 1.4  4.5 ± 2.5 0.13 
Maximum diameter ovulatory follicle (mm) 20.5 ± 0.6 19.0 ± 0.6 19.5 ± 1.2 22.8 ± 2.7 0.14 
Diameter before Ovulation (mm) 20.5 ± 0.6 18.8 ± 0.6 19.5 ± 1.2 21.5 ± 1.5 0.22 
Growth rate to maximum diameter (mm/d) 1.5 ± 0.2 1.4 ± 0.1 1.3 ± 0.2 1.1 ± 0.5 0.71 
Growth rate to ovulatory diameter (mm/d) 1.4 ± 0.2 1.3 ± 0.1 1.3 ± 0.2 0.5 ± 0.1 0.20 
1Early embryo mortality. 
2Late embryo mortality. 
3One cow in the Early embryo mortality group and one cow in the Late embryo mortality group initiated luteolysis but progesterone 
did not fall below 0.5 ng/mL by Day 42. 
Different letters in a same row indicates P< 0.05. 
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Figure 2.1. Schematic representation of experimental procedures. Ninety five lactating Holstein cows were synchronized using the 
Presynch-Ovsynch protocol and at the time of AI (Day = 0) randomly assigned to receive AI with extender only or regular semen in a 
ratio of approximately 1 to 5. Transrectal ovarian ultrasonography was conducted and blood samples were collected at the time of AI 
and then 2 and 7 days after AI to verify ovulation and formation of a functional corpus luteum (progesterone ≥1 ng/mL) based on 
circulating concentrations of progesterone and estradiol. From Day 14 to 42, transrectal ultrasonography was conducted every 24 h to 
record the presence and size (diameter) of all ovarian structures and evaluate uterine content. In addition, blood samples were 
collected every 48 h for determination of circulating concentrations of progesterone, estradiol, and pregnancy-specific protein B. From 
Day 14 to 22, another blood sample was collected every 48 h to harvest peripheral blood mononuclear cells for mRNA extraction and 
determination of interferon stimulated genes (ISG15 and MX2) expression. TAI = timed AI, BS = blood sample, TUS = transrectal 
ultrasonography, ISG = interferon stimulated genes, P4 = progesterone, E2 = estradiol, PSPB = pregnancy-specific protein B.  
0 2 7 14 22 42
P4 + E2 + PSPB
ISG
BS + TUS
TUS every 24 h
BS every 48 h
TAI
Follicular and luteal growth and regression + Uterine content
Regular Semen (n = 75)
Extender Only (n = 20)
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Figure 2.2. Schematic representation of classification of cows to reproductive status groups for 
this study. Cows inseminated with semen extender only (sham AI) were assigned to the Cyclic 
group. Cows that received AI with regular semen were classified into a Pregnant or Nonpregnant 
group based on the visualization or not of a viable embryo with transrectal ultrasonography on 
Day 42. Within the Nonpregnant group, cows were assigned to the Embryo mortality or No 
embryo group based on ISG expression cutoff thresholds established using ROC analysis and 
plasma concentrations of pregnancy-specific protein B. Cows in the Embryo mortality group 
were further subdivided into an Early embryo mortality (ISG mRNA relative abundance above 
established cutoff on Days 18, 20, and 22 after AI and PSPB < 0.7 ng/mL on and after Day 24) 
and Late embryo mortality group (PSPB > 0.7 ng/mL on or after Day 24). *Three cows 
considered nonpregnant on Day 42 based on transrectal ultrasonography presented an embryo 
with a heartbeat 30 to 35 days after AI. These cows were excluded from all analyses because the 
pregnancy reached a further stage of development (embryo with a heartbeat visualized by 
ultrasonography) than for cows classified into the Embryo mortality group. TUS = transrectal 
ultrasonography, ISG = interferon stimulated genes, PSPB = pregnancy-specific protein B. 
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Figure 2.3. Individual profiles for circulating concentrations of pregnancy-specific protein B 
from Day 20 to 42 for cows that underwent late embryo mortality and mean concentrations 
(dashed line with open circles) ± 3 SD (shaded area) for pregnant cows. PSPB = pregnancy-
specific protein B. 
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Figure 2.4. Individual progesterone, estradiol, and pregnancy-specific protein B profiles from Day 14 to 42, and ISG15 and MX2 
mRNA expression fold change from Day 14 to 22 for two representative cows in the Early embryo mortality (A and B) and Late 
embryo mortality reproductive status groups (C and D), respectively. P4 = progesterone, E2 = estradiol, and PSPB = pregnancy-
specific protein B. Black arrows indicate day of ovulation when it corresponds.
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Figure 2.5.  Relative mRNA abundance for ISG15 (A) and MX2 (B) for Cyclic, Nonpregnant and 
Pregnant cows as diagnosed by transrectal ultrasonography. Fold changes were calculated by the 
2-ΔΔCt method using Day 14 as reference. Error bars were calculated as 2- (ΔΔCt ± 1 SEM). Different 
letters within the same day indicate P < 0.05. 
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Figure 2.6. Relative mRNA abundance for ISG15 (A) and MX2 (B) for cows in the Cyclic, No 
embryo, Embryo mortality, and Pregnant reproductive status groups. Embryo mortality was 
determined based on ISG expression cutoff thresholds established using ROC analysis and 
plasma concentrations of pregnancy-specific protein B. Fold changes were calculated by the 2-
ΔΔCt method using Day 14 as reference. Error bars were calculated as 2- (ΔΔCt ± 1 SEM). Different 
letters within the same day indicate P < 0.05. ISG = interferon stimulated genes. 
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Figure 2.7.  Kaplan-Meier survival curves for time to complete luteal regression (progesterone 
<0.5 ng/mL) (A) and ovulation (B) up to Day 42 for cows in the Cyclic (CY), No embryo (NE), 
and Embryo mortality (EM) reproductive status groups.  The hazard of complete luteal 
regression was affected by (P < 0.01) reproductive status group. The hazard of complete luteal 
regression for the different groups compared were: CY vs EM: HR = 5.6 (95% CI: 2.1 – 15.8), 
NE vs EM: HR = 3.5 (95% CI: 1.4 – 8.6), CY vs NE: HR = 1.6 (95% CI: 0.8 – 3.1). The hazard 
of ovulation was affected by (P < 0.01) reproductive status group. Ovulation after AI: CY vs 
EM: HR = 4.6 (95% CI: 1.9 – 11.9), NE vs EM: HR = 2.5 (95% CI: 1.1 – 5.7), CY vs NE: HR = 
1.9 (95% CI: 0.9 – 3.7). 
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Figure 2.8. Concentrations of estradiol (back transformed data of the log of the LSM ± 95% CI) for cows in the Cyclic, No embryo, 
and Embryo mortality reproductive status group relative to the onset of luteal regression (A), complete luteal regression (B) and 
ovulation (C). Only cows that underwent the onset of luteal regression, complete luteal regression, and ovulation were included in the 
respective analyses. Different letters across days indicate P < 0.05. E2 = estradiol.
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Figure 2.9.  Kaplan-Meier survival curves for time to complete luteal regression (progesterone < 0.5 ng/mL) (A) and ovulation (B) up 
to Day 42 for cows in the Cyclic (CY), No embryo (NE), Early embryo mortality (EEM), and Late embryo mortality (LEM) 
reproductive status groups.  The hazard of complete luteal regression was affected by (P <0.01) reproductive status group. The hazard 
of complete luteal regression for the different groups compared were: CY vs LEM (HR = 11.7; 95% CI: 3.2 – 42.7), NE vs LEM (HR 
= 7.2; 95% CI: 2.1 – 25.1), EEM vs LEM (HR = 4.3; 95% CI: 1.2 – 15.9), CY vs NE (HR = 1.6; 95% CI: 0.8 – 3.1), CY vs EEM (HR 
= 2.7; 95% CI: 0.9 – 7.6) and, EEM vs NE (HR = 0.6; 95% CI: 0.2 – 1.6). The hazard of ovulation was affected by (P <0.01) 
reproductive status group. The hazard of ovulation for the different groups compared were: CY vs LEM (HR = 13.6; 95% CI: 2.9 – 
61.9), NE vs LEM (HR = 7.2; 95% CI: 1. 7 – 31.4), EEM vs LEM (HR = 7.3; 95% CI: 1.5 – 36.4), CY vs NE (HR = 1.9; 95% CI: 0.9 
– 3.7), CY vs EEM (HR = 1.8; 95% CI: 0.7 – 4.9) and, EEM vs NE (HR = 1.0; 95% CI: 0.4 – 2.5). 
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DISCUSSION 
A necessary first step to test the hypothesis that EM around the period of CL maintenance 
by IFNT alters ovarian function was to identify cows that underwent EM. In the current study we 
defined EM based on ISG expression in PBMC and circulating concentrations of PSPB (marker 
of a suite of PAG). Greater ISG15 and MX2 mRNA abundance for the PG than CY reproductive 
status group from 18 to 22 days after AI indicated that the presence of an embryo induced 
substantial changes in ISG mRNA relative abundance in PBMC during a period of expected 
IFNT secretion by the embryo and abrogation of luteolysis (Knickerbocker et al., 1986; Meyer et 
al., 1995; Robinson et al., 2006). On the other hand, the lack of difference in ISG mRNA 
expression for the CY and NP reproductive status groups suggested that cows classified as non-
pregnant did not have an embryo present during the period of CL maintenance. Our observations 
for the PG and NP reproductive status groups are in agreement with previous studies that 
retrospectively classified cows based on pregnancy status determined by TUS at 32 to 45 days 
after AI (Han et al., 2006; Gifford et al., 2007; Green et al., 2010). Nevertheless, a major caveat 
of evaluating ISG expression retrospectively in cows diagnosed nonpregnant based on TUS 
several days after determination of ISG expression, is that embryo death from the time of ISG 
determination to the time of TUS cannot be determined. Because of this, we hypothesized that 
within the NP group it would be possible to identify cows with evidence of the presence and 
subsequent demise of an embryo through ISG expression and PSPB concentrations. In our 
experiment, the potential confounding effect of undetected EM for the determination of cutoff 
values for ISG was eliminated by including a group of cyclic cows not exposed to an embryo and 
a group of cows with a viable pregnancy up to 42 days after AI. Thus, in support of our 
hypothesis when cows assigned to the NP group were subdivided in the NE and EM groups, 
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cows in the EM group exhibited ISG15 and MX2 mRNA relative abundance similar to pregnant 
cows and greater than cows in the NE and CY reproductive status groups. In addition, the lower 
ISG mRNA relative abundance exhibited by cows in the EM than PG group on Day 22 was 
likely a reflection of poor embryo quality, delayed embryo development, embryo demise, or a 
combination of these for some cows in the EM group. In agreement, Ribeiro et al. (2016a) 
recently reported lower concentrations of IFNT in the uterine fluid of cows with embryos at 
earlier than later stages of development (ovoid < tubular < filamentous) 15 days after AI.  On the 
other hand, the similar pattern of ISG expression for the NE and CY groups suggests that in cows 
from the NE group, no embryo developed up to the period of CL maintenance by IFNT or that 
embryo development did not involve substantial production of IFNT.  
Based on our criteria to define the presence and subsequent demise of an embryo, 62% of 
the cows inseminated with semen (67% when including the three cows with EM >30 days after 
AI) presented evidence of an embryo around the period of CL maintenance by IFNT. Our results 
are in agreement with recent studies in which 66% [40/60; data combined from references (Mann 
and Lamming, 2001; Mann et al., 2006; Cerri et al., 2012)] of cows had an embryo at slaughter 
16 to 17 days after AI and two recent studies in which 61% (134/220) of cows were considered 
pregnant based on detection of IFNT in the uterine fluid 15 days after AI (Ribeiro et al., 2016a; 
Ribeiro et al., 2016b). Likewise, our estimation of EM is in agreement with the results of Han et 
al. (2006) who reported that 33% (4/12) of lactating dairy cows considered pregnant based on 
their ISG15 mRNA profile were diagnosed nonpregnant by TUS 32 days after AI.  
Unfortunately, the results of our study are not directly comparable to many of the 
previous reports which have estimated EM around the period of maintenance of the CL by IFNT 
because most studies based their estimation of EM on return to estrus, P4 profiles, PAG profiles, 
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or their combination (Humblot, 2001; Grimard et al., 2006; Gábor et al., 2007; Breukelman et al., 
2012). Determination of EM based on P4 profiles after AI lacks specificity because it does not 
provide evidence of the presence of an embryo. The use of PAG provides direct evidence of the 
presence of an embryo but not all cows exhibit detectable concentrations during the early period 
of CL maintenance by IFNT with current laboratory assays (Green et al., 2005; Giordano et al., 
2012a).  
The criteria used in the current study to identify cows with EM also has weaknesses 
because it relied on indirect evidence of IFNT production by the embryo and the presence of an 
embryo was not confirmed by other methods. In addition, it may have underestimated or 
overestimated the presence of embryos based on ISG mRNA relative abundance because ISG 
expression may be affected by factors other than IFNT. For example, infectious processes are 
known to induce ISG expression (Hansen et al., 2010; Smirnova et al., 2012; Weiner et al., 
2012). We attempted to minimize the potential confounding effect of infections on ISG 
expression by removing all cows that exhibited clinical signs of disease; however, it is possible 
that infections that did not cause clinical signs affected our results. Indeed, subclinical infections 
could explain, at least in part, why two cows in the CY group exhibited ISG mRNA relative 
abundance levels indicative of the presence of an embryo. On other hand, we attempted to 
minimize false positive outcomes and overestimating EM by defining the presence of an embryo 
based on ISG when cows presented fold changes for ISG15 or MX2 above the ROC cutoff point 
for three days rather than only one or two. In this regard, Han et al. (2006) reported greater 
predictive ability of pregnancy status in dairy cows when using ISG15 mRNA levels for at least 
four consecutive days beginning 18 days after AI rather than on Day 18 only. However, this 
stringent method to classify cows resulted in the potential misclassification of three cows based 
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on ISG (no embryo present based on ISG) in the LEM group. Detailed examination of ISG 
expression for these cows revealed that two cows had ISG15 or MX2 fold changes above the 
respective cutoff for each gene for at least one day. The other cow presented ISG fold changes 
above the cutoff for two days. It is unclear at the moment why these cows did not exhibit ISG 
expression above the cutoff for each one of the days analyzed but had detectable PSPB 
concentrations. Interestingly, two of these cows were primiparous which in a previous study 
(Green et al., 2010) but not in ours, had greater ISG expression than multiparous cows at the 
same stage of pregnancy. It is possible that these cows had smaller embryos which produced less 
IFNT (Mann and Lamming, 2001; Liebig, 2015; Ribeiro et al., 2016a; Ribeiro et al., 2016b), and 
thereby stimulated less ISG mRNA expression in PBMC (Liebig, 2015). Indeed, a positive dose 
response relationship was documented after intrauterine infusion of IFNT (Matsuyama et al., 
2012) or in vitro treatment (Shirasuna et al., 2012) for ISG expression in PBMC in cattle. 
Likewise, two cows in the PG reproductive status group also failed to present ISG above the 
cutoff during the three days (one cow had ISG expression over the threshold two days whereas 
the other one day only). In agreement, Han et al. (2006) reported that 22% of lactating dairy 
cows diagnosed pregnant by TUS 32 days after AI were incorrectly diagnosed nonpregnant 
based on serial determination of ISG15 mRNA abundance. Thus, additional research is needed to 
better characterize the multiple factors other than IFNT that may induce ISG expression and the 
ISG response in PBMC to embryos of different sizes and stages of development in lactating 
dairy cows. 
The most notable outcome of IFNT secretion by the bovine embryo is the prevention of 
luteolysis (Roberts et al., 1996; Spencer et al., 2006). Thus, we expected cows with EM during or 
immediately after the period of CL maintenance by IFNT to exhibit altered ovarian function; in 
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particular extended luteal phases and/or increased interovulatory intervals. In support of our 
hypothesis, cows with EM were less likely to undergo complete luteal regression, had delayed 
luteal regression, reduced ovulation rate, and longer interovulatory intervals. Moreover, we 
observed substantial variation for the timing of complete luteal regression among cows in the 
EM reproductive status group with a range of 18 to 40 days after AI and ~30% of the cows 
without complete luteal regression by the end of the observation period 42 days after AI. Our 
results are in agreement with previous studies which documented altered ovarian dynamics in 
cows with evidence of pregnancy loss based on PAG concentrations (Humblot, 2001; Grimard et 
al., 2006; Gábor et al., 2007; Breukelman et al., 2012), in cows that received intrauterine 
infusions of IFNT (Meyer et al., 1995), or in cows in which conceptus lysates were infused into 
the uterus before or during the expected time of CL maintenance by IFNT (Northey and French, 
1980). To the best of our knowledge this is the first study to document alterations to ovarian 
dynamics in cows with putative EM based on ISG expression in PBMC and circulating PAG 
concentrations.  
Cows with evidence of EM were separated further in an EEM and LEM groups because 
we speculated that ovarian function could be affected differently depending on the timing of EM. 
Based on the current understanding of ISG expression and PAG concentration patterns, the 
observation of PSPB concentrations similar to those of cows with a viable pregnancy was 
interpreted as an indication of further embryo development than when only ISG mRNA above 
the cutoff points selected was observed. For cows in the EEM reproductive status group it was 
assumed that an embryo survived to produce sufficient IFNT to induce ISG expression, however, 
the embryo died before producing detectable amounts of PSPB. Our observations for the EEM 
and LEM reproductive status groups offered interesting insights about the relationship between 
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EM and ovarian function. Only cows that suffered LEM were less likely to undergo complete 
luteal regression, have delayed luteal regression, and longer interovulatory intervals than cows in 
the CY and NE reproductive status groups, whereas cows in the EEM group exhibited patterns of 
CL regression and ovulation similar to those of cows in the NE and CY reproductive status 
groups. Our observations are in agreement with the traditional definition of EEM and LEM 
based on the timing of return to estrus after AI whereby, return to estrus before 24 days after AI 
is indicative of lack of fertilization or EEM, whereas return to estrus after 24 days after AI is 
indicative of LEM (Humblot, 2001). The traditional definition of EEM and LEM was based on 
the notion that extension of the interestrus interval beyond 24 days is due to embryo demise at 
least 16 days after ovulation when substantial IFNT production is initiated in cattle (Farin et al., 
1990; Robinson et al., 2006). Our current results, however, suggest that embryo death from 16 to 
22 days after AI does not necessarily extend the luteal phase. For cows in the EEM reproductive 
status group there was evidence of the presence of an embryo based on ISG mRNA from 18 to 
22 days after AI but these cows completed luteal regression at a similar time as cows in the CY 
and NE reproductive status groups. A plausible explanation for these observations is that 
embryos from cows in the EEM group survived beyond Day 16 and reached a stage of 
development at which they produced sufficient IFNT to induce ISG expression but insufficient to 
prevent luteolysis. These embryos might have been developmentally impaired, and thereby of 
smaller size than expected during the period of CL maintenance by IFNT. Indeed, the presence 
of a smaller embryo was associated with lower IFNT concentrations in the uterine lumen (Mann 
and Lamming, 2001; Ribeiro et al., 2016a; Ribeiro et al., 2016b) and a greater 13, 14-dihydro-
15-keto-prostaglandin F2alpha (a PGF2α metabolite) response to an oxytocin challenge (Mann 
and Lamming, 2001). Also, greater ISG mRNA abundance in PBMC was reported for cows that 
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received intrauterine infusion of greater doses (1,000 vs. 500 µg) of recombinant IFNT 
(Matsuyama et al., 2012). Despite these observations, we cannot speculate about the size or the 
capability of embryos to produce IFNT in cows with EEM because a quantitative relationship 
between ISG mRNA abundance in PBMC with embryo size and IFNT production in-vivo has 
not been determined for cows. Asynchrony between the actual time of IFNT production and the 
time at which IFNT was necessary to prevent luteolysis is another possible explanation for our 
observations. Indeed, for some cows, the onset of luteolysis was observed before Day 18 to 22 
when ISG expression was evident (Figure 2.4A and 2.4B) suggesting that luteolysis began before 
the embryo was capable of producing sufficient IFNT to prevent it.  
Based on the fact that in cows with evidence of EEM from 18 to 22 days after AI the 
luteal phase and interovulatory interval were not extended, we speculate that in lactating dairy 
cows normal conceptus development needs to continue beyond 22 days of gestation to 
effectively prevent luteolysis and extend the luteal phase substantially. Unfortunately, the exact 
relationship between days of exposure to IFNT or to an embryo in-vivo and the magnitude of the 
extension of the luteal phase is unknown. Notably, studies that intended to mimic the process of 
CL maintenance by IFNT through i.m. injections of IFN-α from Day 14 to 17 (Plante et al., 
1984), uterine infusion of conceptus lysates twice daily from Day 14 to 18 (Northey and French, 
1980), or embryo removal from Day 17 to 19 (Northey and French, 1980) extended the luteal 
phase for only 3 to 4 days. In contrast, the luteal phase was extended by 8 days in cows that 
received twice daily intrauterine infusions of IFNT from Day 14 to 24 (Meyer et al., 1995) and 
some cows did not present complete luteal regression by the end of the observation period 35 
days after ovulation. An implication of our observations for the timing of EM and its relationship 
with ovarian function is that the duration of the luteal phase or the interovulatory interval may 
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not be accurate predictors of the occurrence and timing of EM because embryo demise during 
the period of CL maintenance by IFNT did not necessarily extend the luteal phase and the 
interovulatory interval. In this regard, research to elucidate the mechanisms underpinning EM in 
dairy cattle should not only focus on the pre-hatching period of development when most EM is 
believed to occur (Santos et al., 2004; Diskin and Morris, 2008) but also on the period of 
elongation when the process of CL maintenance occurs. Because immediately before and during 
the period of CL maintenance by IFNT, the conceptus is undergoing rapid growth and elongation 
(Hue et al., 2007; Spencer, 2013), the potential causes of EM may be different than during the 
period from fertilization to the beginning of elongation. 
Another objective of this experiment was to evaluate follicular dynamics in cows that 
underwent EM because it has not been studied in detail. Interestingly, we did not observe 
substantial alterations of the follicular dynamics from the approximate time of the onset of luteal 
regression to ovulation in cows with EM. For cows that exhibited luteal regression and ovulated, 
the patterns of follicle growth and size (diameter) after the onset of luteal regression were not 
different for cows in the EM reproductive status group. It is important to note that there were 
cows that did not undergo complete luteal regression or ovulate 42 days after AI. Therefore, days 
to complete luteal regression and to ovulation were biased towards cows that had the shortest 
interovulatory intervals among cows with EM. The lack of difference in estradiol concentrations 
during the period of CL regression and periovulatory period also supported the notion that the 
presence and subsequent demise of an embryo did not cause direct or indirect (through endocrine 
changes) alterations to the steroidogenic capacity of follicles. Unfortunately, we were unable to 
determine if alterations to follicle development before the onset of luteolysis were responsible, at 
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least in part, for the delay in the onset of luteal regression in cows with EM because the exact 
timing of EM could not be determined.  
Taken together, the results for luteal dynamics and follicle development in lactating dairy 
cows that suffered EM around the period of CL maintenance by IFNT suggest that ovarian 
function alterations were mostly due to delayed luteal regression and not because of major 
alterations of follicular dynamics. Thus, further research should focus on understanding the 
mechanism underpinning the onset of luteal regression after EM. In cyclic cows, or in the 
absence of an embryo during the expected period of CL maintenance by IFNT, the mechanism 
responsible for luteolysis depends upon a series of well-orchestrated hormone release and 
receptor expression patterns in the uterus and ovaries (McCracken et al., 1999; Niswender et al., 
2000; Okuda et al., 2002). In pregnant cows, the presence of the embryo and its secretions (e.g., 
IFNT and other pregnancy-specific proteins) cause profound alterations to these patterns to 
prevent luteolysis and sustain pregnancy. As a result, the series and timing of endocrine events 
that lead to the reestablishment of the luteolytic mechanism in cows that suffer EM may be 
different than in cyclic cows.  
 
 
CONCLUSIONS 
Our current results provided evidence that the combination of ISG mRNA relative 
abundance and circulating PSPB (marker of a suite of PAG) concentrations after AI is a 
reasonable method to experimentally determine the presence or absence of an embryo around the 
period of CL maintenance by IFNT. Cows with evidence of EM based on ISG and PSPB 
exhibited a pattern of ISG expression that more closely resembled that of pregnant than cyclic 
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cows or cows with no evidence of embryo presence during this period of time. This study also 
highlights the substantial number of pregnancies that are present during the period of CL 
maintenance by IFNT that are subsequently lost.  
Among cows with EM, only those with LEM had delayed luteal regression, reduced 
ovulation rate, and longer interovulatory intervals compared with cyclic cows and cows with no 
evidence of the presence of an embryo during the period of CL maintenance by IFNT. Thus, our 
results suggest that embryo development needs to continue beyond 22 days after AI to 
effectively prevent luteolysis and extend the luteal phase substantially. Cows in the EEM 
reproductive status group exhibited evidence of IFNT secretion but the amount and timing of 
IFNT might have been insufficient to effectively prevent luteolysis. Finally, ovarian function 
alterations in cows that underwent EM were mostly due to delayed luteal regression rather than 
alterations of follicle development after the onset of luteolysis.  
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Supplementary table 2.1. Individual ISG15 and MX2 fold changes (Days 18, 20 and 22 after AI) and pregnancy-specific protein B 
(PSPB; Days 24 and 26 after AI) concentrations for cows in the Embryo Mortality reproductive status group. 
  Day 18   Day 20   Day 22   Day 24   Day 26   Outcome 
Cow ID ISG15 MX2   ISG15 MX2   ISG15 MX2   PSPB (ng/mL)   PSPB (ng/mL)   ISG +   PSPB + 
8849 1.0 1.8   1.9 1.7   2.3 3.9   0.6   1.2   -   + 
8964 4.0 4.3   2.1 2.9   4.2 3.1   0.7   1.6   +   + 
9168 6.8 1.7   45.6 14.6   12.1 7.2   0.9   1.2   +   + 
9441 1.5 3.7   6.5 4.0   8.3 5.8   0.6   0.7   +   + 
9538 3.0 2.3   15.2 7.2   15.3 7.7   1.1   1.9   +   + 
9547 0.8 0.8   0.6 1.1   0.9 1.4   0.5   0.8   -   + 
9578* 0.8 0.7   2.7 1.3   1.2 0.9   < 0.3   0.4   -   + 
8066 2.7 1.5   5.0 4.3   1.5 2.8   < 0.3   < 0.3   +   - 
8442 4.9 12.7   2.2 3.9   1.5 2.4   < 0.3   < 0.3   +   - 
8699 5.6 4.6   6.1 5.3   2.9 3.4   < 0.3   < 0.3   +   - 
9197 0.5 1.8   0.3 5.3   0.5 5.3   < 0.3   < 0.3   +   - 
9321 5.5 0.8   14.5 1.4   5.1 1.0   < 0.3   < 0.3   +   - 
9518 26.7 30.7   7.0 7.0   1.0 1.4   < 0.3   < 0.3   +   - 
9611 4.3 7.1   0.6 11.7   3.8 2.9   < 0.3   < 0.3   +   - 
                   *reached 0.7 ng/mL of PSPB in plasma on Day 32. 
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CHAPTER III 
RESYNCHRONIZATION OF OVULATION PROTOCOLS FOR DAIRY COWS 
INCLUDING OR NOT INCLUDING GNRH TO INDUCE A NEW FOLLICULAR 
WAVE: EFFECTS ON RE-INSEMINATION PATTERN, OVARIAN RESPONSES, AND 
PREGNANCY OUTCOMES 
R. Wijma, M. L. Stangaferro, M. Masello, G. E. Granados, and J. O. Giordano 
Journal of dairy Science 2017 (In press) 
DOI 10.3168/jds.2017-12550 
ABSTRACT 
Our objectives were to evaluate the pattern of re-insemination, ovarian responses, and 
pregnancy per AI (P/AI) of cows submitted to different resynchronization of ovulation protocols. 
The base protocol started at 25 ± 3 d after AI and was as follows: GnRH, 7 and 8 d later PGF2α, 
GnRH 32 h after second PGF2α, and fixed timed AI (TAI) 16 to 18 h after GnRH. At 18 ± 3 d 
after AI cows were randomly assigned to the G25 (n = 1,100) or NoG25 (n = 1,098) treatments. 
The protocol for G25 and NoG25 was the same, except that cows in NoG25 did not receive 
GnRH 25 ± 3 d after AI. At nonpregnancy diagnosis (NPD), 32 ± 3 d after AI, cows from G25 
and NoG25 with a corpus luteum (CL) ≥ 15 mm in diameter and a follicle ≥ 10 mm completed 
the protocol (G25 CL = 272, NoG25 CL = 194), whereas cows from both treatments that did not 
meet these criteria received a modified Ovsynch protocol with P4 supplementation [controlled 
internal drug release insert (CIDR) plus GnRH, CIDR removal and PGF2α 7 and 8 d later, 
GnRH 32 h after second PGF2α, and TAI 16 to 18 h after GnRH (G25 NoCL = 53, NoG25 
NoCL = 78)]. Serum concentrations of progesterone (P4) were determined and ovarian 
ultrasonography was performed thrice weekly from 18 ± 3 d after AI until one day after TAI 
(G25 = 46, NoG25 = 44 cows). A greater percentage of NoG25 cows were re-inseminated at 
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detected estrus (NoG25 = 53.5%, G25 = 44.6%), whereas more cows had a CL at NPD in G25 
than NoG25 (83.7 and 71.3%). At 32 d after AI, P/AI was similar for G25 and NoG25 for 
inseminations at detected estrus (38.4 and 42.9%), TAI services for cows with no CL (40.4 and 
36.7%), and for all services combined (39.6 and 39.0%). However, P/AI were greater for cows 
with a CL in G25 than NoG25 (40.6 and 32.8%) that received TAI. More cows ovulated 
spontaneously or in response to GnRH for the G25 than the NoG25 treatment (70 and 36%) but a 
similar proportion had an active follicle at NPD (G25 = 91% and NoG25 = 96%). Largest follicle 
diameter at NPD (G25 = 15.0 ± 0.4 mm, NoG25 = 16.5 ± 0.6 mm) and days since it reached ≥ 10 
mm (G25 = 4.0 ± 0.3 d, NoG25 = 5.8 ± 0.6 d) was greater for the NoG25 than G25 treatment. 
For cows with a CL at NPD, CL regression after NPD, ovulation after TAI, and ovulatory 
follicle diameter did not differ. In conclusion, removing the first GnRH of a modified Resynch-
25 protocol for cows with a CL at NPD and a modified Ovsynch protocol with P4 
supplementation for cows without a CL at NPD resulted in a greater percentage of cows re-
inseminated at detected estrus and a similar proportion of cows pregnant in spite of reduced P/AI 
for cows with a CL at NPD.  
Keyword: resynchronization, estrus detection, GnRH, dairy cow 
 
INTRODUCTION 
An ideal strategy for submitting cows for re-insemination minimizes the interbreeding 
interval and maximizes pregnancy per AI (P/AI).  Many dairy farms reduce the interbreeding 
interval by combining re-insemination of cows after a detected estrus and submission to 
resynchronization of ovulation for timed AI [TAI; (Caraviello et al., 2006; Ferguson and 
Skidmore, 2013; Scott, 2016)]. Re-insemination of cows at estrus with resulting P/AI similar to 
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or better than that observed after re-insemination at fixed time AI benefits herd profitability by 
reducing the overall interbreeding interval and reproductive program cost (Giordano et al., 
2012b; Galvão et al., 2013; Giordano et al., 2013). On the other hand, incorporating a 
resynchronization of ovulation protocol for TAI is essential because it ensures timely re-
insemination of nonpregnant cows not detected in estrus. Therefore, Ovsynch-type protocols are 
usually initiated at the time of or seven days before nonpregnancy diagnosis (NPD) to ensure that 
nonpregnant cows receive TAI as soon as possible (Chebel et al., 2003; Fricke et al., 2003; 
Lopes et al., 2013).  
For farms that enroll cohorts of cows in a resynchronization of ovulation protocol on a 
weekly basis, an effective strategy to minimize the interbreeding interval of TAI services is to 
initiate the Ovsynch protocol (GnRH, 7 d later PGF2α, 56 h later GnRH, and 16 to 20 h later 
TAI) 25 ± 3 d after AI (hereafter referred to as Resynch-25), which results in an interbreeding 
interval of 35 ± 3 d. A caveat of this protocol is that the GnRH treatment 25 ± 3 d after AI may 
reduce estrus expression because many cows are expected to receive the treatment when a 
follicle capable of ovulating in response to a GnRH-induced LH surge is present on the ovaries. 
In cattle, a GnRH-induced LH surge causes an immediate reduction in estradiol production by 
the dominant follicle (Berndtson et al., 1995; Komar et al., 2001; Jo and Fortune, 2003), which 
can prevent the estradiol surge responsible for estrous behavior. Indeed, previous research has 
shown that fewer cows are detected in estrus when GnRH is given to cows 17 to 32 d after AI 
(Chebel et al., 2003; Mendonça et al., 2012; Bruno et al., 2014). Another inconvenience 
associated with the Resynch-25 protocol is that because the pregnancy status of cows is unknown 
25 ± 3 d after AI, a substantial proportion of the cows that receive the first GnRH treatment are 
pregnant. These unnecessary treatments increase the cost and burden (i.e., labor and cow 
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disruption) of the reproductive management program. Thus, removing the first GnRH treatment 
of the protocol may be an alternative strategy to reduce the interbreeding interval without 
disrupting re-insemination at estrus and eliminating the treatment of pregnant cows.  
The first GnRH of the Resynch-25 protocol is meant to induce the emergence of a new 
follicular wave that will give rise to the ovulatory follicle and the formation of a new corpus 
luteum (CL) after ovulation (Pursley et al., 1995). Therefore, removing the first GnRH of the 
Resynch-25 protocol may reduce the synchrony of ovulation, fail to promote a proper endocrine 
environment for follicle growth, and result in poorer oocyte quality because of an extended 
period of dominance of the ovulatory follicle. Indeed, P/AI of cows that ovulate to the first 
GnRH treatment of Ovsynch-like protocols is greater than that of cows that fail to ovulate 
(Chebel et al., 2003; Galvão et al., 2007; Rutigliano et al., 2008; Bisinotto et al., 2010; Keskin et 
al., 2010; Giordano et al., 2012d). Nonetheless, the detrimental effects of lack of ovulation may 
be less relevant when initiating Resynch 25 ± 3 d after AI than when initiating the protocol at 
other intervals after AI (e.g., 32 ± 3 or 39 ± 3 d) or when a group of cows is initiated in the 
protocol at a wider range of days after AI. This is because at 32 ± 3 d after AI, when cows would 
receive the PGF2α treatment of the Resynch-25 protocol, 60 to 85% of the nonpregnant cows 
present a functional CL (Giordano et al., 2012d; Bruno et al., 2014; Giordano et al., 2015; Wijma 
et al., 2015) and almost all cows present an active follicle with potential to continue growing 
after a PGF2α treatment (Wijma et al., 2015). Moreover, the ovulatory response to the first 
GnRH of the Resynch-25 protocol rarely exceeds ~40 to 60% (Giordano et al., 2012c; Lopes et 
al., 2013; Bruno et al., 2014), resulting in not all cows properly synchronized 7 d later.  
Another advantage of management strategies aimed at reducing the interbreeding interval 
of TAI services is that NPD is usually conducted through transrectal ultrasonography (Chebel et 
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al., 2003; Fricke et al., 2003; Giordano et al., 2015). This method of pregnancy testing allows the 
determination of the ovarian status of cows with minimal additional effort. Anticipating that the 
use of the Resynch-25 protocol without the GnRH treatment 25 ± 3 d after AI could result in 
fewer cows at the appropriate stage of the estrous cycle at NPD; using treatments tailored to the 
ovarian status of cows could help maximize P/AI to TAI services (Giordano et al., 2016). For 
example, completing the Resynch-25 protocol only in cows that present a CL and a putative 
ovulatory follicle at NPD could result in reasonable P/AI. Conversely, cows without a CL and/or 
a putative ovulatory follicle may benefit from re-enrollment in a synchronization of ovulation 
treatment including progesterone (P4) supplementation (Bisinotto et al., 2015; Giordano et al., 
2016) through improved synchrony of ovulation and a better endocrine environment before TAI.  
Thus, our objectives were to evaluate the effect of removing the first GnRH of the 
Resynch-25 protocol on the pattern of re-insemination, ovarian responses before and after the 
protocol, and P/AI. We hypothesized that removing the GnRH treatment 25 ± 3 d after AI would 
result in re-insemination of more cows upon detection of estrus. A secondary hypothesis was that 
the expected reduction in P/AI for TAI services in cows that did not receive the GnRH treatment, 
would not reduce the overall proportion of pregnant cows. We expected that cows pregnant after 
insemination at detected estrus would compensate for the reduced fertility to TAI services.  
 
MATERIALS AND METHODS 
This experiment was conducted from March 2015 to December of 2016 at the Dairy Unit 
of the Cornell University Ruminant Center (Harford, NY). All procedures were approved by the 
Animal Care and Use Committee of Cornell University.  
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Cows were housed in free stall barns and were fed a total mixed ration once a day with ad 
libitum access to feed and water. The diet was formulated to meet or exceed nutrient 
requirements for lactating dairy cows producing 45 kg of milk per day (Cornell Net 
Carbohydrate and Protein System). Cows were milked thrice daily at approximately 8 h intervals 
and received recombinant bovine somatotropin (500 mg of Sometribove zinc; Posilac, Elanco 
Animal Health, Indianapolis, IN) at 14 d intervals beginning at 60 ± 3 DIM until dry off. 
Cows received the first service postpartum at 64 ± 3 DIM after synchronization of 
ovulation with the Presynch-Ovsynch protocol [PGF2α, 14 d later PGF2α, 12 d later GnRH, 7 d 
later PGF2α, 56 h later GnRH, and 16 to 18 h later fixed time AI (Moreira et al., 2001)]. Ten 
percent of the cows did not complete the synchronization protocol and received the first service 
at detected estrus after the second PGF2α treatment of Presynch because of management 
decisions from the farm manager. 
Every Monday, the cohort of cows at 18 ± 3 d after AI were blocked by parity 
(primiparous vs. multiparous) and randomly assigned to receive (G25, n = 1,100) or not receive 
(NoG25, n = 1,098) GnRH (Cystorelin, 100 µg, Merial LLC, Duluth, GA) treatment 25 ± 3 d 
after AI (Figure 3.1). Cows could have been enrolled in either one of the treatments more than 
once. At 32 ± 3 d after AI, NPD was performed by transrectal ultrasonography (Ibex Pro, Ibex, 
Loveland, CO) in cows from both treatments not previously re-inseminated at detected estrus. A 
cow was considered pregnant if a viable embryo with a heartbeat or uterine fluid and a CL ≥ 15 
mm were observed. Pregnant cows received no further treatment, whereas nonpregnant cows 
from both treatments (G25 and NoG25) were classified based on the ovarian structures present. 
Cows from the G25 and NoG25 treatments with at least one CL ≥ 15 mm and a follicle ≥ 10 mm 
in diameter received a PGF2α (Estrumate, 500 µg, Merck Animal Health, Summit, NJ, USA) 
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treatment immediately after NPD, a second PGF2α treatment 24 h later, GnRH 32 h after the 
second PGF2α treatment, and TAI 16 to 18 h later (Figure 3.1). Cows from the G25 and NoG25 
treatments that did not meet these criteria received a modified Ovsynch protocol with two 
PGF2α treatments and P4 supplementation through an intravaginal P4 releasing device (Eazi-
Breed CIDR, Zoetis Animal Health, Florham Park, NJ) from the time of NPD to the first PGF2α 
of the protocol (GnRH plus CIDR insertion, 7 d later PGF2α and CIDR removal, 24 h later 
PGF2α, 32 h later GnRH, and 16 to 18 h later TAI; Figure 3.1).  
For the G25 treatment, 272 cows with a CL and 53 cows without a CL received TAI, 
whereas for the NoG25 treatment 194 cows with a CL and 78 cows without a CL received TAI. 
All cows detected in estrus after AI (before or after enrollment) were immediately 
inseminated. Detection of estrus was conducted through visual observation twice a day for ~30 
to 45 min per session by the technician in charge of implementing the farm reproductive 
management program (i.e., artificial insemination, hormonal treatments, and assisting research 
personnel during pregnancy testing). Farm personnel in charge of moving cows to and from the 
parlor and milking also recorded estrus events.  
Reconfirmation of pregnancy was performed at 63 ± 3 d after AI by transrectal palpation 
of the uterine contents. Pregnancy loss was defined as a negative pregnancy outcome at re-
confirmation of pregnancy for a cow pregnant at the initial pregnancy examination or when a 
cow received insemination at detected estrus between the two pregnancy examinations.  
 
Evaluation of Ovarian Responses  
In a sub-group of cows (n = 362) from each treatment (G25 = 166, NoG25 = 196), 
ovarian responses were monitored by transrectal ultrasonography following a Monday, 
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Wednesday, and Friday schedule (enrollment and NPD were performed on Mondays) from 18 ± 
3 d after AI until cows were either diagnosed pregnant or re-inseminated. Two hundred and 
seventy two cows were either detected in estrus and inseminated before NPD or were pregnant, 
thereby the final number of cows with data available from enrolment until TAI was 46 and 44 for 
the G25 and NoG25 treatment, respectively. 
At each examination, the location and size (diameter) of follicles ≥ 8 mm and any corpora 
lutea present was recorded on an individual ovarian map. All measurements were performed 
using the ultrasound machine internal digital calipers. Follicle and CL diameter was the average 
of the two longest perpendicular measurements. Ovulation was defined as the disappearance of at 
least one putative ovulatory follicle ≥ 10 mm between two consecutive examinations. The day of 
ovulation was defined as the day previous to the examination when follicle disappearance was 
detected. Ovulations detected up to 48 h after the GnRH treatment 25 ± 3 d after AI were 
considered induced by GnRH, whereas ovulations before GnRH treatment or more than 48 h 
after GnRH treatment were considered spontaneous ovulations. Follicles were considered active 
(i.e., growing or static phase of development) when their diameter was ≥ 10 mm and either 
continued to grow or did not present two consecutive reductions in size in three consecutive 
examinations.  
 
Blood Sample Collection  
Blood samples were collected at the time of the transrectal ultrasonography examination 
from the subgroup of cows in which ovarian responses were monitored (G25 = 166, NoG25 = 
196). Blood samples were collected using 8-mL serum separator tubes (BD Vacutainer, Franklin 
Lakes, NJ) via puncture of the coccygeal vein or artery and were used to determine circulating 
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concentrations of P4. Samples were centrifuged at 1,700 x g for 20 minutes at room temperature 
within 2 h of collection. Serum was harvested and transferred into different storage vials and 
stored at -20°C until assays were performed.  
 
Determination of Progesterone Concentrations  
Progesterone concentrations in serum were determined in duplicate using a commercial 
solid-phase, no-extraction radioimmunoassay (ImmuChem Coated Tube, MP Biomedicals, Costa 
Mesa, CA). To assess precision of the assay, control samples with high (4.5 ng/mL) and low (0.3 
ng/mL) concentrations of P4 were included at the beginning and end of each assay (n = 7 
assays). Average detection limit for the P4 assay was 0.1 ng/mL. Average intra-assay CV for the 
high-concentration sample was 13%, whereas the inter-assay CV was 16%. For the low-
concentration sample the average intra-assay CV was 22%, whereas the inter-assay CV was 
26%. 
Circulating concentrations of P4 were used to determine the presence or absence of a 
functional CL and luteal regression. The presence of a functional CL was defined as circulating 
concentrations of P4 ≥ 0.5 ng/mL at time points of interest, whereas luteal regression was 
defined as drop in circulating concentrations of P4 to < 0.5 ng/mL. 
 
Statistical Analysis 
 The experiment was conducted as a complete randomized design using parity 
(primiparous vs. multiparous) as blocking factor, and number of AI services as stratification 
factor. Because the experimental unit was the AI service after enrollment, cows were randomized 
each time they reached 18 ± 3 d after a previous AI. 
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A sample size calculation was performed using the sample size calculation option of 
WinPepi version 11.51 (Abramson, 2011). Based on an expected difference between treatments 
in the proportion of cows detected in estrus of 10 percentage points for cows that received GnRH 
treatment at the same range of days after AI (Bruno et al., 2014), a total of 325 cows per 
treatment was needed for a one-tailed test with probability of type I error rate of 5% and  
probability of type II error rate of 20%. Moreover, because P/AI for cows with a CL at NPD that 
did not receive GnRH was a secondary outcome of interest for this experiment, we planned on 
enrolling more cows to have sufficient experimental units (i.e., AI services) to detect a difference 
in P/AI ranging from 11 to 12 percentage points when P/AI for TAI services in cows with a CL 
in the G25 treatment was 35%. A total of 176 to 212 cows per treatment were needed for a one-
tailed test with probability of type I error rate of 5% and probability of type II error rate of 20%. 
We did not expect to detect a difference in P/AI for cows inseminated after a detected estrus or 
cows without a CL at NPD. A one-tailed test was used for the analysis of proportion of cows 
detected in estrus and P/AI for cows with CL at NPD because in both cases the hypothesis was 
that the difference between treatments would be in one direction. Specifically, we anticipated 
observing a greater proportion of cows detected in estrus in the NoG25 treatment based on 
experiments that reported a reduction in estrus expression in cows treated with GnRH (Bruno et 
al., 2014). For P/AI in cows with a CL, we anticipated observing greater P/AI for the G25 
treatment because cows that ovulated in response to the GnRH treatment to induce a follicular 
wave in Ovsynch-type protocols had greater P/AI in previous experiments (Chebel et al., 2003; 
Bisinotto et al., 2010; Keskin et al., 2010). 
Binary outcomes (P/AI, proportion of cows detected in estrus, proportion of cows with a 
CL at NPD, pregnancy loss from 32 ± 3 to 63 ± 3 d after AI, ovulation, presence of an active 
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follicle at NPD, and proportion of cows with P4 ≥ 0.5 ng/mL at NPD) were analyzed using 
logistic regression with the GLIMMIX procedure of SAS (version 9.4, SAS Institute Inc., Cary, 
NC). Treatment and parity (primiparous vs. multiparous) were included as fixed effects, and cow 
was included as random effect when applicable (proportion of cows detected in estrus, 
proportion of cows with a CL at NPD). Days in milk at enrollment and season at the time of 
insemination [warm (June, July, and August) vs. cold (September to May)] were offered to the 
initial models. Both DIM and season were removed from all final models because P > 0.10. 
Luteal regression and presence of an active follicle at the time of GnRH treatment 25 ± 3 d after 
AI were analyzed with the Fisher exact test using the FREQ procedure of SAS because in one of 
the groups 100% of the cows presented luteal regression or an active follicle.  
  Data for circulating concentrations of P4, follicle size, days to ovulation, and days after 
the largest active follicle present 25 ± 3 and 32 ± 3 d after AI reached 10 mm were analyzed by 
ANOVA with the MIXED procedure of SAS including treatment and parity as fixed effects. 
Normality and homoscedasticity of residuals were assessed using graphical methods generated 
with the residual option of the MIXED procedure of SAS. Because progesterone concentration 
data were not normally distributed, square root transformation of the data was used. Days to 
ovulation and days after the largest active follicle present 25 ± 3 and 32 ± 3 d after AI reached 10 
mm did not follow a normal distribution and could not be corrected through data transformation. 
Therefore, data were analyzed using the Kruskal-Wallis test with the NPAR1WAY procedure of 
SAS.  
 Cox’s proportional hazards regression run with the PHREG procedure of SAS was used 
to determine the hazard of ovulation and re-insemination after AI. Treatment and parity were 
included as fixed effects, and cow as a random effect (for hazard of re-insemination only). 
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Kaplan-Meier survival curves were generated to illustrate the hazard of re-insemination in estrus 
after AI using the Survival Analysis option of MedCalc (MedCalc Software bvba, Ostend, 
Belgium).  
All results are presented as arithmetic means ± SE generated with the MEANS procedure 
of SAS. All explanatory variables were considered significant if P ≤ 0.05, whereas P-values > 
0.05 and ≤ 0.10 were considered a tendency.  
 
RESULTS  
Re-insemination Dynamics and Pregnancy per Artificial Insemination 
 Forty four percent of the cows that were enrolled 18 ± 3 d after AI were considered 
pregnant based on transrectal ultrasonography 32 ± 3 d after AI. Pregnancy per AI for these cows 
was similar (P = 0.81) for the G25 (44.4%; 483/1,088) and the NoG25 (43.9%; 479/1,092) 
treatment.  
A greater proportion of cows were inseminated (P <0.01) after a detected estrus in the NoG25 
than in the G25 treatment (Table 3.1). Parity also had an effect on the proportion of cows that 
received AI after estrus detection [primiparous = 55.3% (140/253) and multiparous = 47.3% 
(435/919); P = 0.03]. The hazard of insemination after estrus detection was greater (P = 0.04) 
for cows in the NoG25 treatment [hazard ratio (HR) = 1.20, 95% CI: 1.01 to 1.43; Figure 3.2]. 
Median time to re-insemination at detected estrus for the NoG25 treatment was 31 d (95% CI: 27 
to 35), whereas it could not be calculated for the G25 treatment because less than 50% of the 
cows were re-inseminated at detected estrus. Further, mean days to detection of estrus were 23.2 
± 0.3 and 22.5 ± 0.3 for the NoG25 and G25 treatment, respectively. Primiparous cows had 
greater (P = 0.01) hazard of insemination after estrus detection than multiparous cows (HR = 
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1.35, 95% CI: 1.07 to 1.71). Mean days to estrus detection were 22.1 ± 0.4 d primiparous cows 
and 23.1 ± 0.2 d for multiparous cows.  
In spite of the difference in the proportion of cows detected in estrus and hazard ratio for 
detection of estrus before NPD, the hazard of re-insemination for all services combined (at 
detected estrus and TAI) was similar (P = 0.80) for both treatments (HR = 1.02, 95% CI: 0.90 to 
1.14). Median days to re-insemination were 34 and 31 d for the G25 and NoG25 treatment, 
respectively, whereas mean days to re-insemination were 30.3 ± 0.3 and 29.9 ± 0.3 d for the G25 
and NoG25 treatment, respectively. 
Among cows diagnosed nonpregnant 32 ± 3 d after AI, a greater (P < 0.001) proportion 
of cows in the NoG25 treatment did not have a CL ≥ 15 mm at NPD (Table 3.1). Parity did not 
affect (P = 0.89) the proportion of cows without a CL ≥ 15 mm at NPD. 
 Pregnancy per AI for all AI services combined (after detected estrus and TAI) did not 
differ (P = 0.80) between treatments (Table 3.2) but was greater (P < 0.01) for primiparous 
(46.8%; 117/250) than multiparous cows (37.2%; 332/893). Further, P/AI did not differ for the 
G25 and NoG25 treatments for cows that received AI after a detected estrus (P = 0.30) or for 
cows without a CL ≥ 15 mm at NPD that received TAI (P = 0.82; Table 3.2). Pregnancy per AI 
for cows with a CL ≥ 15 mm at NPD that received TAI was greater (P = 0.05) for the G25 than 
the NoG25 treatment (Table 3.2). 
Five cows from the G25 treatment and five cows from the NoG25 treatment exited the 
herd before pregnancy reconfirmation. Pregnancy per AI 63 ± 3 d after AI was not different (P = 
0.76) between treatments (G25 = 36.2% and NoG25 = 35.6%) and was greater (P < 0.01) for 
primiparous (43.0%, 107/249) than multiparous cows (34.1%, 301/583). Pregnancy loss from the 
initial pregnancy evaluation at 32 ± 3 after AI until pregnancy reconfirmation 63 ± 3 d after AI 
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for all inseminations was similar (P = 0.94) for both treatments (Table 3.2). Further, pregnancy 
loss was not different between the G25 and the NoG25 treatments for cows inseminated at 
detected estrus (G25 = 7% and NoG25 = 6%; P = 0.77), cows that had a CL ≥ 15 mm at NPD 
and received TAI (G25 = 9% and NoG25 = 8%; P = 0.94), and cows that did not have a CL ≥ 15 
mm at NPD and received TAI (G25 = 0% and NoG25 = 11%; P = 0.97). 
 
Ovarian Responses from Enrollment until Nonpregnancy Diagnosis 
Out of 362 cows with data for ovarian responses, 42% (n = 153) were pregnant and 58% 
(n = 209) were nonpregnant 32 ± 3 d after AI. Among nonpregnant cows, 57% (n = 119) were 
inseminated after detection of estrus before NPD and 43% (n = 90; G25: n = 46 and NoG25: n = 
44) were diagnosed nonpregnant 32 ± 3 d after AI. All cows diagnosed nonpregnant received 
TAI. Blood samples were not available for two cows (one from the G25 and one from the 
NoG25 treatment) but ovarian data collected by transrectal ultrasonography was included in the 
analysis.  
The proportion of cows not re-inseminated at detected estrus that ovulated spontaneously 
from 18 ± 3 to 32 ± 3 d after AI and was not affected by treatment (P = 0.20; Table 3.3) or parity 
(P = 0.38). Including spontaneous and induced ovulations, a greater proportion (P < 0.01) of 
cows ovulated in the G25 treatment (72%) than the NoG25 treatment (36%) from 18 ± 3 to 32 ± 
3 d after AI. For cows in the G25 treatment, 50% ovulated in response to the GnRH treatment 
given 25 ± 3 d after AI (Table 3.3). Parity did not affect (P = 0.47) the proportion of cows that 
ovulated. Mean days from the previous AI to ovulation were greater (P < 0.01) for cows in the 
G25 (25.9 ± 0.4 d; range: 21 to 30 d) than the NoG25 treatment (23.7 ± 0.7 d; range: 19 to 29 d; 
Table 3.3). From the time of enrolment until NPD, the hazard of ovulation was greater (P = 
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0.04) for cows in the G25 treatment (HR = 1.89, 95% CI: 1.05 to 3.5; Figure 3.3). Median days 
to ovulation for the G25 treatment were 26 d (95% CI: 26 to 30). Median days to ovulation could 
not be calculated for the NoG25 treatment because less than 50% of the cows ovulated.  
For both treatments combined, 90% (81/90) of the cows had an active follicle 25 ± 3 d 
after AI. For cows in the G25 treatment only, the proportion of cows with an active follicle on 
the day of GnRH 25 ± 3 d after AI was similar (P = 0.99) for cows that did (100%) or did not 
(96%) ovulate. Conversely, diameter of the largest active follicle was greater (P < 0.001) for 
cows that ovulated (17.8 ± 0.9 mm, range = 10 to 29 mm) than for cows that failed to ovulate in 
response to GnRH (13.7 ± 0.7 mm, range = 10 to 20 mm). The largest active follicle present 25 ± 
3 d after AI reached a size of ≥ 10 mm earlier (P = 0.02) in cows that ovulated (5.6 ± 0.4 d 
before GnRH) than in cows that did not ovulate (3.8 ± 0.6 d before GnRH). Further, the 
proportion of cows with P4 ≥ 1 ng/mL at the time of the GnRH treatment did not differ (P = 
0.23) for the group that ovulated or did not ovulate after GnRH [ovulated = 52% (12/23) and not 
ovulated = 70% (16/23)] but, cows that ovulated tended (P = 0.07) to have lesser concentrations 
of P4 (2.1 ± 0.6 ng/mL) than cows that did not ovulate (3.6 ± 0.6 ng/mL).  
Treatment did not (P = 0.67) affect the proportion of cows with at least one active follicle 
at NPD (Table 3.3). Parity, however, tended (P = 0.07) to affect the proportion of cows with at 
least one active follicle at NPD [primiparous = 80% (12/15) and multiparous = 95% (71/75)]. 
Size of the largest active follicle at NPD was greater (P = 0.01) for the NoG25 than for the G25 
treatment (Table 3.3) and was not affected (P = 0.11) by parity. Furthermore, mean days since 
the largest active follicle present at NPD reached a size of ≥ 10 mm, was greater (P < 0.01) for 
the NoG25 than for the G25 treatment (Table 3.3). A similar proportion of cows in both 
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treatments (P = 0.38; Table 3.3) had P4 ≥ 0.5 ng/mL at NPD. Parity did not affect (P = 0.59) the 
proportion of cows with P4 ≥ 0.5 ng/mL at NPD.  
Among cows with a CL ≥ 15 mm at NPD, those in the NoG25 treatment had greater (P = 
0.03) concentrations of P4 at NPD than cows in the G25 treatment (Table 3.4). The proportion of 
cows with luteal regression from the time of NPD to the GnRH treatment before TAI was similar 
for both treatments (P = 0.97; Table 3.4). Ninety five percent and 100% of the cows had 
complete luteal regression in the G25 and NoG25 treatment, respectively. Likewise, mean size of 
the ovulatory follicle one day before TAI (P = 0.15) and the proportion of cows that ovulated 
after TAI (P = 0.35) were similar for both treatments (Table 3.4). For cows without a CL at 
NPD, treatment did not affect concentrations of P4 at NPD (P = 0.28), luteal regression before 
TAI (P = 0.99), size of the putative ovulatory follicle (P = 0.68), or ovulation after TAI (P = 
0.97; Table 3.4). Parity did not affect circulating concentrations of P4 at NPD (P > 0.10), size of 
the ovulatory follicle (P > 0.10), or proportion of cows that ovulated after TAI (P > 0.10) in 
cows with or without a CL at NPD.  
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Table 3.1. Proportion of cows inseminated at detected estrus before nonpregnancy diagnosis and 
proportion of cows with or without a corpus luteum ≥ 15 mm at nonpregnancy for the G25 and 
NoG25 treatments.  
   Treatment 1     
   G25 
% (n/n) 
 
NoG25 
% (n/n) 
 
P-value 
Estrus detection and AI before NPD2   44.6  53.5  <0.01 
 (262/587)  (313/585)  
CL3 ≥ 15 mm at NPD   83.7  71.3  <0.001 
 (272/325)  (194/272)  
No CL ≥ 15 mm at NPD   16.3  28.6  <0.001 
 (53/325)  (78/272)  
1Treatment = 18 ± 3 d after AI cows were randomly assigned to receive (G25) or not (NoG25) 
GnRH 25 ± 3 d after AI. At 32 ± 3 d after AI, nonpregnant cows from both treatments with at 
least one CL ≥ 15 mm received PGF2α-24 h-PGF2α-32 h-GnRH-16 to 18 h-TAI. Cows without 
a CL received a modified Ovsynch protocol with two PGF2α treatments and progesterone 
supplementation. 
   2NPD = nonpregnancy diagnosis.  
     3CL = corpus luteum.  
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Table 3.2. Pregnancy per AI and pregnancy loss for cows that received the G25 and NoG25 
treatment.  
   Treatment1    
 Item 
 G25 
% (n/n) 
 
NoG25 
% (n/n) 
 
P-value 
Overall P/AI2 32 ± 3 d after AI for all 
inseminations  
 39.6 
(226/571) 
 39.0 
(223/572) 
 0.80 
Overall P/AI 63 ± 3 d after AI for all 
inseminations3 
 36.2 
(205/566) 
 35.6 
(202/567) 
 0.76 
Overall pregnancy loss for all inseminations4   7.2 
(16/223) 
 7.3 
(16/218) 
 0.94 
P/AI for inseminations at detected estrus   38.4 
(99/258) 
 42.9 
(132/308) 
 0.30 
P/AI for cows with CL5 ≥ 15 mm at NPD6  40.6 
(106/261) 
 32.8 
(62/189) 
 0.05 
P/AI for cows without a CL ≥ 15 mm at NPD  40.4 
(21/52) 
 36.7 
(29/75) 
 0.82 
1Treatment = 18 ± 3 d after AI cows were randomly assigned to receive (G25 treatment) or not (NoG25 
treatment) GnRH 25 ± 3 d after AI. At 32 ± 3 d after AI, nonpregnant cows from both treatments with at least 
one CL ≥ 15 mm received PGF2α-24 h-PGF2α-32 h-GnRH-16 to 18 h-TAI. Cows without a CL received a 
modified Ovsynch protocol with two PGF2α treatments and progesterone supplementation. 
2P/AI = pregnancy per AI 
3Five cows from the G25 treatment, and five cows from the NoG25 treatment exited the herd before 
reconfirmation of pregnancy. 
4Three pregnant cows from the G25 treatment, and five cows from the NoG25 treatment exited the herd before 
reconfirmation of pregnancy. Pregnancy loss from 32 ± 3 d after AI to the day of herd exited was not observed 
for these cows. 
5CL = corpus luteum  
6NPD = nonpregnancy diagnosis 
 
 
 
 
 
  
112 
 
 
Table 3.3. Ovarian responses and response to resynchronization protocols from enrollment up to 
the time of nonpregnancy diagnosis for cows in the G25 and NoG25 treatment. 
 
  Treatment1 
Item   
 G25  
(n = 46) 
 NoG25  
(n = 44) 
 
P-value 
Spontaneous ovulation before NPD2 (%)  22  36  0.20 
Ovulation after GnRH3 25 ± 3 d after AI (%)  50  -  - 
Mean days to ovulation (d)  25.9 ± 0.4  23.7 ± 0.7  <0.01 
Active follicle at NPD (%)  91  96  0.67 
Active follicle size (mm) at NPD  15.0 ± 0.4  16.5 ± 0.6  0.01 
Days since active follicle at NPD reached ≥ 10 mm  4.0 ± 0.3  5.8 ± 0.6  <0.01 
P44 ≥ 0.5 ng/mL at NPD (%)  83  73  0.38 
1Treatment = 18 ± 3 d after AI cows were randomly assigned to receive (G25 treatment) or not (NoG25 treatment) 
GnRH 25 ± 3 d after AI. At 32 ± 3 d after AI, nonpregnant cows from both treatments with at least one CL ≥ 15 
mm received PGF2α-24 h-PGF2α-32 h-GnRH-16 to 18 h-TAI. Cows without a CL received a modified Ovsynch 
protocol with two PGF2α treatments and progesterone supplementation. Blood samples were not available for two 
cows (one from each treatment). 
2NPD = nonpregnancy diagnosis.  
3One cow in the G25 treatment ovulated on Day 21 and after GnRH treatment 25 ± 3 d after AI.   
4P4 = progesterone 
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Table 3.4. Ovarian responses and response to resynchronization protocols from the time of nonpregnancy diagnosis to the time of 
insemination for cows with or without a corpus luteum at nonpregnancy diagnosis that received the G25 and NoG25 treatment. 
  Ovarian status at nonpregnancy diagnosis 
  Cows with a CL  Cows without a CL 
Item 
 G25 
(n = 41) 
 NoG25 
(n = 32) 
 
P-value 
 G25 
(n = 5) 
 NoG25 
(n = 12) 
 
P-value 
P41 at NPD2 (ng/mL)  2.4 ± 0.4  3.4 ± 0.4  0.03  0.46 ± 0.1  0.30 ± 0.1  0.28 
P4 < 0.5 ng/mL at GnRH before TAI3 (%)  95  100  0.97  100  100  0.99 
Ovulatory follicle size (mm)  17.5 ± 0.4  18.4 ± 0.6  0.15  18.4 ± 0.6  17.7 ± 1.2  0.68 
Ovulation after TAI (%)  83  91  0.35  100  92  0.97 
1P4 = progesterone.  
2NPD = nonpregnancy diagnosis.  
3TAI = timed AI. 
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Figure 3.1. Graphical depiction of experimental procedures. Every Monday, cows at 18 ± 3 d 
after AI (first or second and greater) were stratified by parity (primiparous vs. multiparous) and 
randomly assigned to receive (G25 treatment; n = 1,100) or not receive (NoG25 treatment; n = 
1,098) GnRH treatment 25 ± 3 d after AI. Nonpregnancy diagnosis was performed 32 ± 3 d after 
AI by transrectal ultrasonography in cows from both treatments not previously re-inseminated in 
estrus. Nonpregnant cows from both treatments were classified based on the ovarian structures 
present on their ovaries. Cows with at least one CL ≥ 15 mm and a follicle ≥ 10 mm in diameter 
(G25 = 325 and NoG25 = 272) received a PGF2α treatment immediately after NPD, a second 
PGF2α treatment 24 h later, GnRH 32 h after the second PGF2α treatment, and timed AI 16 to 
18 h later. Cows that did not meet these criteria (G25 = 53 and NoG25 = 78) were treated with 
the Ovsynch protocol with two PGF2α treatments and progesterone supplementation (GnRH and 
CIDR insertion at NPD, CIDR removal and PGF2α 7 d later, PGF2α 1 d later, GnRH 32 h after 
the second PGF2α, and fixed time AI 16 to 18 h after the GnRH).  In a sub-group of cows (G25 
= 166 and NoG25 =196), ovarian responses were monitored by transrectal ultrasonography 
following a Monday, Wednesday, Friday schedule (enrollment and nonpregnancy diagnosis were 
performed on Mondays) from 18 ± 3 d after AI until cows were either diagnosed pregnant or re-
inseminated. At the time of transrectal ultrasonography a blood sample was obtained to measure 
circulating concentrations of progesterone. NPD = nonpregnancy diagnosis, CL = corpus luteum, 
TAI = timed AI.  
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Figure 3.2. Kaplan-Meier survival curves for time to insemination at detected estrus from 
enrolment (18 ± 3 d after AI) until nonpregnancy diagnosis (32 ± 3 d after AI) for cows in the 
G25 and NoG25 treatment. The hazard of insemination at detected estrus was greater (P = 0.04) 
for the NoG25 treatment (hazard ratio = 1.20, 95% CI: 1.01 to 1.43). Median time to re-
insemination at detected estrus for the NoG25 treatment was 31 d (95% CI: 27 to 35), whereas it 
could not be calculated for the G25 treatment because less than 50% of the cows were re-
inseminated at detected estrus. 
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Figure 3.3. Kaplan-Meier survival curves for time to ovulation from enrolment (18 ± 3 d after 
AI) until nonpregnancy diagnosis (32 ± 3 d after AI) for cows in the G25 and NoG25 treatment. 
The hazard of ovulation was greater (P = 0.04) for the G25 treatment (hazard ratio = 1.89, 95% 
CI: 1.05 to 3.5). Median time to ovulation for the G25 treatment was 26 d (95% CI: 26 to 30). 
Median time to ovulation could not be calculated for the NoG25 treatment because less than 50% 
of the cows ovulated. 
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DISCUSSION 
In the present experiment we evaluated a management strategy that consisted of 
removing the first GnRH injection of the Resynch-25 protocol to avoid disrupting estrus 
expression after the previous insemination while achieving a short interval between TAI services 
(i.e., 35 ± 3 d). A treatment to increase P/AI of cows with no CL at NPD was also included 
because these cows were not expected to properly respond to the shortened protocol. In support 
of our hypotheses, removing the first GnRH of the Resynch-25 protocol affected the pattern of 
re-insemination and ovarian responses before NPD. Our current data also supported the 
hypothesis that there would not be a reduction in overall proportion of pregnant cows (combining 
insemination of cows at detected estrus and TAI) despite a reduction in P/AI for cows with a CL 
at NPD in the NoG25 treatment.  
The different pattern of re-insemination after GnRH 25 ± 3 d after AI and the greater 
hazard of AI at detected estrus for the NoG25 treatment supported the hypothesis that estrus 
expression would be limited by GnRH treatment. The reduction in the proportion of cows 
detected in estrus in the G25 treatment was similar to that observed (~10 percentage points) for 
cows that received GnRH in the same range of days after AI (Bruno et al., 2014). The most 
likely mechanism underlying the reduction in estrus expression was lack of an estradiol surge 
due to the shift from estradiol to progesterone secretion by the granulosa cells of the pre-
ovulatory follicle in response to an LH surge (Berndtson et al., 1995; Komar et al., 2001; Jo and 
Fortune, 2003). Indeed, the pattern of estrus expression after AI clearly reflected the effect of 
GnRH treatment because it was similar for the two treatments up to 25 d after AI when the vast 
majority of cows in the G25 treatment received GnRH (data not shown).  
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The physiological response to treatments from 18 ± 3 to 32 ± 3 d after AI also reflected 
the effect of GnRH on ovarian responses. The proportion of cows that ovulated in response to 
GnRH was in agreement with previous experiments (Giordano et al., 2012c; Bruno et al., 2014) 
and was responsible for the greater proportion of cows with a CL at NPD in the G25 treatment. 
Interestingly, the difference between treatments was only 12.7 percentage points which may be a 
reflection of the substantial proportion of cows with a CL formed after the previous AI (data not 
shown) and the occurrence of spontaneous ovulation before NPD in 36% of the cows in the 
NoG25 treatment. Other factors may have been responsible for the small difference in the 
proportion of cows with a CL at NPD between treatments. For example, lack of response to 
GnRH in cows that did not have a CL formed after the previous AI or cows without spontaneous 
ovulation from 18 to 32 d after AI in the G25 treatment. For these cows, lack of ovulation in 
response to GnRH may have been due to the stage of follicle development at the time of GnRH 
treatment. Indeed, there was no difference in the proportion of cows with an active follicle but 
cows that ovulated had larger follicles than cows that did not ovulate. It is also possible that 
ovulation was suppressed by the negative effect of P4 on GnRH-induced LH release (Giordano 
et al., 2012a; Lima et al., 2013; Stevenson and Pulley, 2016) in cows with a CL formed after the 
previous AI (data not shown). In some of these cows; however, the CL present at the time of the 
GnRH injection could have regressed before NPD.  
From a practical perspective, the greatest difference resulting from the two strategies 
compared in this experiment would likely be a different proportion of cows detected in estrus 
before NPD. This could translate into fewer cows needing resynchronization of ovulation and 
TAI. Conversely, the greater percentage of cows without a CL at NPD in the NoG25 treatment 
would lead to more cows needing the Ovsynch protocol with P4 supplementation. For example, 
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13% of the cows in NoG25 and 9% of the cows in the G25 treatment needed the Ovsynch 
protocol with P4 supplementation in our experiment. This protocol is more expensive and delays 
re-insemination by a week. The greater proportion of cows without a CL at NPD in the NoG25 
group was also responsible for the similar interbreeding interval observed (i.e., delayed re-
insemination of cows with NoCL offset the benefit of more inseminations at detected estrus in 
the NoG25 treatment). Although the benefits and drawbacks of each program for nonpregnant 
cows may offset each other, another benefit of the NoG25 treatment would be not giving GnRH 
to pregnant cows 25 ± 3 d after AI. Removing this treatment would reduce reproductive program 
costs and labor because of fewer hormonal treatments while avoiding the unnecessary treatment 
of pregnant cows. Many factors important to the success of the programs tested in this 
experiment such as estrus detection efficiency, response to GnRH, ovarian responses after a 
previous AI, and P/AI vary dramatically across farms. Therefore, the choice of management 
strategy for individual farms could be based on the expected success for each program and/or the 
preference to inseminate more cows at detected estrus or TAI.  
In support of our hypothesis, P/AI for cows with a CL at NPD in the NoG25 treatment 
was reduced, reflecting the detrimental effect of removing the GnRH treatment 25 ± 3 d after AI. 
Few experiments evaluated the effect of removing the first GnRH of Ovsynch-type 
resynchronization protocols in lactating dairy cows. For example, Stevenson and Martel (2009) 
reported no difference in P/AI when cows received either saline or GnRH 25 ± 3 d after AI (24.8 
vs. 27.7%, respectively) but a 50% reduction in P/AI when the same treatments were compared 
32 ± 3 d after AI (29.5 vs 19.8%, respectively). Taken together, the results of previous 
experiments and ours support the notion that the time interval after AI to initiate a shortened 
protocol (i.e., without the initial GnRH) may be relevant to the fertility of TAI services. Initiating 
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such protocol at approximately 32 ± 3 d after AI seems optimal because of the high proportion of 
cows that are at a favorable stage of the estrous cycle at this time point.  
Interestingly, P/AI for cows with a CL in the NoG25 treatment was within the range 
observed for cows resynchronized with Ovsynch (Fricke et al., 2003; Sterry et al., 2006; Bruno 
et al., 2014) despite removing the GnRH treatment to initiate a new follicular wave during the 
protocol. The greater P/AI for cows with a CL in the G25 treatment; however, suggests that 
fertility was suboptimal for cows that did not receive GnRH 25 ± 3 d after AI. This was in spite 
of the fact that only cows at a favorable stage of the estrous cycle at NPD received the shortened 
protocol. The most likely explanation for reduced P/AI was the smaller proportion of cows that 
initiated a new follicular wave 7 d before NPD. Another contributing factor to the reduced P/AI 
could have been greater variation for time to initiation of the follicular wave. Indeed, the well-
documented benefit of ovulation in response to the first GnRH of Ovsynch-type protocols on 
fertility of TAI (Chebel et al., 2003; Bisinotto et al., 2010; Keskin et al., 2010) has been 
attributed, at least in part, to better synchronization of follicle development (Pursley et al., 1995; 
Vasconcelos et al., 1999; Wiltbank et al., 2011). Our data for ovarian responses suggest that for 
most cows the ovulatory follicle in the NoG25 treatment was older. This observation was 
supported by the differences in pattern of ovulation before NPD, follicle size at NPD, and the 
longer period of dominance of the ovulatory follicle. This is relevant because it has been 
suggested that extending the period of dominance of the ovulatory follicle is detrimental to 
embryo quality due to asynchrony between timing of oocyte maturation and ovulation (Revah 
and Butler, 1996). Extending the period of dominance by 2 d, similar to our observations, did not 
reduce fertilization rate but reduced embryo quality (Cerri et al., 2009). Therefore, we speculate 
that the longer period of dominance of the ovulatory follicle for cows with a CL in the NoG25 
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treatment might explain, at least in part, the reduced P/AI for these cows. It is also possible that 
for some cows the opposite problem reduced fertility to TAI. In this case, cows that ovulated 
very close to the day of NPD could have had an immature follicle at the time of the GnRH before 
TAI.  
Although the variation in timing of initiation of the new follicular wave is the most likely 
reason for the difference in P/AI for cows with a CL, we cannot separate or rule out the potential 
confounding effect of inseminating more cows at detected estrus in the NoG25 treatment. It is 
possible that some cows inseminated at detected estrus in NoG25 may have conceived if they 
received TAI. This is supported by the relatively high P/AI for cows inseminated at detected 
estrus in NoG25 and the similar P/AI for both treatments when combining data for all AI 
services. On other hand, we explored the potential confounding effect of parity on P/AI because 
more primiparous than multiparous cows were detected in estrus before NPD. However, the 
proportion of primiparous cows that had a CL at NPD and received TAI was similar for NoG25 
and G25 (~19%), thereby the lower P/AI for the NoG25 treatment could not be attributed to the 
effect of parity.  
Customizing synchronization of ovulation protocols to the ovarian status of cows can 
reduce the interbreeding interval (current experiment), increase AI at detected estrus (Stevenson 
et al., 2003, Giordano et al., 2015), and optimize P/AI (Sterry et al., 2006; Bisinotto et al., 2015; 
Giordano et al., 2016). Differential treatment of cows without a CL at NPD in our experiment 
ensured substantially greater P/AI than expected if these cows would have received the shortened 
protocol. Indeed, P/AI for cows with no CL (39.4% for both treatments combined) was relatively 
high and similar to that observed in other experiments (Giordano et al., 2016). These cows did 
not benefit from a shorter interbreeding interval; however, greater P/AI because of the Ovsynch 
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protocol with P4 supplementation was likely more than a shorter interbreeding interval. This is 
because time to pregnancy is extended more if cows receive TAI with a low chance of 
conception than if they are re-started in a synchronization of ovulation protocol that leads to 
greater P/AI.   
Adding the second PGF2α before TAI to all protocols in our experiment may explain the 
relatively high P/AI observed for TAI services. This treatment was added because it has been 
well-documented that luteal regression in lactating dairy cows is suboptimal (Brusveen et al., 
2009; Martins et al., 2011; Giordano et al., 2012d). Therefore, two rather than one PGF2α 
treatment is more effective to induce complete luteal regression and minimize circulating 
concentrations of P4 before TAI (Ribeiro et al., 2012; Carvalho et al., 2015; Wiltbank et al., 
2015). Also, extended luteal phases and interovulatory intervals are common in lactating dairy 
cows because of the incidence of embryonic death around the period of maternal recognition of 
pregnancy (Wijma et al., 2016). Therefore, we expected and observed (data not shown) that 
some cows would ovulate less than 7 d before NPD. A second PGF2α treatment would be 
necessary to induce complete luteal regression for these cows with a less mature CL (Henricks et 
al., 1974; Wiltbank et al., 2015).  
  
CONCLUSIONS 
 We conclude that removing the first GnRH treatment of the Resynch-25 protocol with 
two PGF2α treatments for cows with a CL at NPD, and using a modified Ovsynch protocol with 
P4 supplementation for cows with no CL at NPD allowed insemination of a greater proportion of 
cows at a detected estrus but did not affect the overall proportion of pregnant cows. 
Nevertheless, P/AI for cows with a CL at NPD was reduced in cows that did not receive GnRH 
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25 ± 3 d after AI. The most likely reason for reduced P/AI was more variation in timing of 
initiation of the follicular wave that gave rise to the ovulatory follicle. Nevertheless, because of 
differences in detection of estrus before NPD we could not separate or rule out the potential 
effect of having differences in the population of cows that received TAI.  
Additional research is needed to determine the impact of the treatments tested in this 
experiment on time to pregnancy during lactation and profitability of dairy herds.  
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CHAPTER IV 
A SHORT RESYNCHRONIZATION PROTOCOL BASED ON OVARIAN 
STRUCTURES PRESENT AT NONPREGNANCY DIAGNOSIS REDUCED TIME TO 
PREGNANCY IN LACTATING DAIRY COWS 
R. Wijma, M. M. Pérez, M. Masello, D. G. García, M. L. Stangaferro, and J. O. Giordano 
Submitted for review to the Journal of Dairy Science 
 
ABSTRACT 
Our objectives were to evaluate time to pregnancy after the first service postpartum and 
pregnancy/AI (P/AI) in dairy cows managed with two resynchronization of ovulation programs. 
After first service, lactating Holstein cows were blocked by parity (primiparous vs. multiparous) 
and randomly assigned to the Day 32-Resynch (R32; n = 1,010) or Short-Resynch (SR; n = 
1,000) treatments. Nonpregnancy diagnosis (NPD) was conducted 32 ± 3 d after AI by 
transrectal ultrasonography (TUS). Nonpregnant cows in R32 received the Ovsynch protocol 
[GnRH-7 d-PGF2α-56 h-GnRH-16 to 18 h-timed AI (TAI)]. Cows in SR with a corpus luteum 
(CL) ≥15 mm and a follicle ≥10 mm at NPD received PGF2α, PGF2α 24 h later, GnRH 32 h 
later, and TAI 16 to 18 h later. Cows in SR without a CL ≥15 mm and/or a follicle ≥10 mm at 
NPD received a modified Ovsynch protocol with two PGF2α treatments and progesterone (P4) 
supplementation (GnRH+CIDR-7 d-CIDR removal+PGF2α-24 h-PGF2α-32 h-GnRH-16 to 18 
h-TAI). Blood samples were collected from a subgroup of cows at NPD (R32 = 143 and SR = 
204), and GnRH before TAI (R32 = 114 and SR = 121) to measure P4 concentration. Binomial 
outcomes were analyzed with logistic regression and hazard of pregnancy (R32 = 485 and SR = 
462) with Cox’s proportional regression in SAS. For P/AI analysis, the TAI service was the 
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experimental unit (R32 = 615 and SR = 748). Models included treatment and parity as fixed 
effects and farm as random effect. The hazard of pregnancy was greater for the SR treatment 
(hazard ratio = 1.18, 95% CI: 1.01 to 1.37). Median time to pregnancy was 95 and 79 d for the 
R32 and SR treatments, respectively. At NPD, 71.4 and 72.9% of cows had a CL for the R32 and 
SR treatments, respectively. Treatment did not affect overall P/AI 32 ± 3 d after AI (R32 = 
29.6% vs. SR = 33.0%), or for cows with a CL at NPD (R32 = 31.9% vs. SR = 31.6%). For cows 
with no CL at NPD, P/AI was greater for the SR (37.0%) than the R32 (23.9%) treatment. 
Pregnancy loss from 32 to 63 d after AI was similar for all services combined (R32 = 7.3% vs. 
SR = 10.9%), and for cows with no CL at NPD (R32 = 12.2% vs. SR = 8.5%) but tended to be 
affected by treatment for cows with a CL at NPD (R32 = 5.8% vs. SR = 12.0%). Treatment 
affected the proportion of cows with P4 ≤ 0.5 ng/mL at the GnRH before TAI for all cows (R32 
= 68.4% vs. SR = 81.8%), tended to have an effect among cows with a CL (R32 = 70.0% vs. SR 
= 81.8%), and had no effect for cows with no CL (R32 = 64.7% vs. SR = 81.8%). We concluded 
that the SR program reduced time to pregnancy because of a reduction of the interbreeding 
interval for cows with a CL at NPD and greater P/AI in cows with no CL at NPD. 
 
INTRODUCTION 
 Dairy farm profitability depends on the reproductive performance of lactating dairy cows 
which is primarily determined by the rate at which cows become pregnant after the end of the 
voluntary waiting period (Louca and Legates, 1968; Oltenacu et al., 1981). In spite of recent 
gains on first service P/AI due to improved dairy herd management and the adoption of 
synchronization of ovulation protocols (Wiltbank and Pursley, 2014), a substantial proportion of 
lactating dairy cows remain nonpregnant after the first service and need immediate re-
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insemination. Therefore, to minimize the interbreeding interval many farms use reproductive 
management strategies for second and greater AI services that combine insemination at detected 
estrus and timed AI (TAI) after resynchronization of ovulation with Ovsynch-type protocols 
[(Pursley et al., 1995); commonly referred to as Resynch]. These protocols are usually initiated 
at the time of or seven days before nonpregnancy diagnosis [NPD; (Fricke et al., 2003; 
Bartolome et al., 2005; Giordano et al., 2012c)].  
Farms that combine AI at detected estrus and TAI can initiate Resynch as early as 25 ± 3 
d after AI. Although this strategy can be beneficial because of the relatively short interbreeding 
interval for cows that receive TAI (i.e., 35 ± 3 d), the first GnRH treatment of the protocol 
coincides with the time at which many cows are expected to display estrus (Remnant et al., 2015; 
Wijma et al., 2017). The GnRH-induced LH surge reduces the proportion of cows displaying 
natural estrus (Mendonça et al., 2012; Bruno et al., 2014; Wijma et al., 2017) through induction 
of ovulation and/or by suppressing the estradiol surge responsible for estrous behavior 
(Berndtson et al., 1995; Komar et al., 2001; Jo and Fortune, 2003). Further, the pregnancy status 
of cows at the time of the GnRH treatment 25 ± 3 d is unknown because none of the currently 
available methods for pregnancy testing for dairy cows allows accurate pregnancy detection at or 
before 25 ± 3 d after AI. Therefore, a substantial proportion of cows receive an unnecessary 
treatment because they are pregnant; increasing treatment costs, labor costs, and in some cases 
disrupting cow normal resting behavior.   
Thus, to take advantage of a short interbreeding interval for TAI services while avoiding 
a reduction in the proportion of cows AI at detected estrus before NPD and unnecessary 
treatment of pregnant cows with GnRH, we recently conducted a proof of concept experiment to 
evaluate a reproductive management strategy based on the ovarian structures present at NPD 32 
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± 3 d after AI (Wijma et al., 2017). Cows with a CL ≥ 15 mm and follicle ≥ 10 mm at NPD 
(hereafter CL cows) received a resynchronization of ovulation protocol without an initial GnRH 
treatment to induce a new follicular wave (Short-Resynch; PGF2α, 1 d later PGF2α, 32 h later 
GnRH, and TAI 16 to 18 h after GnRH). On the other hand, cows not expected to respond to the 
Short-Resynch protocol because of their ovarian status (i.e., no CL ≥15 mm and/or no follicle 
≥10 mm; hereafter no CL cows) received a modified Ovsynch protocol with progesterone (P4) 
supplementation (GnRH + P4 intravaginal device-7 d-PGF2α + P4 intravaginal device removal-1 
d-PGF2α-32 h-GnRH-16 to 18 h-TAI). This management strategy was compared to a similar 
program in which all cows received GnRH treatment 7 d before NPD (i.e., 25 ± 3 d after AI). 
Removing the GnRH treatment 25 ± 3 d after AI resulted in ~17% more cows inseminated at 
detected estrus (GnRH = 44.6% and NoGnRH = 53.5%) but it also resulted in a P/AI reduction 
of ~ 8 percentage points for TAI services in CL cows (GnRH = 40.6% and NoGnRH = 32.8%). 
Nevertheless, the cumulative proportion of cows pregnant after AI at detected estrus and TAI 
was similar for both groups (GnRH = 39.6% and NoGnRH = 39.0%) because of the greater 
number of pregnancies generated through insemination of cows at detected estrus before NPD in 
the Short-Resynch treatment. Although results from this experiment (Wijma et al., 2017) were 
promising, additional research is needed to determine if the strategy based on ovarian status at 
NPD is superior to traditional programs combing AI at detected estrus and TAI after blanket use 
of resynchronization of ovulation with the Resynch protocol. Moreover, additional data is 
necessary to corroborate that removal of the initial GnRH treatment does not compromise P/AI 
for cows with CL at NPD to an extent that may offset the benefit of shorter interbreeding interval 
for TAI services.  
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Thus, we hypothesized that a resynchronization program based on ovarian structures 
present at the time of NPD (hereafter referred to as Short-Resynch) would reduce time to 
pregnancy after the first service when compared with blanket use of TAI after the D32-Resynch 
protocol. Time to pregnancy would be reduced because of the shorter interbreeding interval for 
CL cows and increased P/AI for no CL cows. Therefore, the objectives of this experiment were 
to evaluate the effect of Short-Resynch on time to pregnancy after the first service, P/AI, and 
physiological outcomes before TAI.  
 
MATERIALS AND METHODS 
This experiment was conducted from February 2016 to May of 2017 in two commercial 
dairy farms located in Tompkins and Cayuga counties in New York State. All procedures were 
approved by the Animal Care and Use Committee of the College of Agriculture and Life 
Sciences at Cornell University.  
In both farms, cows were housed in free stall barns and were fed a total mixed ration once 
a day with ad libitum access to feed and water. Farm A milked ~1,300 cows with average milk 
yield of ~43 kg/d. Cows were milked thrice daily at approximately 8 h intervals until February 
2017 when milking frequency changed to four times per day at approximately 6 h intervals. All 
cows received recombinant bovine somatotropin (500 mg of Sometribove zinc; Posilac, Elanco 
Animal Health, Indianapolis, IN) at 10 or 11 d intervals beginning at 80 ± 3 DIM in primiparous 
cows and 110 ± 3 DIM in multiparous cows until dry off. Primiparous cows received first service 
at 82 ± 3 DIM and multiparous cows at 67 ± 3 DIM after synchronization of ovulation with the 
Double-Ovsynch protocol (Souza et al., 2008). Farm B milked ~1,900 cows thrice daily at 
approximately 8 h intervals and had average milk yield per cow of ~42 kg/d. All cows received 
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recombinant bovine somatotropin at 14 d intervals beginning at 60 ± 3 DIM until dry off. 
Primiparous and multiparous cows where synchronized with the Presynch-Ovsynch protocol 
(Moreira et al., 2001). Cows were eligible to receive AI after the first and second PGF2α 
treatments of Presynch-Ovsynch at 53 ± 3 and 67 ± 3 DIM, whereas cows not detected in estrus 
received TAI at 79 ± 3 DIM. During the experiment, 86.5% (1,103/1,274) of the cows enrolled 
received the first service at detected estrus whereas the remaining 13.4% (171/1274) of the cows 
received TAI.  
Every week, cows that received a previous AI service were blocked by parity 
(primiparous vs. multiparous) and randomly assigned to the D32-Resynch (R32) or Short 
Resynch (SR) treatment. Cows remained in the same treatment until the end of the experiment. 
Cows that received their first service postpartum at or after the beginning of the experiment (R32 
= 1,010 and SR = 1,000) were included for the evaluation of time to pregnancy. Conversely, 
cows that had already received their first service before the beginning of the experiment were 
enrolled but only data from individual TAI services were collected (R32 = 207 and SR = 270) for 
subsequent analysis of P/AI and pregnancy loss. All cows detected in estrus after AI were 
immediately inseminated. In farm A, detection of estrus was conducted using a combination of 
visual observation and physical activity monitoring with leg-mounted activity tags (Afi-ActII, 
Afikim, Kibbutz Afikim, Israel), whereas in Farm B detection of estrus was conducted through 
visual observation and tail paint removal. Nonpregnancy diagnosis was performed by transrectal 
ultrasonography (TUS; Ibex Pro, Ibex, Loveland, CO) 32 ± 3 d after AI in cows from both 
experimental treatments not previously re-inseminated at detected estrus. In nonpregnant cows, 
size of follicles and corpora lutea present at NPD was estimated using the ultrasound machine 
goggle’s screen grid lines comprising squares of 10 mm by 10 mm. Pregnant cows received no 
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further treatment. All TUS examinations were conducted by veterinarians. In farm A, the 
veterinarian was one of the co-authors, whereas in farm B it was one of the co-authors and the 
practicing veterinarian.  
Nonpregnant cows from the SR experimental treatment were classified and then treated 
based on the ovarian structures present at NPD (Figure 4.1). Cows with at least one CL ≥ 15 mm 
and at least one ovarian follicle ≥ 10 mm in diameter (CL cows) received PGF2α (500 µg of 
Cloprostenol Sodium, Estrumate, Merck Animal Health, Summit, NJ, USA) immediately after 
NPD, a second PGF2α 24 h later, GnRH (100 µg of Gonadorelin diacetate tetrahydrate, Fertagyl, 
Merck Animal Health, Summit, NJ, USA) 32 h after the second PGF2α, and TAI 16 to 18 h later 
(Figure 4.1). Cows that did not meet these criteria (No CL cows) received a modified Ovsynch 
protocol with two PGF2α treatments and P4 supplementation through an intravaginal P4 
releasing device (1.38 g of Progesterone, Eazi-Breed CIDR, Zoetis, Florham Park, NJ) from the 
time of the first GnRH to the first PGF2α treatment of the protocol (GnRH + CIDR-7 d-CIDR 
removal + PGF2α-24 h-PGF2α-32 h-GnRH-16 to 18 h-TAI; Figure 4.1). Cows detected in estrus 
after NPD and before TAI were immediately inseminated. Every time a cow in the SR treatment 
was diagnosed nonpregnant was classified as CL or No CL cow and received the stipulated 
treatment based on ovarian status.   
Nonpregnant cows in the R32 treatment were immediately enrolled in the D32-Resynch 
protocol (32 ± 3 d after AI GnRH-7 d-PGF2α-56 h-GnRH-16 to 18 h-TAI; Figure 4.1) to receive 
TAI. A combination of AI at detected estrus and TAI after the D32-Resynch protocol without 
differential treatment based on ovarian structures was selected as control treatment because it is 
one of the most commonly used strategies to manage second and greater AI services in lactating 
dairy cows in the U.S. (Caraviello et al., 2006; Ferguson and Skidmore, 2013; Scott, 2016). 
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Reconfirmation of pregnancy was performed 63 ± 3 d after AI by TUS in both farms. A 
cow was considered to have undergone pregnancy loss when confirmed pregnant at the initial 
examination and nonpregnant at the time of reconfirmation. Cows with an insemination after a 
detected estrus between the two pregnancy examinations were also considered to have suffered 
pregnancy loss. Cows not pregnant at pregnancy reconfirmation were immediately enrolled in 
the Ovsynch protocol. If they failed to conceive to the insemination immediately after detection 
of pregnancy loss, cows received the treatments stipulated per their experimental treatment (i.e., 
R32 or SR). 
 
Transrectal Ultrasonography and Blood Sample Collection for Monitoring Ovarian Responses  
Ovarian responses were monitored at the time of NPD and the GnRH treatment before 
TAI in a subgroup of cows from each treatment (153 and 146 in R32 and SR, respectively) in 
Farm A. Transrectal ultrasonography was conducted to record size (diameter) of the largest 
follicle and corpora lutea present on the ovaries. Size of follicles and corpora lutea was estimated 
using the ultrasound machine (same used for NPD) goggle screen grid lines comprising squares 
of 10 mm by 10 mm. If the largest follicle was greater than 25 mm and thereby, a potential 
follicular cyst, the second largest follicle was considered the dominant follicle for analysis. From 
the same group of cows, blood samples were collected to determine circulating concentration of 
P4. Blood samples were collected using 8-mL heparinized evacuated tubes (Vacutainer, BD, 
Franklin Lakes, NJ) via puncture of the coccygeal vein or artery. Samples were placed in a 
cooler with ice until transported to the laboratory within ≤ 4 h of collection. Samples were 
centrifuged at 1,700 x g for 20 minutes at 4°C. Plasma aliquots were harvested and transferred to 
vials for storage at -20°C until assays were performed. Progesterone concentration data at NPD 
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was available for 205 cows with a CL ≥15 mm and 78 cows with no CL ≥ 15 mm at NPD from 
both treatments. Data from ovarian structures and P4 concentration at the GnRH treatment before 
TAI was available for 114 and 121 cows from the R32 and SR treatments, respectively. The 
proportion of cows with a functional CL based on circulating concentration of P4 (P4 ≥ 1 ng/mL) 
was the outcome of interest at NPD. At the time of the GnRH injection before TAI outcomes of 
interest were (1) the proportion of cows with low P4 based on a cutoff value of ≤ 0.5 ng/mL or 1 
ng/mL and (2) size of the largest ovarian follicle present. 
 
Determination of Progesterone Concentration  
Concentration of P4 in plasma was determined in duplicate with a commercial solid-
phase, no-extraction radioimmunoassay (ImmuChem Coated Tube, MP Biomedicals, Costa 
Mesa, CA). To assess precision of the assays, control samples with high (5.8 ng/mL) and low 
(0.3 ng/mL) concentrations of P4 were included at the beginning and end of each assay (n = 6 
assays). Average detection limit for the P4 assay was 0.1 ng/mL. Average intra-assay CV for the 
high-concentration sample was 9.7% whereas the inter-assay CV was 13.4%. For the low-
concentration sample the average intra-assay CV was 24.2% whereas the inter-assay CV was 
31.3%. 
 
Statistical Analysis 
 This experiment was conducted as a complete randomized block design using parity 
(primiparous vs. multiparous) as blocking factor. According to sample size calculations 
conducted using the sample size calculation option of WinPepi version 11.51 (Abramson, 2011), 
a total of 398 cows per treatment were needed to detect a hazard ratio for pregnancy of 1.25 with 
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an average probability of survival at the end of the experimental period of 20%, with probability 
of type I error rate of 5%, and probability of type II error rate of 20%.  
Cox’s proportional hazards analysis for pregnancy after the first service postpartum was 
conducted using the PHREG procedure of SAS (version 9.4, SAS Institute Inc., Cary, NC) with 
treatment, parity, and milk production tercile (calculated for farm and parity group within farm) 
as fixed effects, and farm as random effect. Milk production level was removed from the final 
model because P > 0.10. Only cows that did not conceive to first AI and had at least 210 d at risk 
of becoming pregnant after the first service were included in the analysis. A cow was considered 
pregnant for the analysis of time to pregnancy only if it was reconfirmed pregnant 63 ± 3 d after 
AI. Cows that became not eligible for AI due to a farm management decision (i.e., coded as do 
not breed), or left the herd due to sale or death were right censored. Kaplan-Meier survival 
curves were generated to illustrate the rate of pregnancy after the first service postpartum using 
the survival analysis option of MedCalc (version 12.5.0.0; MedCalc Software bvba, Ostend, 
Belgium). 
Binary outcomes (i.e., P/AI, pregnancy loss, proportion of cows inseminated at detected 
estrus, proportion of cows not pregnant 210 d after the first service, and proportion of cows with 
high or low P4 concentration at NPD and the GnRH before TAI) were analyzed using logistic 
regression with the GLIMMIX procedure of SAS. Treatment and parity (primiparous vs. 
multiparous) were included as fixed effects and farm as random effect. Days in milk at 
insemination (≤100, >100 and ≤ 150, >150 and ≤ 200, and >200 days) and season of 
insemination [warm (June, July, and August) vs. cold (September to May)] were offered to the 
initial models for P/AI and pregnancy loss. Season was removed from all final models and DIM 
from the pregnancy loss models because P >0.10.   
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The level of agreement between TUS and P4 concentration (reference test) to detect the 
presence of an active CL was determined through calculation of the kappa value for inter-rater 
agreement obtained with the FREQ procedure of SAS. 
Size of the largest ovarian follicle at the time of GnRH before TAI was analyzed by 
ANOVA using the MIXED procedure of SAS including treatment and parity as fixed effects. 
All proportions reported were generated using the FREQ procedure of SAS whereas 
values for quantitative outcomes are reported as arithmetic means calculated using the MEANS 
procedure of SAS. All explanatory variables were considered significant if P ≤ 0.05 whereas a P 
> 0.05 and ≤ 0.10 was considered a tendency.  
 
RESULTS 
Time to Pregnancy after First Service 
In total, 485 and 462 cows from the R32 and SR treatments, respectively were not 
pregnant after the first service postpartum and were at least 210 days at risk of becoming 
pregnant after the first service postpartum unless left the herd due to sale or death. The 
proportion of second and greater AI services that occurred after estrus detection [P = 0.56; R32 = 
66.4% (739/1,113) vs. SR = 67.7% (594/878)] and P/AI for these services [P = 0.26; R32 = 
34.4% (277/805) vs. SR = 37.2% (245/658)] was similar for both treatments.   
The hazard of pregnancy was greater (P = 0.03) for the SR than the R32 treatment 
[hazard ratio (HR) = 1.18, 95% CI: 1.01 to 1.37; Figure 4.2] and was similar (P = 0.15) for 
primiparous and multiparous cows [HR = 1.12, 95% CI: 0.96 to 1.31]. Median time to pregnancy 
was 95 (95% CI: 84 to 108) and 79 d (95% CI: 71 to 96) for the R32 and SR treatment, 
respectively. Mean time to pregnancy was 111 ± 3 and 100 ± 3 d for the R32 and SR treatment, 
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respectively. At 210 d after first service, a greater (P < 0.02) proportion of cows were not 
pregnant in the R32 (29.3%; 142/485) than the SR treatment (22.3%; 103/462) and a greater (P < 
0.01) proportion of multiparous (29.3%; 177/605) than primiparous (19.9%; 68/342) cows were 
not pregnant.  
 
Pregnancy per Artificial Insemination and Pregnancy Loss 
 The proportion of cows inseminated at detected estrus after NPD and before TAI was 
greater for the R32 treatment for all cows [P < 0.001; R32 = 14.7%; (108/734) and SR = 8.7%; 
(71/819)] and cows with a CL at NPD [P < 0.001; R32 = 14.6%; (77/527) and SR = 6.5%; 
(38/583)]. No effect of treatment (P = 0.68) was observed for cows with no CL at NPD [R32 = 
15.3%; (34/221) and SR = 14.0%; (33/236)]. For the R32 treatment, 50.9% of the AI services at 
detected estrus were conducted from the time of the first GnRH until the PGF2α injection of the 
protocol whereas the remaining 49.1% were conducted after the PGF2α and before the morning 
of TAI. Treatment did not affect P/AI (P = 0.54) for AI services that occurred before TAI [R32 = 
38.9% (42/108) and SR = 43.7% (31/71)]. These services were not included in the analyses for 
P/AI and pregnancy loss for TAI services. At NPD the proportion of CL cows was 71.4% 
(439/615) for R32 and 72.9% (545/748) for the SR treatment. The rest of the cows were 
classified as No CL cows in both treatment groups. 
 Overall, P/AI at 32 ± 3 d after TAI was not affected by treatment (P = 0.14; Table 4.1) or 
parity [P = 0.41; primiparous = 32.3% (181/561) vs. multiparous = 30.9% (248/802)]. Among 
cows with a CL at NPD, P/AI was not affected (P = 0.94) by treatment (Table 4.1) and tended (P 
= 0.09) to be affected by parity [primiparous = 34.4% (138/401) vs. multiparous = 29.8% 
(174/583)]. For cows with no CL at NPD, P/AI was greater (P < 0.01) for the SR than for the 
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R32 treatment (Table 4.1), but there was no effect of parity [P = 0.31; primiparous = 26.9% 
(43/160) vs. multiparous = 33.8% (74/219)]. Days in milk at TAI affected P/AI for all AI 
services (P = 0.02) and for AI services in cows with no CL at NPD (P < 0.001) whereby, cows 
with >200 DIM had reduced (P < 0.05) P/AI when compared with cows inseminated at earlier 
DIM. On the other hand, DIM at insemination did not affect (P = 0.43) P/AI in cows with a CL 
at NPD. 
Overall P/AI at 63 ± 3 d after TAI was not affected by treatment (P = 0.62; Table 4.1) or 
parity [P = 0.50; primiparous = 28.2% (156/553) vs. multiparous = 27.0% (213/788)]. Among 
cows with a CL at NPD there was no effect of treatment [P = 0.27; R32 = 29.6% (129/436) vs. 
SR = 26.2% (139/531)] or parity [P = 0.11; primiparous = 30.4% (120/395) vs. multiparous = 
25.9% (148/572)] on P/AI. For cows with no CL at NPD, P/AI was greater (P < 0.01) for the SR 
(32.7%; 65/199) than for the R32 treatment (20.6%; 36/175) but, there was no effect of parity [P 
= 0.24; primiparous = 22.8% (36/158) vs. multiparous = 30.1% (65/216)]. Days in milk at TAI 
affected P/AI 63 ± 3 d after AI for all AI services (P = 0.02) and for cows with no CL at NPD (P 
< 0.001) because cows with DIM >200 had reduced (P < 0.05) P/AI when compared with cows 
inseminated at earlier DIM. On the other hand, DIM did not affect (P = 0.70) P/AI for cows with 
a CL at NPD. 
 Pregnancy loss for all AI services combined was similar for both treatments (P = 0.17; 
Table 4.1) and was not affected by parity [P = 0.76; primiparous = 9.8% (17/173) vs. 
multiparous = 9.0% (21/234)]. For cows with a CL at NPD, pregnancy loss tended (P = 0.06) to 
be greater for the SR (12.0%; 19/158) than for the R32 (5.8%; 8/137) treatment but there was no 
effect of parity [P = 0.95; primiparous = 9.1% (12/132) vs. multiparous = 9.2% (15/163)]. For 
cows with no CL at NPD, treatment (P = 0.59) and parity (P = 0.59) did not affect pregnancy 
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loss [R32 = 12.2% (5/41) vs. SR = 8.5% (6/71); primiparous = 12.2% (5/41) vs. multiparous = 
8.5% (6/71)].  
 
Ovarian Structures and Progesterone Concentration at Nonpregnancy Diagnosis  
 Among cows with a CL ≥15 mm, 84.4% had P4 ≥1 ng/mL, 3.9% had P4 >0.5 and <1 
ng/mL, and 11.7% had P4 ≤0.5 ng/mL.  Among cows with no CL ≥15 mm at NPD, 29.5% had 
P4 ≥1 ng/mL, 5.1% had P4 >0.5 and < 1 ng/mL, and 65.4% had P4 ≤0.5 ng/mL. Among cows 
with no CL ≥15 mm and P4 ≥1 ng/mL at NPD, 43.5% (10/23) had at least one fluid filled cavity 
≥25 mm (usually considered an ovarian cyst) present on their ovaries. The agreement between 
TUS and P4 concentration to determine the presence of a functional CL (P4 ≥1 ng/mL) was 
moderate [kappa = 0.53 (95% CI: 0.42 to 0.64); P < 0.001].  
  
Ovarian Structures and Progesterone Concentration at the GnRH Treatment before Timed 
Artificial Insemination 
Overall, a greater (P = 0.02) proportion of cows had P4 concentration <0.5 ng/mL in the 
SR (81.8%; 99/121) than the R32 treatment (68.4%; 78/114). In addition, for cows with a CL at 
NPD the proportion of cows with P4 ≤0.5 ng/mL tended (P = 0.08) to be greater for the SR than 
for the R32 treatment (Table 4.2). There was no effect of treatment (P = 0.14) for cows without a 
CL at NPD (Table 4.2). When the cutoff for low circulating P4 concentration was 1 ng/mL, the 
overall proportion of cows with P4 concentration below the cut off was greater (P = 0.05) for the 
SR (88.4%; 107/121) than for the R32 (79.0%; 90/114) treatment. The proportion of cows with 
P4 <1ng/mL was not affected by treatment (P = 0.27) among cows with a CL at NPD and tended 
to be affected (P = 0.09) by treatment among cows with no CL at NPD (Table 4.2). 
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Cows in the R32 treatment tended (P = 0.10) to have larger follicles (18.0 ± 0.4 mm) 
than cows in the SR treatment (17.1 ± 0.4 mm). For cows with a CL at NPD treatment did not 
affect (P = 0.74) size of the largest follicle at the time of GnRH (Table 4.2), whereas for cows 
with no CL at NPD follicle size at GnRH treatment tended (P = 0.07) to be greater for cows in 
the R32 treatment (Table 4.2). 
  
  
144 
 
Table 4.1. Pregnancy per AI and pregnancy loss for cows that received the experimental treatments.  
  Treatment1   
 Item 
R32 
% (n/n) 
SR 
% (n/n) 
P-value 
Overall P/AI2 32 ± 3 d after AI for all inseminations  29.6 
(182/615) 
33.0 
(247/748) 
0.14 
        P/AI for CL cows3 31.9 
(140/439) 
31.6 
(172/545) 
0.94 
        P/AI for No CL cows4 23.9 
(42/176) 
37.0 
(75/203) 
< 0.01 
Overall P/AI 63 ± 3 d after AI for all inseminations  27.0 
(165/611) 
28.0 
(204/730) 
0.62 
Overall pregnancy loss for all inseminations 7.3 
(13/178) 
10.9 
(25/229) 
0.17 
1Treatment = cows were randomly assigned to the D32-Resynch (R32) or Short Resynchronization (SR) treatments. Nonpregnancy diagnosis was performed 32 
± 3 d after AI. Nonpregnant cows in the R32 treatment received the Ovsynch protocol (GnRH-7 d-PGF2α-56 h-GnRH-16 to 18 h-TAI) for resynchronization of 
ovulation, whereas cows in the SR treatment were resynchronized based on the ovarian structures at nonpregnancy diagnosis. Cows with at least one corpus 
luteum ≥ 15 mm and a follicle ≥ 10 mm received PGF2α, 24 h later PGF2α, 32 h later GnRH, and TAI 16 to 18 h after GnRH, whereas cows that did not fulfill 
the CL and follicle criteria received a modified Ovsynch protocol with two PGF2α treatments and progesterone supplementation (GnRH plus CIDR-7 d-PGF2α 
plus CIDR removal-24 h- PGF2α-32 h-GnRH-16 to 18 h-TAI). 
2P/AI = pregnancy per AI. 
3Cows with at least one corpus luteum ≥ 15 mm and a follicle ≥ 10 mm 
4 Cows with no corpus luteum ≥ 15 mm and/or no follicle ≥ 10 mm 
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Table 4.2 Ovarian status at the time of GnRH treatment before timed AI for cows that received the experimental treatments. 
    Group based on ovarian structures present at NPD1 
    CL2 ≥ 15 mm and follicle ≥ 10 mm   No CL ≥ 15 mm and/or no follicle ≥ 10 mm  
Item   
R32  
(n = 80) 
 SR  
(n = 88) 
 P-value  
R32  
(n = 34) 
 SR 
(n = 33) 
 P-value 
P41 ≤ 0.5 ng/mL (%; n) 
  
70.0 (56) 
 
81.8 (72) 
 
0.08  64.7 (22) 
 
81.8 (27) 
 
0.14 
P4 < 1 ng/mL (%; n) 81.3 (65) 87.5 (77) 0.27  73.5 (25) 90.9 (30) 0.09 
Size of the largest follicle (mm)   17.1 ± 0.5   16.8 ± 0.4   0.74  19.9 ± 0.8   17.8 ± 0.9  0.07 
1Treatment = cows were randomly assigned to the D32-Resynch (R32) or Short Resynchronization (SR) treatments. Nonpregnancy diagnosis was performed 
32 ± 3 d after AI. Nonpregnant cows in the R32 treatment received the Ovsynch protocol (GnRH-7 d-PGF2α-56 h-GnRH-16 to 18 h-TAI) for 
resynchronization of ovulation, whereas cows in the SR treatment were resynchronized based on the ovarian structures at nonpregnancy diagnosis. Cows 
with at least one corpus luteum ≥ 15 mm and a follicle ≥ 10 mm received PGF2α, 24 h later PGF2α, 32 h later GnRH, and TAI 16 to 18 h after GnRH, 
whereas cows that did not fulfill the CL and follicle criteria received a modified Ovsynch protocol with two PGF2α treatments and progesterone 
supplementation (GnRH plus CIDR-7 d-PGF2α plus CIDR removal-24 h- PGF2α-32 h-GnRH-16 to 18 h-TAI). 
1NPD = nonpregnancy diagnosis 
2CL = corpus luteum 
3P4 = progesterone
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Figure 4.1. Graphical representation of experimental procedures. After first service postpartum 
cows were stratified by parity (primiparous vs. multiparous) and randomly assigned to the D32-
Resynch (R32; n = 1,010) or Short Resynchronization (SR; n= 1,000) treatment. Nonpregnancy 
diagnosis (NPD) was performed 32 ± 3 d after AI, nonpregnant cows from the R32 treatment 
received the Ovsynch protocol (GnRH-7 d-PGF2α-56 h-GnRH-16 to 18 h-TAI) whereas cows in 
the SR treatment were resynchronized based on the ovarian structures present at nonpregnancy 
diagnosis. Cows with at least one corpus luteum ≥ 15 mm and follicle ≥ 10 mm received PGF2α, 
24 h later PGF2α, 32 h later GnRH, and TAI 16 to 18 h after GnRH. Cows that did not fulfill 
these criteria received a modified Ovsynch protocol with two PGF2α treatments and 
progesterone (P4) supplementation (GnRH + CIDR-7 d-CIDR removal + PGF2α-24 h-PGF2α-
32 h -GnRH-16 to 18 h-TAI). In a sub-group of cows blood samples were collected to measure 
P4 concentration at NPD and at the time of GnRH treatment before TAI. Size of the largest 
ovarian follicle was also estimated and recorded.  
NPD = nonpregnancy diagnosis, CL = corpus luteum, TUS = transrectal ultrasonography, BC = 
blood collection, TAI = timed AI.  
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Figure 4.2.  Kaplan-Meier survival curves for time to pregnancy from enrolment up to 210 d 
after the first service postpartum for cows in the D32-Resynch (R32) and Short 
Resynchronization (SR) treatments that failed to conceive after the first service. The hazard of 
pregnancy was affected (P = 0.03) by treatment (hazard ratio = 1.18, 95% CI: 1.01 to 1.37). 
Median time to pregnancy was 95 (95% CI: 84 to 108) and 79 d (95% CI: 71 to 96) for the R32 
and SR treatments, respectively. Mean time to pregnancy was 111 ± 3 and 100 ± 3 d for the R32 
and SR treatments, respectively. 
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DISCUSSION 
The goal of reproductive management programs for second and greater AI services is to 
minimize the interbreeding interval and maximize conception risk for nonpregnant cows which, 
in turn minimizes time to pregnancy after the first service and reduces the proportion of cows 
leaving the herd due to reproductive failure. In our current experiment, a program that relied on 
resynchronization of ovulation treatments given to cows based on the ovarian structures present 
at NPD was compared with blanket use (i.e., regardless of ovarian structures present) of the D32-
Resynch protocol. In support of our hypothesis, cows in the Short-Resynch (SR) program had 
fewer days to pregnancy after the first service. Another benefit of the SR treatment was a 
reduction in the proportion of nonpregnant cows at the end of experimental period (i.e., 210 d 
after first service corresponded with at ~250 to 295 DIM depending on DIM at first service). 
Thus, the SR treatment may benefit dairy herds when compared with blanket use of the D32-
Resynch protocol through a reduction in both time to pregnancy during lactation and the 
proportion of nonpregnant cows removed from the herd at the end of lactation. Of note, the 
reduction in interbreeding interval for cows with a CL at NPD in the SR treatment was possible 
without the GnRH 25 ± 3 d after AI eliminating two unintended consequences: (1) interfering 
with estrus expression before NPD and (2) unnecessarily treating all pregnant cows with GnRH. 
In addition, we observed that cows with a CL ≥15 mm and a follicle ≥10 mm at NPD that 
received the short resynchronization protocol (PGF-24 h-PGF-32 h-GnRH-16 to 18 h -TAI) had 
similar P/AI than cows with the same ovarian status resynchronized with the D32-Resynch 
protocol. Conversely, cows that did not have a CL ≥15 mm and/or a follicle ≥10 mm at NPD 
clearly benefited from P4 supplementation and the two PGF2α treatments as they had greater 
P/AI than cows that received the D32-Resynch protocol.  
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Various strategies for resynchronization of ovulation to maximize P/AI (Dewey et al., 
2010; Giordano et al., 2012b; Giordano et al., 2012c), shorten the interval between TAI services 
(Fricke et al., 2003; Galvão et al., 2007; Sinedino et al., 2014), or maximize the number of cows 
inseminated upon estrus detection (Bruno et al., 2013; Chebel et al., 2013; Giordano et al., 2015) 
have been developed and tested. Nonetheless, few experiments evaluated the effect of these 
strategies on time to pregnancy during lactation or after the first service, which is the ultimate 
driver of the positive relationship between good reproductive efficiency and dairy cow 
profitability. This is particularly relevant when cows are re-inseminated at different intervals 
because differences in interbreeding interval or re-insemination dynamics (i.e., proportion of 
cows AI at detected estrus vs. TAI) can compensate for a lack of gain or even reductions in P/AI 
in the group with shorter interbreeding interval. Indeed, the greater hazard of pregnancy for cows 
in the SR treatment in our experiment was primarily due to the 7 d shorter interbreeding interval 
for the ~70% of cows with a CL at NPD in spite of no gain in P/AI. The 13-percentage point 
greater P/AI without extending the interbreeding interval in cows with no CL at NPD in the SR 
treatment also contributed to reduce time to pregnancy; however, only ~30% of the total 
nonpregnant cows benefited from greater P/AI.   
The similar P/AI for cows with CL in the SR than the D32-Resynch treatment was 
critical for reducing time to pregnancy because if cows that received the short resynchronization  
protocol would have had reduced P/AI, the benefit of shorter interbreeding interval could have 
been counterbalanced by the reduction in P/AI. For cows that did not receive GnRH to induce a 
new follicular wave in the SR treatment the detriment of suboptimal control of the follicular 
wave dynamics (Wijma et al., 2017) must have been compensated, at least in part, by the two 
PGF2α treatments to induce luteal regression. Indeed, the proportion of cows with a CL at NPD 
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that had low P4 concentration (for the 0.5 ng/mL cutoff) at the time of GnRH treatment before 
TAI tended to be greater in the SR treatment. We speculate that maximizing the proportion of 
cows with low circulating P4 concentration (i.e., ≤ 0.5 ng/mL) at the time of inducing ovulation 
before TAI had a greater effect on P/AI than reduced control of the follicular wave from which 
the ovulatory follicle emerged. In this regard, previous experiments with resynchronized 
lactating dairy cows reported greater P/AI for cows that failed to ovulate to the first GnRH 
treatment of Ovsynch but had complete luteolysis before TAI than for cows that ovulated in 
response to the GnRH treatment but had incomplete luteolysis before TAI (Giordano et al., 
2012c). Other potential issues with synchronization of ovulation protocols that do not tightly 
control follicular wave dynamics before TAI include lack of ovulation to the GnRH before TAI 
and the potential to increase pregnancy losses due to poor oocyte quality or luteal insufficiency 
after insemination. Cows in which the follicular wave of the ovulatory follicle was initiated less 
than 5 d before induction of luteal regression may have either failed to ovulate in response to the 
GnRH before TAI (Vasconcelos et al., 1999) or ovulated a small follicle that led to the formation 
of a small CL incapable of supporting pregnancy (Vasconcelos et al., 2001). Cows that initiated 
the follicular wave of the ovulatory follicle more than 5 d before induction of luteal regression 
may have been more likely to have poor embryo quality because of ovulation of an aged oocyte 
around insemination (Cerri et al., 2009). All these issues were expected for some cows with CL 
at NPD in the SR treatment because GnRH was not given to induce a follicular wave from which 
the ovulatory follicle would emerge. In this regard, we recently reported greater variation for age 
of the largest follicle and greater follicle size at NPD 32 ± 3 d after AI in cows that did not 
receive GnRH compared with cows that received GnRH 7 d earlier (Wijma et al., 2017). 
Although our observations need confirmation with additional data, we speculate that the 
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tendency for greater pregnancy loss in the SR treatment for CL cows could be explained, at least 
in part, by reduced control of the follicular wave dynamics before TAI. In our experiment; 
however, the differences in pregnancy loss between groups may have also been less dramatic 
because the follicular wave dynamics of cows resynchronized with Ovsynch-type protocols is 
not optimal due to the high proportion of previously inseminated cows that fail to ovulate in 
response to the first GnRH of the protocol (Giordano et al., 2012c; Lopes et al., 2013; Wijma et 
al., 2017). In particular, poor ovulatory response has been reported for cows with a functional CL 
at the time of the GnRH treatment (Galvão and Santos, 2010; Giordano et al., 2012c; Lopes et 
al., 2013).  
In spite of no reduction of the interbreeding interval for No CL cows, the substantial 
increment in P/AI from 23.9 to 37.0% likely contributed to the overall reduction of time to 
pregnancy for the SR treatment. Greater P/AI for resynchronized inseminations that occur at the 
same interbreeding interval reduces overall time to pregnancy by decreasing the need for re-
inseminations at a later time either at detected estrus or TAI. In cows with No CL at NPD, the 
beneficial effect of P4 supplementation and two PGF2α treatments likely synergized. 
Supplemental P4 in cows without a CL at the initiation of Ovsynch-type protocols has been 
proven effective to increase P/AI (Bartolome et al., 2009; Bisinotto et al., 2013; Bisinotto et al., 
2015) due to a combination of physiological mechanisms including: (1) improved embryo 
quality because of improved endocrine environment for oocyte development (Rivera et al., 
2011), (2) improved uterine environment (Cerri et al., 2011), and (3) reduction of premature 
estrus and ovulation before TAI (Stevenson et al., 2006). The latter, however, may not have been 
as relevant in the current experiment because cows detected in estrus any time were immediately 
inseminated and had reasonable P/AI. An additional PGF2α treatment after induction of luteal 
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regression is known to increase the proportion of cows with complete luteolysis before TAI 
(Brusveen et al., 2009; Ribeiro et al., 2012; Wiltbank et al., 2015) which, in turn, increases P/AI 
after TAI services (Souza et al., 2007; Brusveen et al., 2009; Santos et al., 2016). In our 
experiment, the additional PGF2α treatment may explain a substantial portion of the gain in P/AI 
for cows with No CL at NPD. Cows without a functional CL at the beginning of Ovsynch-type 
protocols are more likely to ovulate after GnRH (Galvão and Santos, 2010; Giordano et al., 
2012c; Lopes et al., 2013) due to a greater GnRH-induced LH response (Giordano et al., 2012a; 
Lima et al., 2013; Pulley et al., 2015) thereby, are more likely to have only one 6 d old CL not 
fully responsive to PGF2α at the time of induction of luteolysis. That may explain the relatively 
low proportion of cows with low P4 at the time of the GnRH before TAI even for cows that 
received two PGF2α treatments. Our results should be interpreted with caution because they do 
not necessarily represent actual luteal regression as we did not have data for P4 concentration at 
the time of the PGF2α treatment in these cows.  
Accurate determination of the physiological status of cows through identification of 
ovarian structures is important for the success of reproductive management strategies relying on 
treatments designed for a particular ovarian status. In the current experiment, the proportion of 
nonpregnant cows bearing a CL 32 ± 3 observed was in agreement with previous research 
(Bruno et al., 2014; Giordano et al., 2015; Wijma et al., 2017). Nevertheless, the agreement 
between TUS and P4 concentration for the determination of the presence of an active CL was 
only moderate and lower than that reported in other experiments from our laboratory (Giordano 
et al., 2015) and others (Bicalho et al., 2008). Lack of agreement between TUS and P4 was 
expected for some cows because of the limitations of B-mode ultrasonography to predict the P4 
secretion ability of luteal tissue (Battocchio et al., 1999), lack of a strong linear correlation 
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between CL size and P4 secretion (Sprecher et al., 1989; Mann, 2009), and the ability of fluid-
filled cavities with apparently no luteal tissue or a small amount of luteal tissue to produce P4 
(Farin et al., 1990; Giordano et al., 2016). For example, the 11.4% of cows with P4 <0.5 ng/mL 
and a CL ≥15 mm visualized through TUS may have had a CL that completed functional but not 
structural luteolysis, whereas the 3.9% of cows with P4 ≥0.5 and <1 ng/mL were likely to have a 
CL from a recent ovulation. Applying the short resynchronization of ovulation treatment in these 
cows may have been detrimental because cows with an already regressed CL may have shown 
estrus prematurely, whereas incomplete luteolysis could have been limiting in cows with an 
immature CL at the time of induction of luteolysis (Henricks et al., 1974; Wiltbank et al., 2015). 
Although not evaluated in this experiment, we speculate that these two subgroups of cows may 
have had better performance if they would have received the modified Ovsynch protocol with P4 
supplementation. In particular, the group with an immature CL because more time until 
induction of luteolysis would have allowed the CL to become fully responsive to PGF2α. On the 
other hand, almost half (i.e., 43.5%) of the cows with no CL ≥15 mm visualized through TUS 
and P4 ≥1 ng/mL had a fluid filled cavity ≥25 mm (usually considered ovarian cysts) with the 
potential to produce P4. The rest of cows with P4 >0.5 ng/mL may have had a small CL formed 
after a recent ovulation but not easily visualized through TUS or a CL <15 mm in diameter. 
Unfortunately, it is not possible to determine if cows with a small but mature CL visualized 
through TUS would have benefited more by the 7 d shorter interbreeding interval if they 
received the short resynchronization protocol than by receiving the treatment for cows with no 
CL. Conversely, the other subgroups of cows likely benefited by receiving the modified Ovsynch 
protocol with P4 supplementation. Until more accurate methods to determine circulating 
concentration of P4 become available for on-farm use, a small proportion of cows will be 
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misclassified based on TUS into the CL or no CL group and receive a treatment that may not 
necessarily optimize their fertility or justify delaying their re-insemination. 
Although the control group in this experiment could have easily incorporated the 
modified protocol with two PGF2α treatments and P4 supplementation for cows with no CL at 
NPD, our reasoning to not do so was to maintain the treatment as simple as possible to reflect the 
conditions of many dairy herds in the U.S. that use this strategy for resynchronization of 
ovulation (Caraviello et al., 2006; Ferguson and Skidmore, 2013; Scott, 2016). Most farms likely 
choose to either not treat cows based on their ovarian status at NPD 32 ± 3 d after AI or even 
conduct NPD 39 ± 3 d coincident with the time of the PGF2α treatment before TAI. Whether 
differential treatment of cows with no CL at NPD 32 ± 3 d after AI in the R32 treatment would 
have offset the gain in reproductive performance from the 7 d shorter interbreeding interval in 
the SR treatment is unknown. Nevertheless, it is rather unlikely because the majority of 
nonpregnant cows 32 ± 3 d after AI had a CL at NPD thereby, they benefited by the reduced 
interbreeding interval of the SR protocol. 
Finally, another important consideration for the use of the SR treatment as a management 
strategy in dairy farms is the potential extra cost of the program as compared with blanket use of 
D32-Resynch. The expected reduction in time to pregnancy and proportion of cows not pregnant 
in late lactation for the SR treatment must offset the additional cost of the synchronization 
protocol for cows without a CL at NPD and the potential additional cost of conducting TUS in 
farms that do not routinely use TUS for NPD. Thus, the economics of more complex and 
potentially more expensive management strategies such as SR warrants further investigation.  
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CONCLUSIONS 
A reproductive management program designed to (1) reduce the interbreeding interval for 
TAI services in cows with a CL ≥15 mm and a follicle ≥10 mm at NPD and (2) increase P/AI of 
cows without a CL at NPD through a modified Ovsynch protocol with two PGF2α treatments 
and P4 supplementation, reduced time to pregnancy during lactation and the proportion of 
nonpregnant cows 210 d after first service when compared with blanket use of the D32-Resynch 
protocol. Therefore, the SR program is a new management strategy for second and greater AI 
services with the potential to improve reproductive performance of dairy herds that enroll all 
nonpregnant cows not re-inseminated at detected estrus in typical Ovsynch-type 
resynchronization of ovulation protocols regardless of their ovarian status. Removing the GnRH 
treatment to induce a new follicular wave in the SR treatment not only helped reduce the 
interbreeding interval for a majority of cows without disrupting estrous behavior but also 
reduced unnecessary treatment of pregnant cows with GnRH 25 ± 3 d after their previous 
insemination.    
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SECTION II 
THE VAGINA AS A ROUTE OF HORMONE DELIVERY FOR SYNCHRONIZATION 
OF OVULATION IN CATTLE 
 
CHAPTER I 
INTRAVAGINAL DELIVERY OF PROSTAGLANDIN F2α AND GONADOTROPIN 
RELEASING HORMONE  
 
1. General introduction 
Synchronization of estrus and/or ovulation programs have been widely adopted in both 
beef (Lamb et al., 2010) and dairy (Wiltbank and Pursley, 2014) cattle production systems. The 
development of these programs has allowed the dairy industry to reduce time to pregnancy 
through timely insemination after the end of the voluntary waiting period (Pursley et al., 1997) 
and between inseminations not resulting in pregnancy (Fricke et al., 2003; Giordano et al., 2012). 
Some of these programs not only ensure timely insemination but also lead to greater pregnancy 
risk than insemination after a detected estrus (Borchardt et al., 2017). Despite the widespread use 
of synchronization of ovulation programs, the need to treat females multiple times with different 
hormones before insemination continues to limit adoption by cattle operations and is a 
disadvantage for correct implementation. Lack of compliance with protocols is one of the main 
reasons for poor outcomes during synchronization of ovulation protocols (Stevenson and Phatak, 
2005; Galvão and Santos, 2010; Macmillan, 2010), mainly because finding cows and performing 
treatments at specific time points requires adequate facilities and access to labor. Furthermore, 
the need to either restrain cows in head gates, sort in sorting pens, or force them to pass through 
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palpation rails multiple times during each round of synchronization disrupts cow time budgets 
and may limit the ability of cows to express other behaviors such as feeding and resting when 
desired. 
Thus, automating hormone delivery for synchronization of ovulation may be an 
alternative to successfully overcome some of the main limitations of proper implementation of 
synchronization of ovulation protocols for TAI. For example, automating hormone delivery may 
help farms with limited access to qualified labor or inadequate facilities to apply treatments and 
may also improve cow performance and welfare through a reduction in cow manipulation. 
Treatment automation may be possible through an electronically controlled device loaded with 
the hormones to be administered to synchronize ovulation. The device could be placed in an 
easily accessible body cavity (e.g., vagina) to deliver the appropriate dose of hormones at pre-
defined time points and be removed at the time of insemination. Therefore, the number of times 
that cows would have to be located and the numbers of handlings would decrease dramatically. 
Automating hormone delivery could also maximize protocol compliance through proper dosing 
and timing of treatments, allow to more closely mimic physiological hormone release patterns, 
and tailor hormonal treatments to individual cows based on their specific physiological status. 
Even though there has been some interest in the past to develop this kind of technology (Cross et 
al., 2004; Künnemeyer et al., 2004), published research regarding the effectiveness of the 
intravaginal (IVG) route for PGF2α and GnRH delivery is scarce. The limited research 
performed in cattle (Zdunczyk et al., 1994; Heinonen et al., 1996) and other species (Okada et 
al., 1982; Viudes-De-Castro et al., 2007; Stewart et al., 2010) has shown intriguing results and 
suggest that the vagina may be a feasible route of PGF2α and GnRH delivery. This chapter 
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intends to review relevant information regarding current knowledge of intravaginal delivery of 
PGF2α and GnRH in cattle and other animal species.  
 
2. Anatomy, histology, and physiology of the vagina in bovine females 
The vagina is a fibromuscular tubular organ located caudal from the cervix and cranial to 
the vestibule. In the adult cow the vagina measures approximately 25 cm (Blazquez et al., 1989). 
The vagina receives irrigation from the uterine artery and the vaginal artery, and it is drained by 
a rich venous plexus which returns through the vaginal vein and accessory vaginal vein to the 
internal iliac vein (Dyce et al., 2009).  
The histology of the vaginal epithelium of the cow is heterogeneous across the different 
portions of the organ and through the different stages of the estrous cycle. Using vaginas 
obtained from slaughtered cows at different stages of the estrous cycle, Cole (1930) described in 
detail the cyclic changes experienced by the vaginal mucosa. During proestrus, the caudal part of 
the vagina, 6 to 10 cm from the cervix until the urethral opening, showed a two layer flat 
epithelium, and an edematous highly vascularized stroma. During estrus, the epithelium became 
stratified columnar and there was major lymphocytic infiltration with epithelial breakdown and 
blood extravasation. Ten to eleven days after estrus (i.e., diestrus phase), the vaginal epithelium 
was almost entirely disrupted and in some portions limited to the germinal layer. The portion of 
the vagina immediately caudal to the cervix (i.e., cranial portion) is the one that experiences the 
most dramatic changes during the estrous cycle. During proestrus, the mucosa is covered by a 
columnar epithelium composed by 2 to 8 layers of cells. The superficial layer contains large 
mucus secreting cells. During estrus, most of the extension of the epithelium is reduced to a 
single layer of very active mucus secreting cells, nevertheless the size of these cells provides the 
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epithelium with a considerable thickness. During diestrus, the epithelium consists of two to four 
layers composed by a mixture of flattened and columnar cells. Cole (1930) also described the 
presence of mucosal folds. This folds are longitudinal in the caudal portion and become more 
tortuous as they get closer to the cervix where depth also increases to up as much as 1 mm. 
The vaginal cavity is bathed by cervical and vaginal mucus, which varies in quantity, 
viscosity, and pH across the estrous cycle. Schilling and Zust (1968) performed a study where 
vaginal pH was measured at different stages of the estrous cycle and at different portions of the 
vagina. They observed an increasing gradient with the lowest pH in the most cranial portion and 
the highest in the most caudal zone. Moreover, pH also changed among phases of the estrous 
cycle: it was more acidic during estrus (6.45 ± 0.24 in the most cranial portion) and closer to 
neutrality during diestrus (6.94 ± 0.28 in the most cranial portion). Furthermore, they observed 
changes in viscosity, which started to decrease during proestrus, reached its minimum at the time 
of ovulation, and rapidly increased thereafter.   
 
3. Intravaginal hormone delivery 
Due to its ease of access, high permeability to low molecular weight molecules, and the 
presence of a rich venous and lymphatic drainage, the vagina is a promising alternative route for 
parenteral hormone delivery (Hussain and Ahsan, 2005). Further, the size and position of the 
vagina in cattle may allow to hold hormone delivery systems for prolonged periods of time.  
A prerequisite for successful hormone delivery through body cavities is efficient 
absorption and absence of factors or molecules that cause degradation or modification of the 
hormone of interest before absorption in the body cavity. Hormone transport across membranes 
can occur in three different manners: a) transcellular transport by diffusion through cell walls due 
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to a concentration gradient, b) receptor mediated or vesicular transport, and c) intercellular 
transport by diffusion through intercellular tight junctions (Richardson and Illum, 1992). 
Absorption of substances through the vaginal mucosa is determined by factors inherent to the 
nature of the molecule, as well as anatomical and physiological factors. The latter refer mainly to 
the cyclic changes in epithelium structure and mucus abundance described above. 
Physicochemical properties of hormones, including molecular weight, charge, 
lipophilicity, and ionization also affect absorption (Richardson and Illum, 1992; Hussain and 
Ahsan, 2005). Experiments in monkeys (Owada et al., 1977) and rabbits (Hwang et al., 1976) 
have shown that vaginal permeability to unbranched aliphatic alcohols increased with chain 
length and lipophilicity. Despite this, it is well accepted that lower molecular weight lipophilic 
hormones are better absorbed than larger molecules (Hussain and Ahsan, 2005). Moreover, 
Flynn et al. (1976) observed a greater permeability of the rabbit’s vaginal mucosa to lipophilic 
steroids (e.g., progesterone, estrone) than to hydrophilic steroids (e.g., hydrocortisone, 
testosterone). Furthermore, due to the aqueous nature of the vaginal fluid, any molecule that is to 
be administered through the vaginal route must be soluble in water to some extent (Hussain and 
Ahsan, 2005).  
In cattle, the intravaginal route has been used for more than 30 years primarily for P4 
supplementation in synchronization of ovulation and/or estrus treatments (Webel, 1976; 
Macmillan et al., 1991; Macmillan and Peterson, 1993). Progesterone controlled release 
intravaginal devices consist of a silicone matrix containing a homogeneous dispersion of P4 
allowing gradual release and absorption through the vaginal mucosa (Rathbone and Burke, 
2013). This system has been widely adopted by farmers and veterinarians and is used in many 
synchronization of ovulation protocols for both dairy and beef cattle. On the other hand, 
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hormones such as PGF2α and GnRH that exert their effect in an acute manner need to be rapidly 
absorbed by the mucosa to reach their target tissues and cells to induce an acute response 
(Karsch et al., 1997; Niswender et al., 2000). Therefore, sustained release does not seem to be a 
feasible option for these reproductive hormones.  Administration of GnRH and PGF2α through 
the intravaginal route requires a delivery system that can automatically control the release of the 
desired amount of hormone at once at predefined time points so that the physiological effect can 
be achieved (i.e., GnRH-induced LH surge for induction of ovulation and luteal regression for 
PGF2α). The device should allow programmed release of each hormone at a given time to 
eliminate the need for repeated treatments through injections and to mimic physiological patterns 
of secretion more closely so that the response to protocols can be maximized. In this regard, 
Cross et al. (2004) reported the design of a device that fulfils most of the requirements of an 
automated controlled device for synchronization of ovulation. It allowed to release a pre-
programed or externally controlled amount of hormone into the vagina, thus enabling to perform 
treatments at different times without the need to interact with the cow. The device also had the 
ability to record body temperature and these data could be monitored in real time. In a 
publication from the same laboratory, Künnemeyer et al. (2004) described a similar device 
equipped with an antenna to remotely control timing and amount of hormone to be released. 
These devices could hold up to 40 mL, and were very accurate to deliver the desired amount of 
volume at the programed times (volume accuracy ~ 3%). Despite this, the fact that devices 
consisted of a single chamber would be one of the limitations for its use on synchronization of 
ovulation protocols that require treatment with different hormones. 
Although the availability of multiple technologies for automated cow monitoring and 
management (Sørensen et al., 2016; Stangaferro et al., 2016) has increased, the refinement of 
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electronically controlled intravaginal hormone release devices available for commercial use, has 
not been explored extensively. Developing these devices would allow to reduce human 
interactions with cows as well as number of injections, improving cow welfare. Further, it would 
also allow to maximize treatment compliance and tailor protocols to the individual cow level. 
Hence, further research is required to develop devices capable of delivering multiple hormones at 
different times, and to test the feasibility of using the vagina as a route of administration for 
GnRH and PGF2α in cattle. 
 
4. Intravaginal administration of Prostaglandin F2α  
Prostaglandin F2α is an eicosanoid molecule synthetized in cattle by the endometrium 
among other tissues. It is derived from arachidonic acid which is released from cell membrane 
phospholipids by phospholipase A2 and converted to prostaglandin H2 by cyclooxygenase and 
finally converted into PGF2α by PGF synthase (Funk, 2001). Like most eicosanoid molecules, 
PGF2α has a short half-life being totally metabolized in the lungs within a few (~ < 9) minutes 
(Shrestha et al., 2012). In cattle, PGF2α is responsible for triggering luteolysis and it has been 
used to synchronize estrus and ovulation for more than 30 years (Manns and Hafs, 1976; Pursley 
et al., 1995; Moreira et al., 2001). Luteolysis and its importance for synchronization of ovulation 
programs are discussed in detail in Chapter I of Section I. 
The most commonly used PGF2α synthetic analogues are Dinoprost and Cloprostenol. 
The first one is structurally homologous to the natural form of PGF2α and therefore has a half-
life of 7 to 8 minutes (Kimball et al., 1976). Conversely, due to the addition of an oxyaryl 
function to its molecule, Cloprostenol has a slower metabolization rate and a half-life of 
approximately 3 hours (Reeves, 1978; Bourne et al., 1980). Another difference between these 
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analogues is their potency. Whereas the luteolytic dose of Dinoprost in cattle is 25 mg, the dose 
of Cloprostenol to cause luteolysis is 0.5 mg (Dukes et al., 1974).  
Information regarding IVG administration of PGF2α and its analogues in cattle is scarce. 
In an experiment using non-lactating Bos indicus cattle, Heinonen et al. (1996) tested the 
efficacy of IVG administration of Cloprostenol to induce estrus expression. Cows (n = 73) were 
either treated with 175 µg of Cloprostenol through the IVG route or with 500 µg of Cloprostenol 
intramuscular (i.m.). Estrus detection was performed for 12 days and cows not detected in estrus 
were treated again. Three days after the second treatment, cows that failed to express estrous 
behavior were examined by transrectal palpation and those presenting prominent uterine tone 
and/or vaginal discharge were considered to be in estrus. The experiment lacked a negative 
control and the statistical comparison was performed against an assumed 4.8% of daily estrus 
detection in non-treated cows. Estrus response was considered to be greater for cows that 
received IVG (62.5%) and i.m. (60.6%) treatment with Cloprostenol than for the modeled 
population. Although presence of a CL at the time of treatment and P4 concentration dynamics 
after treatment were not determined, the similar proportion of cows detected in estrus was similar 
for the groups treated with Cloprostenol through the IVG and i.m. route, suggested that IVG 
administration of PGF2α analogues might induce luteal regression in cattle. 
In a more controlled experiment, Zdunczyk et al. (1994) observed an effect of IVG 
treatment with Cloprostenol on circulating P4 concentration. Cows (n = 22) presenting an active 
CL (P4 > 2 ng/mL in circulation) were treated with 500 µg of Cloprostenol either through the 
IVG or i.m route. Blood samples were collected at four hour intervals from 0 to 12 hours after 
treatment, and then from 24 to 36 hours after treatment. Cows had a similar pattern of decline in 
P4 concentration in the group treated through the IVG or i.m. route, and at 32 hours after 
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treatment both groups had mean P4 concentration below 1 ng/mL. Although this experiment also 
lacked a negative control group, results supported the hypothesis that luteal regression could be 
induced through IVG administration of PGF2α analogues. It is important to note that cows were 
at an unknown stage of the estrous cycle, and no individual P4 profiles were described, therefore 
it is possible that some cows had an immature CL at the time of treatment and did not undergo 
complete luteal regression. Another caveat of this experiment was that P4 concentration was only 
measured for up to 36 hours after treatment precluding drawing conclusions about complete 
luteal regression and circulating P4 levels at 56 to 72 hours after treatment which are 
approximate time points at which GnRH treatment and TAI take place in most synchronization 
of ovulation protocols. 
Although available research regarding IVG administration of PGF2α in cattle is scarce 
and experiments present important limitations, available data supports the hypothesis that it is 
feasible to induce luteolysis through IVG delivery of PGF2α. Further research is required to 
describe in detail P4 dynamics after IVG administration of PGF2α in lactating dairy cows and to 
determine the efficacy of PGF2α to induce luteolysis when administered intravaginally. 
 
5. Intravaginal administration of Gonadotropin releasing hormone 
Gonadotropin releasing hormone is one of the main regulators of the reproductive 
physiology of cattle controlling the production and release of luteinizing hormone (LH) and 
primarily the synthesis of follicle stimulating hormone (FSH) (Millar, 2005). Therefore, as 
described in Chapter I of Section I, the availability of GnRH for its use in cattle provides 
veterinarians, producers, and researchers with an invaluable tool for controlling reproductive 
function in cattle. 
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Gonadotropin releasing hormone is a decapeptide molecule [pGlu-His-Trp-Ser-Tyr-Gly-
Leu-Arg-Pro-Gly·NH2; (Schally et al., 1971)] produced and stored in neurons from the medio-
basal hypothalamus, and released by axon terminals in the median eminence of the brain 
(Sealfon et al., 1997). The most important structural features of the GnRH molecule are: (1) a 
bend in the Gly in position six, (2) presence of a NH2 terminus (pGlu-His-Trp-Ser), and (3) the 
COOH terminus (Pro-Gly·NH2). These features are critical for receptor binding and response, 
thus amino acids substitutions in these portions will affect the potency of analogues and 
antagonists (Millar et al., 2004).  
Substitutions of L-isomers with D-isomers in synthetic GnRH analogues provides them 
with either greater or lower affinity and activation capacity for the receptor as well as extended 
or reduced half-life (Padula, 2005). Several of these analogues and their potency were tested for 
their use in cattle to control reproductive cycles. The most widely used analogue is Gonadorelin 
(hereafter referred as GnRH) which is homologous to the natural hormone. Another commonly 
used analogue for reproductive management of cattle (not approved in the U.S.) is Buserelin. 
The latter is a nonapeptide lacking Gly in position 10 of the natural GnRH molecule and with a 
D-Ser substitution in position 6. These two modifications confer the molecule greater affinity for 
the GnRH receptor and an extended half-life (Karten and Rivier, 1986). In a randomized study, 
Chenault et al. (1990) compared the potency of GnRH and Buserelin. Heifers were treated with 
10 or 20 µg of Buserelin or 150, 250, or 500 µg of GnRH between Days 8 and 16 of the estrous 
cycle. Both doses of Buserelin elicited an LH surge of greater magnitude (measured as area 
under the curve and maximum LH concentration) than the three different doses of GnRH, 
indicating a potency of approximately 50 times greater for Buserelin than Gonadorelin.  
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Although there are no reports in the literature regarding the use of the IVG route for the 
administration of GnRH or its analogues in cattle, there are several reports for other species such 
as rabbit (Viudes-De-Castro et al., 2007), swine (Stewart et al., 2010), and rats (Okada et al., 
1982; Okada et al., 1983).  
Viudes-De-Castro et al. (2007) performed two experiments to test the feasibility of 
inducing ovulation by including Buserelin or Triptorelin in the semen extender for intravaginal 
insemination in rabbit does. In the first experiment, they compared two different doses of 
Buserelin (2 and 5 µg) or Triptorelin (1 and 5 µg) to a negative control (no GnRH) and a positive 
control (1 µg Buserelin i.m.) using weaned does (n = 255). Animals were slaughtered three days 
after treatment and ovulatory response was measured by counting ovulatory stigmas. The 
positive control group had greater ovulatory response (97.8%) than the rest of the treatments, 
except than the group which received 2 µg of Buserelin through the IVG route (88.9%). Further, 
all groups receiving IVG Buserelin or Triptorelin had greater ovulatory response (70.0 to 88.9%) 
than the negative control group (32.5%). There was no difference in ovulatory response among 
IVG treatments. In a second experiment, does (n = 702) were inseminated and treated with 1 µg 
i.m. Buserelin or including 5 µg of Buserelin or 5 µg of Triptorelin in the semen diluent. There 
was no difference in pregnancy rate or kindling rate among treatments. Based on these results it 
was concluded that the inclusion of GnRH analogues in the semen diluent for IVG insemination 
can effectively induce ovulation in rabbits. 
Stewart et al. (2010) carried out an experiment to evaluate the feasibility of inducing an 
LH surge and ovulation after IVG administration of Triptorelin with different concentrations of a 
methylcellulose gel in sows (n = 48). After weaning, sows were treated with 2 mL of 1.2% 
methylcellulose gel (negative control), or 100 µg of Triptorelin in 0.9, 1.2, or 1.5% 
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methylcellulose gel. The rationale for using different methylcellulose concentrations was that 
transmembrane transport efficiency increases when the vehicle and membrane viscosity are 
similar (Edwards et al., 1996). Blood samples were collected every 2 hours for 30 hours after 
treatment to measure LH concentration. Transabdominal ultrasonography was performed every 
12 hours from 36 hours pretreatment until treatment, and every 4 hours thereafter until ovulation 
was confirmed. All sows receiving Triptorelin were inseminated 8 and 32 hours after treatment. 
Negative control and other 48 untreated sows were treated following conventional management 
practices consisting of insemination once a day for each day of estrus. Groups receiving 
Triptorelin in 1.2 and 1.5% methylcellulose gel had a significant increase in LH concentration 8 
to 12 hours after treatment. Further, although there was no treatment effect on ovulatory rate, 
ovulations in sows receiving 1.2 and 1.5% methylcellulose plus Triptorelin occurred in a 
narrower period of time. No effect of treatment was observed on farrowing rate or number of 
piglets born alive per litter. These results showed that vaginal administration of GnRH analogues 
can induce an LH surge and ovulation in sows, and that viscosity of the vehicle has a direct 
impact on treatment efficacy.  
Using rats in diestrus stage, Okada et al. (1982) compared the efficacy of intravenous, 
subcutaneous, nasal, oral, and intravaginal administration of Leuprolide (a GnRH analogue). For 
intravaginal administration both an aqueous and an oleaginous base including different types of 
organic acids were used. Leakage of Evan’s blue into the vaginal mucosa after intravenous 
administration was used as a measure of membrane permeability. When using ovulatory 
response after treatment as the outcome of interest, the IVG route of delivery showed the greatest 
potency among all parenteral routes of administration and no difference was observed between 
the aqueous and the oleaginous vehicle. Moreover, addition of organic acids to the IVG 
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preparation increased the ovulatory response. Relative potency was maximum when adding 10% 
citric acid (relative potency = 4.9), 10% succinic acid (relative potency = 5.4), and glycholic acid 
(relative potency = 5.6). These acids also increased staining of the vaginal mucosa with Evan’s 
blue, suggesting increased permeability of the vaginal mucosa. In a second experiment, Okada et 
al. (1983) evaluated the effect of adding different concentrations of citric acid and different pH 
on permeability of the vaginal mucosa and ovulatory response to IVG administration of 
Leuprolide to rats in diestrus. Decreasing pH from 6.7 to 2.02 resulted in a fourfold increase in 
ovulatory response. Ovulatory response increased with concentration of citric acid in the vehicle, 
reaching maximum response at 7 to 10%. Further, addition of 5% citric acid at pH 3.5 and 1.8 
resulted in a threefold increase of potency. These two experiments together provided evidence 
that the addition of citric acid as an absorption enhancer and acidification of the vehicle 
increased permeability of the vaginal mucosa to Leuprolide resulting in a greater ovulatory 
response in rats.  
Although these experiments were not performed in cattle, they provide strong evidence 
that the vagina is a feasible route for GnRH administration. Data also suggest that due to the low 
lipophilicity of GnRH and its analogues, the use of vehicles that facilitate transmembrane 
transport should be used for IVG administration of GnRH. Further research in cattle is required 
to determine the feasibility of inducing an LH surge and ovulation through IVG administration of 
GnRH. 
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6. Summary 
The objective of this literature review was to summarize important aspects regarding the 
potential use of the vagina as a hormone delivery route for synchronization of ovulation 
programs and current knowledge regarding the use of PGF2α and GnRH through the IVG route. 
Due to its anatomy and vascularization, the vagina is a practical and effective route for 
hormone delivery in several species. Its anatomy allows holding hormone delivery devices for 
prolonged periods of time and it is currently used for P4 administration in cattle. Although 
research regarding IVG administration of PGF2α in cattle is limited and published experiments 
have experimental design limitations, most data support the idea that it is feasible to induce 
luteolysis through IVG administration of PGF2α analogues.  
Additionally, there is a substantial amount of published research from non-cattle species 
supporting the feasibility of using the IVG route for delivery of GnRH analogues. Conversely, to 
my knowledge no data from experiments with cattle have been reported. 
Thus, the objective of the experiments presented in Chapters II and III of Section II was 
to test the feasibility of using the IVG route for delivery of PGF2α and GnRH in dairy cattle. In 
the experiments presented in Chapter II, we tested the feasibility of inducing luteal regression 
after IVG administration of PGF2α in lactating dairy cows. The objective of the experiments 
presented in Chapter III was to test the feasibility of inducing an LH surge of similar magnitude 
of that induced after i.m. administration of GnRH using the IVG route. 
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CHAPTER II 
CIRCULATING PROGESTERONE DYNAMICS AFTER INTRAVAGINAL 
INSTILLATION OF PROSTAGLANDIN-F2α TO LACTATING DAIRY COWS 
Robert Wijma, Matias. L. Stangaferro, and Julio. O. Giordano 
Theriogenology 2016; 85:1660 - 1668 
DOI 10.1016/j.theriogenology.2016.01.025  
ABSTRACT 
Our objectives were to evaluate circulating progesterone (P4) concentration dynamics 
and test the feasibility of inducing luteal regression after intravaginal (IVG) instillation of the 
PGF2α analogue Dinoprost (PGF) in lactating dairy cows. In two experiments, cows were 
synchronized using the Ovsynch protocol to induce the formation of a corpus luteum (CL). Cows 
with at least one functional (P4 ≥1 ng/mL) CL ≥15 mm 7.5 d after Ovsynch remained in the 
studies. In Exp 1, cows (n = 31) were stratified by parity group and received: 5 mL of saline IVG 
(SAL-IVG, n = 6), 25 mg of PGF2α i.m. (PGF25-IM, n = 7), 25 mg of PGF2α IVG (PGF25-
IVG, n = 6), 50 mg of PGF2α IVG (PGF50-IVG, n = 6), and 125 mg of PGF2α IVG (PGF125-
IVG, n = 6). Experiment 2 was conducted to test the hypothesis that IVG instillation of two 25 
mg doses of PGF2α 12 h apart would be more effective than a 25 or 50 mg dose in a single 
application. Cows (n = 32) were stratified by parity and received: SAL-IVG (n = 7), PGF25-IM 
(n = 7), PGF25-IVG (n = 6), and PGF50-IVG (n = 6) as in Exp 1, whereas another group 
received two IVG instillations of 25 mg of PGF2α 12 h apart (PGF25-2X-IVG, n = 6). Blood 
was collected at -1 h, every 6 h from 0 h to 24 h, and every 12 h up to 96 h after treatment (trt). 
In Exp 1, there was an effect of trt (P <0.01), time (P <0.001), and an interaction between trt and 
time on P4 concentrations (P <0.001). All PGF-treated groups had lower (P <0.05) 
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concentrations of P4 than cows in the SAL-IVG group from 12 to 96 h after trt. Although an 
initial decline in P4 concentrations was induced in all PGF-treated cows, some cows in the IVG-
treated groups presented a rebound in plasma P4, indicating CL recovery. More cows in the 
PGF25-IVG and PGF125-IVG groups than in the PGF50-IVG and PGF25-IM groups presented 
CL recovery, suggesting that greater doses of PGF2α may not necessarily improve CL 
regression. In Exp. 2, there was an effect of trt (P <0.001), time (P <0.001), and an interaction 
between trt and time on P4 concentrations (P <0.001). All PGF-treated groups had lower (P 
<0.05) P4 than the SAL-IVG group from 12 to 96 h after trt. Cows in the PGF25-2X-IVG group 
had a P4 profile that was similar to that of cows in the PGF25-IM group and the lowest P4 
concentrations after treatment among the IVG-treated groups, and all cows presented complete 
CL regression (defined as P4 <0.4 ng/mL). We conclude that CL regression can be induced 
through IVG instillation of PGF2α in lactating dairy cows and that instillation of two IVG doses 
of 25 mg of PGF2α 12 h apart was the most effective strategy. 
 
INTRODUCTION 
Reproductive efficiency in cattle is critical to farm success, notably affecting farm 
profitability (De Vries, 2006; Giordano et al., 2011; Rodgers et al., 2012). In this regard, 
synchronization of ovulation protocols for timed AI (TAI) are essential to reproductive 
management in modern cattle operations, assuring timely insemination and greatly improving 
fertility (Wiltbank and Pursley, 2014). Also, synchronization protocols can serve as a therapeutic 
approach for treating specific physiological limitations, or can be adapted to suit the 
physiological status of individual cows (Stevenson et al., 2006; Bisinotto et al., 2015; Giordano 
et al., 2015). The need to provide multiple hormone injections is a major barrier to adoption of 
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TAI, with some protocols requiring up to six injections over a period of 35 days. Many dairy and 
beef farms in the U.S. and across the world are unable to take advantage of TAI because they 
lack the necessary facilities, tools, qualified labor, or the frequency of access to cows that is 
necessary for properly implementing a protocol. For current users, issues regarding labor 
efficiency and animal welfare are also becoming more important, as protocols continue to evolve 
to include more hormone injections at inconvenient frequencies. 
Thus, developing devices that allow cattle operations to fully automate hormone administration 
for synchronization of ovulation could be a solution to these major barriers to adoption of TAI 
programs. Automating hormone administration could also create opportunities for developing 
novel protocols and optimizing current ones to maximize fertility by closely mimicking or 
enhancing physiological processes. A potential alternative to automated hormone administration 
for synchronization of estrus and ovulation is intravaginal (IVG) administration of hormones 
through electronically controlled devices (Rathbone et al., 1998; Cross et al., 2004; Künnemeyer 
et al., 2004). Nevertheless, feasibility data to support IVG administration of some of the most 
widely used reproductive hormones (PGF2α and GnRH) for synchronization of estrus and 
ovulation in cattle is lacking. 
The vagina presents favorable attributes as a route of hormone administration; it is easily 
accessible, the mucosa is densely vascularized, and it is highly permeable to molecules with low 
molecular weight (Okada et al., 1982; Hussain and Ahsan, 2005). In cattle, the use of the IVG 
route for administration of reproductive hormones has been limited to sustained progesterone 
(P4) release over prolonged periods of time (≥ 7 d) (Macmillan et al., 1991; Macmillan and 
Peterson, 1993; Chebel et al., 2006). Conversely, little is known about hormones used to elicit an 
immediate response through im injection such as PGF2α and GnRH. For example, the efficacy 
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of PGF2α in inducing luteolysis after IVG instillation has been studied very rarely. To the best of 
our knowledge, only two studies have tested the efficacy of IVG treatment with PGF2α to induce 
luteolysis in cattle (Zdunczyk et al., 1994; Heinonen et al., 1996). These studies provided some 
evidence to support the feasibility of using IVG PGF2α to induce luteal regression but they were 
inconclusive because only estrus expression in small groups of cows (Heinonen et al., 1996) or 
estrus expression and concentrations of P4 36 h after treatment were evaluated (Zdunczyk et al., 
1994). Thus, our objective is to characterize and optimize the response of cattle to IVG treatment 
with PGF2α to facilitate the future development of automated IVG hormone delivery devices for 
synchronization of ovulation in cattle. 
We conducted two experiments to study P4 concentration dynamics after IVG instillation 
of PGF2α 7.5 d following induction of ovulation in lactating dairy cows. In Experiment 1, our 
objectives were to compare P4 concentration dynamics after instillation of varying doses of PGF. 
Our specific hypothesis was that IVG instillation of PGF2α would induce luteal regression and 
the changes in circulating P4 would be similar to those observed after an i.m. injection of PGF. 
In addition, we hypothesized that the response to IVG instillation of PGF2α would be dose-
dependent so that greater doses would be more effective than lower doses at reducing circulating 
concentrations of P4. Based on the results of Experiment 1, we conducted Experiment 2 to test 
the hypothesis that instillation of two IVG doses of 25 mg of PGF2α 12 h apart would be more 
effective than instillation of a single IVG dose of 25 or 50 mg of PGF, and would be similar to 
an i.m. injection of 25 mg of PGF2α for reducing circulating P4 concentrations. Thus, the 
objectives of Experiment 2 were to evaluate P4 concentration dynamics after instillation of two 
IVG doses of 25 mg PGF2α 12 h apart. 
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MATERIALS AND METHODS 
Animals 
Lactating Holstein cows from the dairy unit of the Cornell University Ruminant Center 
(Harford, NY) were used for this experiment conducted from November 2013 to October 2014. 
Cows were housed in free-stall barns with cooling fans placed above the feeding lane and free 
stalls with sprinklers above the feed bunk. All cows were fed a TMR diet once daily and had ad 
libitum access to feed and water. The diet was formulated to meet or exceed nutritional 
requirements for lactating Holstein cows producing 45 kg of milk based on the Cornell Net 
Carbohydrate and Protein System version 6.5 (CNCPS). Cows were milked thrice daily at ~8 h 
intervals and received bovine somatotropin (Posilac, 500 mg; Elanco Animal Health, 
Indianapolis, IN) at 14 d intervals beginning ~60 DIM until dried off.  All procedures were 
approved by the Animal Care and Use Committee of Cornell University.  
Treatments 
In Experiments 1 (Exp 1) and 2 (Exp 2), lactating non-pregnant cows at various DIM 
received the Ovsynch-56 protocol (Brusveen et al., 2009) with two PGF2α injections (GnRH-7 
d-PGF-1 d-PGF-32 h-GnRH) to synchronize ovulation. At the time of the second GnRH 
injection of Ovsynch and 48 h later, transrectal ovarian ultrasonography (TUS) was performed 
using a portable ultrasound machine with a 7.5 MHz linear array transducer (IbexPro, E.I 
Medical Imaging, Colorado, USA) to confirm ovulation after GnRH. Ovulation was defined as 
the disappearance of at least one follicle ≥10 mm and the presence of a putative CL on the same 
ovary. Seven and a half days after the second GnRH injection of Ovsynch, cows that ovulated 
were re-examined by TUS and only those with a CL ≥ 15 mm remained in the study (Figure 2.1). 
Plasma concentrations of P4 were used to confirm that the CL was functional (P4 >1 ng/mL) in 
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all cows that received the treatments. For synchronization of ovulation with the Ovsynch 
protocol and the respective PGF2α treatments, Dinoprost tromethamine (Lutalyse, Zoetis Animal 
Health, New York, NY) was used, whereas the GnRH product was Gonadorelin diacetate 
tetrahydrate (Cystorelin, Merial LLC, Duluth, GA). 
 
Experiment 1: Cows (15 primiparous and 24 multiparous) with average DIM of 420 (range 124 
to 772) and average BCS of 3.9 (range 3.5 to 4.5) were used for this experiment. After 
confirmation of the presence of a CL ≥ 15 mm  7.5 d after induction of ovulation, cows (15 
primiparous and 16 multiparous) were stratified by parity group (primiparous vs. multiparous) 
and randomly assigned to one of five treatments: 1) 5 mL of saline solution IVG (SAL-IVG, n = 
6), 2) an i.m. injection of 25 mg of PGF2α in the semimembranosus or semitendinosus muscle 
(PGF25-IM, n = 7), 3) 25 mg of PGF2α IVG (PGF25-IVG, n = 6), 4) 50 mg of PGF2α IVG 
(PGF50-IVG, n = 6), and 5) 125 mg of PGF2α IVG (PGF125-IVG, n = 6). Seven cows had two 
corpora lutea present and were randomly assigned to the PGF2α treatment groups only (two 
cows in groups PGF25-IM, PGF25-IVG, and PGF50-IVG and one cow in the PGF125-IVG 
group).    
  
Experiment 2: Cows (16 primiparous and 23 multiparous), with average DIM of 124 (range 51 
to 740) and average BCS of 3.1 (range 2.5 to 4.75) were used for this experiment. After 
confirmation of the presence of a CL ≥ 15 mm  7.5 d after induction of ovulation, cows (15 
primiparous and 17 multiparous) were stratified by parity group and randomly assigned to one of 
five treatments: 1) 5 mL of saline solution IVG (SAL-IVG, n = 7), 2) an i.m. injection of 25 mg 
of PGF2α in the semimembranosus or semitendinosus muscle (PGF25-IM, n = 7), 3) 25 mg of 
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PGF2α IVG (PGF25-IVG, n = 6), 4) 50 mg of PGF2α IVG (PGF50-IVG, n = 6), and 6) two 
doses of 25 mg of PGF2α IVG administered 12 h apart (PGF25-2X-IVG, n = 6). Two cows had 
two corpora lutea present and were randomly assigned to the PGF2α treatment groups only (one 
cow each in groups PGF25-IM and PGF50-IVG). 
In both experiments cows received the IVG instillations of PGF2α or saline following the 
same procedures while cows were restrained in self-locking headgates after their morning 
milking. The vulva was manually cleaned and disinfected using chlorhexidine solution and dried 
off using paper towels. After cleaning the vulva, the vulvar labia were manually opened by one 
technician while another technician inserted a uterine infusion catheter (44.5 cm long by 0.5 cm 
of external diameter) attached to a plastic syringe. The catheter was carefully inserted into the 
vagina until the cervix or vaginal fornix was reached. Once in the cranial portion of the vagina, 
the catheter was pulled backwards 1 to 2 cm and the volume of saline solution or PGF2α for the 
specific treatment was released. After treatment, cows remained standing in self-locking 
headgates for a period of 45 to 60 minutes to record urination activity, backflow of fluid from the 
vagina, and signs of distress. Fresh TMR was offered to cows during the observation period.  
 
Blood sampling and determination of progesterone concentrations  
Blood samples were obtained from the coccygeal vein or artery using evacuated tubes 
containing sodium heparin (Vacutainer, BD, Franklin Lakes, NJ). Blood samples were collected 
at -1 h, 0 h, every 6 h for the first 24 h, and then every 12 h up to 96 h after treatment (Figure 
2.1). Samples were immediately placed into crushed ice and centrifuged within 2 h at 2000 x g 
for 20 minutes at 4°C. Plasma was harvested and stored at -20°C until assayed for P4. Plasma 
concentrations of P4 were determined in duplicate using a commercial solid-phase, no-extraction 
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radioimmunoassay (Coat-a-count; Diagnostic Products Corp., Los Angeles, CA). In the nine 
assays performed two quality control samples with concentrations of P4 representative of the 
diestrus (high concentration = 7.4 ng/mL) and proestrus (low concentration = 0.5 ng/mL) phases 
of the estrous cycle were included twice (at the beginning and end) across each assay to 
determine the variation within and across assays. Average sensitivity for the nine P4 assays was 
0.03 ng/mL. The average intra-assay CV for the high-concentration sample was 5.7% whereas 
the interassay CV was 9.3%. For the low-concentration sample the intra-assay CV was 5.7% 
whereas the inter-assay CV was 14.9%. 
For these experiments, the presence of an active or functional CL was defined as 
circulating P4 concentrations ≥1 ng/mL (Ginther et al., 2010), whereas complete luteal 
regression was defined as circulating P4 concentrations <0.4 ng/mL (Carvalho et al., 2015) for at 
least one sample collected after treatment. 
 
 Statistical Analysis 
Data for Exp 1 and Exp 2 were analyzed following the same methodology. Before 
statistical analysis, normality of data for concentrations of P4 was assessed using the Shapiro-
Wilk statistic and graphical methods (histogram and Q-Q plot) with PROC UNIVARIATE of 
SAS (version 9.4, SAS Institute Inc., Cary, NC). In addition, during statistical analysis normality 
of residuals was assessed using graphical methods generated with the residual option of PROC 
MIXED of SAS. Because all methodologies indicated that values for concentrations of P4 were 
not normally distributed, square root transformation was used to correct for non-normality. After 
transformation, the square root of the concentration of P4 was analyzed by ANOVA with 
repeated measures using PROC MIXED of SAS. A spatial power covariance structure was used 
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to adjust for the varying time intervals at which blood was collected. Treatment, time, and 
treatment-by-time interaction were included as fixed effects, whereas cows within the treatment 
group were used as a random effect in the models. Parity group (primiparous vs. multiparous) 
was also offered to each model as a categorical fixed effect. The Least Significant Difference 
(LSD) post-hoc mean separation test was used to determine differences between Least Square 
Means (LSM).  
An analysis similar to that conducted for Exp 1 and Exp 2 was performed by combining 
data from both experiments. Four of the treatments (SAL-IVG, PGF25-IM, PGF25-IVG, and 
PGF50-IVG) were identical in both experiments, whereas the PGF125-IVG and PGF125-2X-
IVG treatments were included  in Exp 1 and Exp 2, respectively, but not in both. Both 
experiments were conducted in the same facilities, by the same technicians, using cows from the 
same herd, and were conducted seven months apart. 
In addition, the combined data set was used to evaluate concentrations of P4 at 48, 60, 
and 72 h after treatment. Differences in concentrations of P4 at 48, 60, and 72 h were determined 
by ANOVA with PROC MIXED of SAS with a model that contained treatment as the sole 
explanatory variable. The LSD post-hoc mean separation test was used to determine differences 
between LSMs. 
For clarity of presentation all values are reported as arithmetical means and SE generated 
with PROC MEANS of SAS, whereas proportions were generated using PROC FREQ of SAS. 
All explanatory variables and their interactions were considered significant if P ≤ 0.05, whereas 
0.05 < P ≤ 0.10 were considered a tendency.  
 
RESULTS 
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During the observation period following application of the experimental treatments, none 
of the cows in the treatment groups urinated or presented backflow of fluid from the vagina. 
Also, no signs of distress or abnormalities in behavior were observed. 
  
Experiment 1: Progesterone concentration dynamics  
From -1 to 96 h after treatment, there was an effect of treatment (P <0.01), time (P 
<0.001), and an interaction between treatment and time (P <0.001) on circulating concentrations 
of P4 (Figure 2.2A). At 6 h after treatment cows in the PGF50-IVG group presented lower (P 
<0.05) concentrations of P4 than cows in the SAL-IVG group (negative control), whereas cows 
in the PGF25-IM, PGF25-IVG, and PGF125-IVG groups tended (P <0.10) to have lower 
concentrations of P4 than cows in the SAL-IVG group. From 12 to 96 h after treatment, cows in 
all PGF-treated groups had lower (P <0.05) concentrations of P4 than cows in the SAL-IVG 
group. Concentrations of P4 were similar (P >0.05) for all PGF-treated groups during the entire 
sampling period, except that cows in the PGF25-IM group had lower P4 concentrations than 
cows in the PGF25-IVG group at 96 h. Parity did not affect (P = 0.46) circulating concentrations 
of P4. 
 
Experiment 2: Progesterone concentration dynamics  
From -1 to 96 h after treatment, there was an effect of treatment (P <0.001), time (P 
<0.001), and an interaction between treatment and time (P <0.001) on circulating concentrations 
of P4 (Figure 2.2B). At 6 h after treatment, cows in the PGF25-2X-IVG group had lower (P 
<0.05) whereas cows in the PGF25-IM group tended (P <0.10) to have lower concentrations of 
P4 than cows in the SAL-IVG group. From 12 to 96 h after treatment, cows in all PGF-treated 
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groups had lower (P <0.05) concentrations of P4 than cows in the SAL-IVG group. Parity tended 
to affect (P = 0.07) circulating concentrations of P4 (overall mean = 1.4 ± 0.1 vs. 1.3 ± 0.1 
ng/mL for primiparous and multiparous, respectively). 
Also, concentrations of P4 differed across the PGF-treated groups (Figure 2.2B). At 48 h 
cows in the PGF25-2X-IVG and PGF25-im groups tended (P <0.10) to have lower 
concentrations of P4 and from 60 to 96 h after treatment had lower (P <0.05) concentrations of 
P4 than cows in the PGF25-IVG group. At 84 and 96 h after treatment, cows in the PGF25-2X-
IVG group tended (P <0.10) to have lower concentrations of P4 than cows in the PGF50-IVG 
group, whereas cows in the PGF25-IM group tended (P <0.10) to have lower concentrations of 
P4 than cows in the PGF50-IVG group only at 96 h after treatment. 
 
Experiment 1 and Experiment 2 combined: Progesterone dynamics  
From -1 to 96 h after treatment, there was an effect of treatment (P <0.001), time (P 
<0.001), and an interaction between treatment and time (P <0.001) on circulating concentrations 
of P4 (Figure 2.3). From 6 to 96 h after treatment, concentrations of P4 were lower (P < 0.05) for 
cows in all the PGF-treated groups than for cows in the SAL-IVG group. At 60 h after treatment, 
cows in the PGF25-2X-IVG group had lower (P< 0.05) concentrations of P4 than cows in the 
PGF25-IVG, PGF50-IVG, and PGF125-IVG groups, a difference that persisted up to 96 h with 
the PGF25-IVG group only (Figure 2.3). A similar pattern was observed for cows in the PGF25-
IM and PGF25-IVG groups, except that at 60 h only a tendency was detected (Figure 2.3). Parity 
did not affect (P = 0.67) circulating concentrations of P4. 
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Progesterone concentration patterns and luteal regression for cows in Experiment 1 and 
Experiment 2 combined  
Among cows treated with PGF, three distinct subgroups were identified based on their P4 
concentration patterns. A subgroup of cows presented the expected pattern of P4 decline after 
treatment [79% (11/14), 42% (5/12), 50% (6/12), 67% (4/6), and 100% (6/6) of cows in the 
PGF25-IM, PGF25-IVG, PGF50-IVG, PGF125-IVG and PGF25-2X-IVG groups, respectively]. 
These cows had an 81% to 99% reduction in concentrations of P4 by 36 h after the PGF2α 
treatment. Their plasma concentrations of P4 were below the cutoff value that indicates the 
presence of an active CL (1 ng/mL) by 36 h after treatment and all but one cow (P4 = 0.43 
ng/mL) had P4 concentrations indicating complete luteal regression (<0.4 ng/mL) by 72 h after 
treatment (Figure 2.4A). Thereafter, concentrations of P4 continued to decline or remained 
steady but did not increase above 1 ng/mL (indicating the presence of active CL) up to the end of 
the sampling period (0.04 to 0.61 ng/mL). Another subgroup of cows from the PGF25-IVG [17% 
(2/12)], PGF50-IVG [50% (6/12)], and PGF25-IM [7% (1/14)] groups had an initial 56% to 91% 
reduction in concentrations of P4 from -1 to 36 h after treatment, reaching nadir concentrations 
of P4 of 0.30 to 0.94 ng/mL (Figure 2.4B). However, by 96 h after treatment, concentrations of 
P4 were above 1 ng/mL (1.75 to 4.55 ng/mL), indicating the presence of an active CL and lack 
of complete luteal regression (<0.4 ng/mL). Finally, a third subgroup of cows [14% (2/14), 41% 
(5/12), and 33% (2/6), of the cows in the PGF25-IM, PGF25-IVG, and PGF125-IVG treatment 
groups, respectively] presented an initial 26% to 74% decline in concentrations of P4, reaching a 
nadir during the first 36 h after treatment. In these cows, concentrations of P4 were never below 
the cutoff that indicates the presence of an active CL (1 ng/mL) or complete luteal regression 
(0.4 ng/mL). The nadir was followed by a substantial increase in concentrations of P4, reaching 
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up to >100% of their original concentrations of P4 by 96 h after treatment (2.45 to 9.98 ng/mL; 
Figure 2.4C). 
 
Concentrations of progesterone at 48, 60, and 72 h after treatment 
Concentrations of P4 at 48, 60, and 72 h after treatment are presented in Table 2.1. At the 
three time points evaluated, concentrations of P4 were greater (P <0.05) for cows in the SAL-
IVG group than for cows in all the PGF-treated groups. Concentrations of P4 for cows in the 
PGF25-2X-IVG group were lower (P <0.05) than for cows in the PGF25-IVG group at the three 
time points of interest. For cows in the PGF25-IM group, concentrations of P4 were lower (P 
<0.05) than for cows in the PGF25-IVG group at 48 and 72 h after treatment. Concentrations of 
P4 for cows in the PGF50-IVG and PGF125-IVG groups were similar to those of cows in the 
PGF25-IVG, PGF25-2X-IVG, and PGF25-IM groups at the three time points evaluated.    
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Table 2.1. Concentrations of progesterone at 48, 60, and 72 h after treatment for cows in 
Experiments 1 and 2 combined. 
  Time after treatment (h) 
Treatment1  48  60  72 
  P42 (ng/mL)  P4 (ng/mL)  P4 (ng/mL) 
SAL-IVG  5.96 ± 0.53a  6.26 ± 0.54a  5.99 ± 0.47a 
PGF25-IM  0.63 ± 0.27c  0.67 ± 0.23bc  0.57 ± 0.24c 
PGF25-IVG  1.55 ± 0.42b  1.74 ± 0.50b  2.24 ± 0.64b 
PGF50-IVG   0.83 ± 0.25bc  0.79 ± 0.24bc  1.13 ± 0.40bc 
PGF125-IVG  1.81 ± 1.01bc  2.15 ± 1.35bc  1.65 ± 0.98bc 
PGF25-2X-IVG  0.27 ± 0.07c  0.19 ± 0.04c  0.21 ± 0.07c 
1Cows received the following treatments 7.5 d after the second GnRH injection of 
the Ovsynch protocol: SAL-IVG = 5 mL of saline IVG (n = 13), PGF25-IM = i.m. 
injection of 25 mg of PGF2α (n = 14), PGF25-IVG = 25 mg of PGF2α IVG (n = 12), 
PGF50-IVG = 50 mg of PGF2α IVG (n = 12), PGF125-IVG = 125 mg of PGF2α 
IVG (n = 6), and PGF25-2X-IVG = two IVG doses of 25 mg of PGF,12 h apart (n = 
6).abcDifferent superscripts within a colum differ statisctically (P < 0.05). 2P4 = 
progesterone. 
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Figure 2.1 Cows were synchronized using the Ovsynch protocol with two PGF2α injections 
(GnRH-7 d-PGF-1 d-PGF-32 h-GnRH). Cows with at least one functional (P4 ≥1 ng/mL) CL 
≥15 mm 7.5 d after the second GnRH injection of Ovsynch remained in the study to receive the 
treatments. In Exp 1, cows (n = 31) stratified by parity received: 5 mL of saline solution IVG 
(SAL-IVG, n = 6), an i.m. injection of 25 mg of PGF2α (PGF25-IM, n = 7), 25 mg of PGF2α 
IVG (PGF25-IVG, n = 6), 50 mg of PGF2α IVG (PGF50-IVG, n = 6), and 125 mg of PGF2α 
IVG (PGF125-IVG, n = 6). In Exp 2, cows (n = 32) stratified by parity received: SAL-IVG (n = 
7), PGF25-IM (n = 7), PGF25-IVG (n = 6), PGF50-IVG (n = 6) as in Experiment 1, and another 
group of two IVG doses of 25 mg of PGF2α 12 h apart (PGF25-2X-IVG, n = 6). Blood was 
collected at -1 h, 0 h, every 6 h up to 24 h, and then every 12 h up to 96 h after treatment. TUS = 
transrectal ultrasonography, BC = blood collection. 
 
  
GnRH PGF
Treatment
GnRH 
+ TUS
Ovsynch
BC/6h BC/12h
7 d 32 h 5.5 d
PGF
1 d 2 d
TUS
TUS + BC
1 d 3 d
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Figure 2.2. (A) Circulating concentrations of progesterone (P4) from -1 to 96 h after treatment 
for Experiment 1. Seven and a half days after the second GnRH injection of the Ovsynch 
protocol, cows with at least one functional (P4 ≥1 ng/mL) CL ≥15 mm received the following 
treatments: SAL-IVG = 5 mL of saline IVG (n = 6), PGF25-IM = an i.m. injection of 25 mg of 
PGF2α (n = 7), PGF25-IVG = 25 mg of PGF2α IVG (n = 6), PGF50-IVG = 50 mg of PGF2α 
IVG (n = 6), and PGF125-IVG = 125 mg of PGF2α IVG (n = 6). There was an effect of 
treatment (P <0.01), time (P <0.001), and an interaction between treatment and time (P <0.001) 
on circulating concentrations of P4. * = concentrations of P4 for cows in the PGF25-IM, PGF25-
IVG, and PGF125-IVG groups tended (P <0.10) to be lower than for cows in the SAL-IVG 
group. ** = concentrations of P4 for cows in the PGF50-IVG group were lower (P <0.05) than 
for cows in the SAL-IVG group. † = concentrations of P4 were lower (P <0.05) for cows in all 
PGF2α treatment groups than for cows in the SAL-IVG group. Concentrations of P4 were 
similar (P >0.05) for cows in all PGF-treated groups during the entire sampling period, except 
that cows in the PGF25-IM group differed from cows in the PGF25-IVG group at 96 h.  
(B) Circulating concentrations of P4 from -1 to 96 h after treatment for Experiment 2. Cows 
were set up as described for Experiment 1 and received the following treatments: SAL-IVG = 5 
mL of saline solution IVG (n = 7), PGF25-IM = an i.m. injection of 25 mg of PGF2α (n = 7), 
PGF25-IVG = 25 mg of PGF2α IVG (n = 6), PGF50-IVG = 50 mg of PGF2α IVG (n = 6), and 
PGF25-2X-IVG = two IVG doses of 25 mg of PGF2α administered 12 h apart (n = 6). There was 
an effect of treatment (P <0.001), time (P <0.001), and an interaction between treatment and time 
(P <0.001) on circulating concentrations of P4. * = concentrations of P4 for cows in the PGF25-
IM group tended (P <0.10) to be lower than for cows in the SAL-IVG group. ** = concentrations 
of P4 for cows in the PGF25-2X-IVG group were lower (P <0.05) than for cows in the SAL-IVG 
group. † = concentrations of P4 for cows in all PGF2α treated groups were lower (P <0.05) than 
for cows in the SAL-IVG group. ‡ = concentrations of P4 at 48 h tended (P <0.10) to be lower 
for cows in groups PGF25-2X-IVG and PGF25-IM than for cows in the PGF25-IVG group. £ = 
concentrations of P4 from 60 to 96 h were lower (P <0.05) for cows in groups PGF25-2X-IVG 
and PGF25-IM than for cows in the PGF25-IVG group. Also, at 84 and 96 h, concentrations of 
P4 for cows in the PGF25-2X-IVG group tended (P <0.10) to be lower than for cows in the 
PGF50-IVG group. At 96 h concentrations of P4 for cows in the PGF25-IM group tended (P 
<0.10) to be lower than for cows in the PGF50-IVG group. 
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Figure 2.3. Circulating concentrations of Progesterone (P4) from 1 h before to 96 h after 
treatment for Experiments 1 and 2 combined. Cows with at least one functional (P4 ≥1 ng/mL) 
CL ≥15 mm received the following treatments 7.5 d after the second GnRH injection of the 
Ovsynch protocol: SAL-IVG = 5 mL of saline IVG (n = 13), PGF25-IM = an i.m. injection of 25 
mg of PGF2α (PGF; n = 14), PGF25-IVG = 25 mg of PGF2α IVG (n = 12), PGF50-IVG = 50 
mg of PGF2α IVG (n = 12), PGF125-IVG = 125 mg of PGF2α IVG (n = 6), and PGF25-2X-IVG 
= two IVG doses of 25 mg of PGF2α administered 12 h apart (n = 6). There was an effect of 
treatment (P <0.01), time (P <0.001), and an interaction between treatment and time (P <0.001) 
on circulating concentrations of P4. * = cows in the SAL-IVG groups were different (P <0.05) 
from cows in all other treatments. † = at 60 h, cows in group PGF25-2X-IVG had lower (P 
<0.05) concentrations of P4 than cows in groups PGF25-IVG, PGF50-IVG, and PGF125-IVG, a 
difference that persisted up to 96 h for cows in the PGF25-2X-IVG and PGF25-IVG groups only. 
‡ = a tendency (P <0.10) at 60 h and then lower (P <0.05) concentrations of P4 up to 96 h was 
observed for cows in group PGF25-IM than for cows in the PGF25-IVG, PGF50-IVG, and 
PGF125-IVG groups. 
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Figure 2.4. Individual plasma progesterone (P4) profiles of representative cows within 
subgroups, based on concentration of P4 patterns after receiving experimental treatments. (A) 
Cows with the expected pattern of P4 decline after the PGF treatment. These cows presented an 
81% to 99% reduction in concentration of P4 during the first 36 h after treatment and reached the 
cutoff value for complete luteal regression (P4 <0.4 ng/mL) by 72 h in all but one cow, which 
reached a nadir of 0.43 ng/mL of P4. (B) Cows with an initial 56% to 91% reduction in 
concentrations of P4 from -1 to 36 h after treatment that reached nadir concentrations of P4 of 
0.30 to 0.94 ng/mL. However, by 96 h after treatment, concentrations of P4 were above 1 ng/mL 
(1.75 to 4.55 ng/mL), indicating the presence of an active CL and lack of complete luteal 
regression (<0.4 ng/mL). (C) Cows with an initial decline in P4 concentrations of 26% to 74% 
followed by a substantial increase in P4 concentrations up to >100% of their original 
concentrations by 96 h after treatment (2.45 to 9.98 ng/mL). Concentrations of P4 were never 
below the cutoff indicating the presence of an active CL (1 ng/mL) or complete luteal regression 
(0.4 ng/mL). 
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DISCUSSION 
The results of our experiments support the initial hypothesis that IVG administration of 
PGF can successfully induce luteal regression in cattle. An initial decline in concentrations of P4 
indicating induction of luteolysis was evident for cows in all PGF-treated groups during the first 
12 to 24 h after treatment in both experiments. Nevertheless, complete CL regression was not 
observed for all cows in all treatments. In all PGF-treated groups there were cows that presented 
complete luteal regression (P4 <0.4 ng/mL), but some cows (from all groups except those in the 
IVG25-2X-IVG group) presented a substantial initial decline in plasma P4 followed by a major 
increase in P4 production. These findings suggest that luteolysis was initiated but the CL was 
able to recover its functionality. This phenomenon was more prevalent for cows in the PGF25-
IVG and PGF125-IVG groups. Although failure to induce complete luteal regression is 
commonly observed in ~10% to 28% of lactating dairy cows after an i.m. injection of the labeled 
dose of PGF in the U.S. (Brusveen et al., 2009; Ribeiro et al., 2012; Giordano et al., 2013), based 
on the observed pattern of P4 production after treatment and the high percentage of cows (33% 
to 50%) failing to complete luteolysis after the single IVG instillation of 25 to 125 mg of PGF, it 
appears that this treatment strategy may not be as effective as a single i.m. injection of 25 mg of 
PGF.  
It is uncertain at the moment which factors are responsible for the incomplete luteal 
regression and rebound in P4 production by the CL. A better response to the 50 than the 25 mg 
dose of PGF would suggest that absorption of insufficient amounts of PGF from the vagina may 
have been a leading factor in the failed response. Nevertheless, the poor overall response to the 
125 mg dose of PGF and the fact that at least some cows from the two higher-dose treatments 
failed to complete luteal regression does not support that notion. Indeed, our hypothesis that 
higher doses of PGF would be more effective than lower doses was not fully supported. While 
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we observed that the 50 mg dose of PGF was more effective than a 25 mg dose, the 125 mg dose 
of PGF did not further reduce concentrations of P4. Future research should include larger 
numbers of cows to confirm that higher doses of PGF are less effective in inducing complete CL 
regression than lower doses. Moreover, estimations of IVG PGF absorption through 
determination of 13,14-dihydro-15-keto-PGF2α (PGFM; metabolite of PGF2α) in circulation 
could help determine whether absorption of PGF limits the response to the higher-dose 
treatments. 
Our results from Exp 2 strongly support our hypothesis that two IVG instillations of 25 
mg of PGF 12 h apart should further reduce concentrations of P4 when compared to single IVG 
treatments. As opposed to the treatment groups that received similar or higher doses of PGF 
through IVG instillation, the two instillations 12 h apart resulted in mean concentrations of P4 
<0.4 ng/mL from 48 to 96 h after treatment and complete CL regression in 100% of the cows. 
Unlike cows in the other groups that received IVG PGF, none of the cows in the PGF25-2X-PGF 
group presented a rebound in P4 production of sufficient magnitude to indicate full CL recovery 
(P4 ≥ 1 ng/mL). Some of the cows (3/6) presented a rebound in P4 concentrations (0.5 to 2.5 
ng/mL range) within the first 24 h after treatment, but the second PGF treatment blunted the 
rebound and these cows successfully completed luteolysis (data not shown). In spite of the 
reduced scale of our studies for determining the efficacy of IVG instillation of PGF for complete 
luteal regression, our current results are encouraging. Additional research with sufficient 
numbers of cows to validly test the hypothesis that two IVG treatments of PGF is as effective as 
a single i.m. injection of PGF at the dose used in synchronization of estrus and ovulation 
protocols is warranted. 
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It is certainly possible that the rebound in circulating concentrations of P4 observed in 
some cows may have resulted from premature ovulation before the end of the sampling period. 
We cannot rule out this possibility because we did not monitor estrous behavior or ovulation; 
however, we speculate that it is rather unlikely because all cows had a functional CL at the time 
of treatment and in most of these cows P4 never declined below 1 ng/mL. 
Even though very limited data are available about P4 concentration dynamics and luteal 
regression after IVG instillation of PGF in cattle, our current results agree with those of a 
previous study that documented a decline in concentrations of P4 after IVG instillation of a 500 
µg dose of the PGF analogue Cloprostenol in lactating dairy cows with functional CLs 
(Zdunczyk et al., 1994). Unlike our study, Zdunczyk et al. (1994) reported complete luteal 
regression (defined as P4 <1 ng/mL) in all treated cows (12/12) by 32 h after treatment. A caveat 
of their study was that cows were monitored for only 36 h after treatment, precluding the 
detection of rebounds in concentrations of P4 similar to those observed in our study and others in 
which cows failed to complete luteal regression (Ginther et al., 2009; Nascimento et al., 2014). 
Differences in cows (breed, physiological status), experimental conditions, or the PGF analogue 
used may also be plausible explanations for the differences between the two studies’ findings. 
Interestingly, Zdunczyk et al. (1994) also reported that 66.6% of cows (8/12) that received PGF 
through IVG instillation presented estrous behavior within 10 d after treatment, compared with 
70% of cows (7/10) receiving the same dose through i.m. injection. Despite the limited number 
of cows, this study provided partial evidence that cows may undergo complete luteal regression 
and express estrous behavior after IVG instillation of PGF. A second set of studies conducted 
with non-lactating Zebu cattle of unknown cyclicity status documented estrous behavior after 
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IVG instillation of a 175 µg dose of Cloprostenol; however, concentrations of P4 were not 
monitored (Heinonen et al., 1996).   
In one experiment without a control group, 61.5% (24/39) of cows that received PGF 
through IVG instillation were detected as being in estrus within three days of treatment and 
66.7% (16/24) of the inseminated cows became pregnant. In a second study in which cows 
received an i.m. injection or IVG instillation of Cloprostenol, the estrus response determined by 
visual observation or rectal palpation was 62.5% (25/40) and 60.6% (20/33) for the IVG and i.m. 
groups, respectively. Interestingly, these data may support the notion that IVG instillation of 
Cloprostenol is an effective strategy for inducing luteal regression because the estrus response 
fell within the expected range for cattle treated with PGF (Walker et al., 1996) but involved a 
65% lower dose than the luteolytic dose used in synchronization of estrus and ovulation 
protocols (500 µg). Whether Cloprostenol can be used at very low doses or is more effective than 
Dinoprost for causing luteal regression after IVG instillation is unknown and warrants further 
investigation.   
Collectively, these previous studies and our current research, which has documented in 
detail the dynamics of concentration of P4 after instillation of PGF at varying doses and 
frequencies, provide evidence that the IVG instillation of PGF may be effective in inducing 
luteal regression in cattle. Furthermore, the improved response observed after IVG instillation of 
two 25 mg doses of PGF 12 h apart suggests that such a treatment strategy may be the most 
suitable alternative for testing the efficacy of IVG instillation of PGF for synchronizing estrus 
and ovulation protocols in large field studies.  
Because 48 and 60 h after PGF treatment are the approximate time intervals at which 
cows enrolled in Ovsynch-type protocols would receive the last GnRH injection of the protocol 
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and 72 h is the approximate time of insemination, we evaluated concentrations of P4 at these 
time points. This is relevant because low circulating concentrations of P4 at the time of a GnRH 
injection are critical for inducing an effective LH surge and subsequent ovulation in dairy cattle 
(Walker et al., 1996; Ginther et al., 2009). As expected, cows in the SAL-IVG group (negative 
control) had greater concentrations of P4 than cows in all the PGF-treated groups at the time 
points of interest because the CL remained functional (P4 ≥ 1 ng/mL) in all cows. Conversely, 
either partial (presenting an initial P4 decline but where P4 is never <0.4 ng/mL) or complete 
(with P4 <0.4 ng/mL) luteal regression was induced in all cows in the PGF-treated groups. Also, 
the fact that concentrations of P4 for cows in the PGF25-2X-IVG group were similar to what we 
observed for cows in the PGF25-IM group and lower than for cows in the PGF25-IVG group at 
all time points evaluated reinforces the notion that the PGF25-2X-IVG treatment may be as 
effective as the i.m. treatment and more effective than the single IVG treatment with 25 mg of 
Dinoprost. Remarkably, concentrations of P4 for cows in the PGF25-2X-IVG group were below 
1.0 ng/mL by 36 h after treatment and continued to decline to levels (<0.4 ng/mL) known to be 
optimal for maximal fertility in lactating dairy cows receiving TAI (Carvalho et al., 2015). The 
lack of difference between the PGF25-IM and PGF25-2X-IVG groups and the PGF50-IVG and 
PGF125-IVG groups is likely the result of a Type II error because of the limited number of cows 
per group and the substantial variation in P4 concentrations due to incomplete luteal regression 
in some cows.  
 
CONCLUSION 
Our studies confirm the feasibility of inducing luteal regression through IVG instillation 
of PGF in lactating dairy cattle. Our research indicates that two instillations of 25 mg of PGF 12 
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h apart may be an effective strategy for inducing complete luteal regression. Unlike the other 
groups receiving PGF through IVG instillation, there was no CL recovery in any of the cows 
receiving the two instillations after induction of luteolysis. Further research with a greater 
number of cows is needed to determine the best IVG instillation regimens for causing complete 
luteal regression in synchronization of ovulation protocols in cattle.  
Despite the feasibility of inducing luteal regression through IVG instillation of PGF that 
we demonstrated in these experiments, our research should not be used as evidence to support or 
recommend the use of IVG instillation of PGF in commercial cattle operations because it 
constitutes off-label use of PGF products. 
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CHAPTER III 
INTRAVAGINAL INSTILLATION OF GNRH ANALOGUES WITH AN ABSORPTION 
ENHANCER INDUCED A SURGE OF LH IN LACTATING DAIRY COWS 
R. Wijma, M. L. Stangaferro, M. Masello, M. A. Elmetwally, G. E. Granados, F. Amovilli and J. 
O. Giordano 
Journal of Dairy Science (In Press); 
DOI 10.3168/jds.2016-12513 
ABSTRACT 
Our objectives were to evaluate circulating LH concentrations after intravaginal (IVG) 
instillation of GnRH analogues in lactating dairy cows. In two experiments, lactating Holstein 
cows (Experiment 1: n = 32; Experiment 2: n = 47) received the experimental treatments 48 h 
after the first of two PGF2α treatments given 12 h apart and 7 d after a modified Ovsynch 
protocol (GnRH-7 d-PGF2α-24 h-PGF2α-56 h-GnRH). In Experiment 1, cows were stratified by 
parity and randomly allocated to receive the following treatments: 2 mL of saline IVG (SAL, n = 
6), 100 µg of Gonadorelin (Gon) i.m. (G100-IM, n = 5), and 100 (G100, n = 7), 500 (G500, n = 
8), or 1,000 µg of Gon IVG (G1000, n = 7). In Experiment 2, treatments were: 2 mL of saline 
IVG (SAL, n = 8), 100 µg of Gon i.m. (G100-IM, n = 8), 1,000 µg of Gon IVG (G1000, n = 7), 
1,000 µg of Gon plus 10% citric acid (CA) IVG (G1000CA, n = 8), 80 µg of Buserelin IVG 
(B80, n = 8), and 80 µg of Buserelin plus 10% CA IVG (B80CA, n = 8). In both experiments, 
blood was collected every 15 min from -15 min to 4 h, and every 30 min from 4 to 6 h after 
treatment. Data for area under the curve (AUC), mean LH concentrations, and time to maximum 
LH concentration were analyzed by ANOVA with (mean LH only) or without repeated measures 
using PROC MIXED of SAS. The proportion of cows with a surge of LH was evaluated with 
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Fisher’s exact test using PROC FREQ of SAS. In both experiments LH concentrations were 
affected by treatment, time, and the treatment by time interaction. In Experiment 1, the AUC for 
LH and maximum LH concentration were greatest for the G100-IM treatment and were greater 
for the G1000 than for the SAL and G500 treatments. The proportion of cows with an observed 
surge of LH was 100% and 0% for cows that received Gon i.m. and IVG, respectively. In 
Experiment 2, the AUC and maximum LH concentrations were greater for the G100-IM, 
G1000CA, and B80CA treatments than for the other IVG treatments. The proportion of cows 
with a surge of LH differed by treatment (SAL = 0%, G100-IM = 100%, G1000 = 14%, 
G1000CA = 88%, B80 = 13% and B80CA = 100%). For the treatments with a surge of LH, time 
to maximum concentration of LH was the shortest for the G100-IM treatment, intermediate for 
the G1000CA treatment, and the longest for cows in the B80CA treatment. In conclusion, 
Gonadorelin (up to 1,000 µg) absorption through intact vaginal epithelium after a single IVG 
instillation was insufficient to elicit a surge of LH of normal magnitude. Conversely, IVG 
instillation of 1,000 µg of Gonadorelin and 80 µg of Buserelin with the addition of citric acid as 
absorption enhancer resulted in a surge of LH of similar characteristics than that induced after 
i.m. injection of 100 µg of Gonadorelin. 
 
Keywords: intravaginal, GnRH analogue, citric acid, LH surge 
 
INTRODUCTION 
 Timed artificial insemination (TAI) is one of the most widely used biotechnologies in 
cattle operations around the world (Lamb et al., 2010; Wiltbank and Pursley, 2014). In dairy 
farms, systematic implementation of synchronization of ovulation protocols ensures timely 
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insemination (Pursley et al., 1997; Fricke et al., 2003) and improves fertility outcomes (Moreira 
et al., 2001; Souza et al., 2008; Giordano et al., 2012b). Synchronization of ovulation protocols 
are continuously evolving to optimize follicle development, luteal regression, timing of 
ovulation, and the endocrine environment before and after TAI. As a result, groups of cows must 
receive hormonal treatments on multiple days of the week and different times of the day which 
may reduce protocol compliance and success in farms without appropriate facilities, frequent 
access to animals, and availability of qualified labor. Frequent cow manipulation also disrupts 
time budgets and normal behavior. Thus, fully automated hormone delivery systems may be an 
alternative to individual injections for facilitating implementation and improving compliance 
with synchronization of ovulation protocols. Automating hormone delivery may also allow 
designing more effective treatments and/or treatments tailored to individual or subgroups of 
cows based on their physiological or health status.  
Ideally, the body cavity to insert and hold an automated hormone delivery system should 
allow holding the device for prolonged periods of time and easy access to the device for removal 
after use. Because the vagina meets these criteria, fully automated electronically-controlled 
intravaginal (IVG) drug delivery devices have been described (Rathbone et al., 1998; Cross et 
al., 2004; Künnemeyer et al., 2004) and could be developed for use in cattle. Another important 
attribute of a body cavity to insert an automated hormone delivery device is to allow proper 
absorption of hormones to elicit the desired physiological response. Although sustained release 
of progesterone (P4) through non-automated delivery devices has been extensively studied and is 
currently used in synchronization of estrus and ovulation protocols (Macmillan et al., 1991; 
Macmillan and Peterson, 1993; Chebel et al., 2006), the feasibility of IVG administration of 
important reproductive hormones such as, GnRH and PGF2α, has been rarely studied and IVG 
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administration is not currently used in cattle. Beyond potential differences in molecular structure 
that may affect IVG absorption, a fundamental difference between IVG treatments with P4 and 
hormones like GnRH and PGF2α is that the former can effectively exert its biological function 
through sustained release because an acute effect is not necessary. Conversely, administration of 
exogenous GnRH is only effective to induce a surge of LH and PGF2α to trigger luteolysis 
through immediate absorption and an acute effect on their target tissues (i.e., pituitary gland for 
GnRH and corpus luteum for PGF2α).  
The feasibility of inducing a surge of LH of similar magnitude after IVG than i.m. 
administration of GnRH or its analogues has been previously studied in other species such as the 
sow (Stewart et al., 2010), the rat (Okada et al., 1982; 1983), and the rabbit (Viudes-de-Castro et 
al., 2007) but not in cattle. Although GnRH absorption through epithelial walls can occur 
through transmembrane diffusion, vesicle receptor mediated transport, or para cellular diffusion 
(Richardson and Illum, 1992), vaginal absorption may be challenging. Transmembrane transport 
is probably limited due to the hydrophilic nature of GnRH and a receptor mediated transport 
mechanism in the vaginal epithelium seems unlikely. Further, para cellular transport may be 
limited by inter cellular apical junction complexes (Hussain and Ahsan, 2005) formed by tight 
junctions and adherens junctions (Ivanov et al., 2005).  
To overcome challenges associated with absorption efficiency of molecules through 
intact tissues, absorption enhancers can be included to disrupt the integrity of intercellular 
junctions so that para cellular transport increases (Okada et al., 1982; 1983; Fatakdawala and 
Uhland, 2011). For example, using a rat model, Okada et al. (1982, 1983) observed an increase 
in absorption and vaginal permeability to Leuprolide (i.e., a GnRH analogue) when including 
citric acid in the vehicle. Carboxylic acids, such as citric acid, chelate calcium which has been 
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shown to loosen intercellular tight junctions, thus facilitating intercellular transport of molecules  
(Cho et al., 1989). In addition to absorption enhancers, a potential strategy to increase the 
efficacy of hormones administered through the IVG route may be the use of more potent 
hormone analogues. Although absorption of all analogues may be equally compromised, more 
potent analogues could be more effective because smaller amounts are needed to elicit a 
satisfactory physiological response. In the case of GnRH, multiple analogues of varying potency 
are available. For example, Buserelin has been shown to be up to 50 times more potent than 
Gonadorelin (Chenault et al., 1990; Picard-Hagen et al., 2015), thereby Buserelin may be an 
alternative to Gonadorelin for IVG administration. 
 We performed two experiments to evaluate the feasibility of inducing a surge of LH after 
IVG instillation of GnRH analogues in lactating dairy cows. We aimed to determine if it was 
possible to induce a surge of LH of similar magnitude, timing, and duration after IVG instillation 
of GnRH analogues than after i.m. injection of the labeled dose of Gonadorelin to induce 
ovulation in cattle (i.e., 100 µg). Specifically, the objective of Experiment 1 was to compare 
circulating LH concentrations after IVG instillation of different doses of the GnRH analogue 
Gonadorelin. We hypothesized that IVG instillation of Gonadorelin would induce a surge of LH 
similar to that observed after i.m. injection of 100 µg of Gonadorelin. Also, we hypothesized that 
instillation of greater doses of Gonadorelin would result in greater circulating LH concentrations. 
Based on the results of Experiment 1, we conducted a second experiment to evaluate LH 
concentrations after IVG instillation of Gonadorelin or Buserelin with or without the inclusion of 
citric acid as an absorption enhancer. We hypothesized that the inclusion of citric acid to the 
GnRH solution and the use of a GnRH analog of greater potency than Gonadorelin (i.e., 
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Buserelin) would result in a surge of LH similar to that observed after i.m. injection of 100 µg of 
Gonadorelin. 
 
MATERIALS AND METHODS 
Animals 
All procedures were approved by the Animal Care and Use Committee of Cornell 
University. 
Lactating Holstein cows from the dairy unit of the Cornell University Ruminant Center 
(Harford, NY) were used for these experiments conducted from October 2014 to March 2016. 
Cows were housed in free stall barns up to the day before intensive blood sample collection 
when they were moved to a tie-stall barn. Free-stall barns were equipped with deep bedded sand 
stalls, cooling fans placed above the feeding lane and free-stalls, and sprinklers above the feed 
bunk. The tie-stall barn was equipped with deep bedded wood dust stalls, individual waterers, 
feed bins, and tunnel ventilation. All cows were fed a TMR diet once daily and had ad libitum 
access to feed and water. The diet was formulated to meet or exceed nutritional requirements for 
lactating Holstein cows producing 45 kg of milk based on the Cornell Net Carbohydrate and 
Protein System version 6.5. Cows were milked thrice daily at ~ 8 h intervals and received bovine 
somatotropin (Posilac, 500 mg; Elanco Animal Health, Indianapolis, IN) at 14 d intervals 
beginning 60 ± 3 DIM until dried off.   
 
Treatments  
Experiment 1. Lactating non-pregnant primiparous (n = 8) and multiparous (n = 31) 
Holstein cows at various DIM were synchronized using the Ovsynch protocol (Pursley et al., 
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1995) with two PGF2α (25 mg Lutalyse, Zoetis Animal Health, New York, NY) injections 
(GnRH-7 d-PGF2α-1 d-PGF2α -32 h-GnRH). At the time of and 48 h after the second GnRH 
treatment of Ovsynch, transrectal ultrasonography (TUS) of the ovaries was performed to 
confirm ovulation which was defined as the disappearance of at least one follicle ≥10 mm and 
the presence of a putative corpus luteum (CL) on the same ovary. Six cows were excluded 
because they failed to ovulate after the GnRH treatment. Average (± SD) DIM and body 
condition score [BCS; scale 1 to 5 (Edmonson et al., 1989)] for the 6 primiparous and 27 
multiparous cows that responded to the synchronization treatment and ovulated were 340 ± 244 d 
and 3.3 ± 0.7, respectively. 
Seven days after induction of ovulation with the second GnRH treatment of Ovsynch, 
cows received two PGF2α treatments 12 h apart to induce luteal regression. Forty eight hours 
after the first PGF2α treatment (Day = 0), cows were stratified by parity (primiparous vs 
multiparous) and DIM and randomly assigned to one of five treatments: 1) 2 mL of saline 
solution IVG (SAL, n = 6), 2) 100 μg (2 mL) of Gonadorelin i.m. in the semimembranosus or 
semitendinosus muscle (G100-IM, n = 5), 3) 100 μg (2 mL) of Gonadorelin IVG (G100, n = 7), 
4) 500 μg (10 mL) of Gonadorelin IVG (G500, n = 8), and 5) 1,000 μg (20 mL) of Gonadorelin 
IVG (G1000, n = 7).  
Before application of the IVG treatments, the vulva and perineal area were washed and 
disinfected with chlorhexidine solution and dried off with paper towels. Thereafter, vulvar labia 
were manually opened by one technician while another technician inserted a uterine infusion 
catheter (44.5 cm long by 0.5 cm of external diameter) attached to a plastic syringe into the 
vaginal opening. The catheter was moved cranially until the cervix or vaginal fornix was 
reached. Once in the cranial portion of the vagina the catheter was pulled backwards 1 to 2 cm 
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and the volume of saline solution or GnRH analogue for the specific treatment was instilled. 
After treatment, cows remained standing for a minimum of 45 minutes to record urination 
activity and any significant amount of fluid backflow from the vagina. 
On Day -2, Day 0 (< 30 min before treatment), and every 8 h for up to 48 h after 
treatment, the position and size of all antral follicles ≥ 8 mm in diameter was determined by TUS 
and recorded for subsequent determination of the occurrence and timing of ovulation after 
treatment. Timing of ovulation was defined as the mid-point between the last examination in 
which the putative ovulatory follicle was visualized and the first examination in which the 
putative ovulatory follicle was not visualized through TUS. 
Experiment 2. Lactating nonpregnant multiparous (parity 2 to 5) Holstein cows (n = 59) 
were enrolled and received the synchronization of ovulation protocol described for Experiment 1 
except that a different PGF2α product was used (Estrumate, Merck Animal Health, Summit, NJ). 
Average (± SD) DIM, body weight (BW), and BCS for the 48 cows that responded to the 
synchronization treatment and ovulated were 83 ± 48 d, 721 ± 54 kg and 3.3 ± 0.5 respectively.  
At the time of treatment (Day = 0; 48 h after first PGF2α treatment following the 
Ovsynch protocol) cows were randomly assigned to receive one of six treatments: 1) 2 mL of 
saline solution IVG (SAL, n = 8), 2) 100 μg (2 mL) of Gonadorelin i.m. in the semimembranosus 
or semitendinosus muscle (G100-IM, n = 8), 3) 1,000 μg (20 mL) of Gonadorelin IVG (G1000, n 
= 8), 4) 1,000 μg of Gonadorelin plus 10% citric acid (20 mL) IVG (G1000CA , n = 8), 5) 80 μg 
(20 mL) of Buserelin IVG (B80, n = 8), and 6) 80 μg of Buserelin plus 10% citric acid (20 mL) 
IVG (B80CA, n = 8). The dose selected for Buserelin treatment was equivalent to 10 times the 
recommended dose to induce ovulation in cattle. Treatments were performed following the same 
procedures described for Experiment 1. 
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To determine if the IVG treatments caused irritation of the vaginal mucosa, on Day -1 
and 8 h after treatment, the vaginal mucosa was visually inspected using a speculum and a source 
of light.  
 
GnRH Analogue Solutions Used for Treatments 
In Experiment 1, the GnRH analogue Gonadorelin (50 µg/mL of Gonadorelin diacetate 
tetrahydrate, Cystorelin, Merial LLC, Duluth, GA) was used for the i.m. and IVG treatments. In 
Experiment 2, Gonadorelin was used for the i.m. treatment and either Gonadorelin or Buserelin 
were used for the IVG treatments. The same commercially available Gonadorelin product was 
used in Experiment 2, whereas Buserelin solution (no commercially available product for cattle 
in the U.S.) was prepared in our laboratory using Buserelin acetate salt (Sigma-Aldrich, Saint 
Louis, MO). The solution was prepared by adding Buserelin and benzyl alcohol (Sigma-Aldrich, 
Saint Louis, MO) to reach a final concentration of 4 µg/mL of Buserelin and 9 mg/mL of benzyl 
alcohol. Thereafter, the pH of the solution was adjusted using NaOH and HCl to reach a mean 
pH of 6.7. Solutions of Gonadorelin and Buserelin with citric acid were prepared by adding citric 
acid (C0759-500G, Sigma -Aldrich, Saint Louis, MO) 10% m/v. The final pH was balanced 
using NaOH and HCl to reach a mean of 4.01 because an acid pH has been shown to increase 
GnRH absorption by the vagina in rats (Okada et al., 1983). Citric acid was chosen as absorption 
enhancer because it chelates calcium which has been shown to loosen intercellular tight 
junctions, thus facilitating intercellular transport (Cho et al., 1989). In addition, there was 
evidence that citric acid increased absorption and vaginal permeability of the GnRH analogue 
Leuprolide in rats (Okada et al., 1982, 1983).  
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Blood Sample Collection 
  On Day -7, -2, and 0 (time of treatment) blood samples were collected from the 
coccygeal vein or artery using evacuated tubes containing sodium heparin (Vacutainer, BD, 
Franklin Lakes, NJ) for P4 and estradiol (E2; Day 0 only) analysis to confirm response to the 
synchronization of ovulation protocol, and circulating concentrations of P4 and E2 before 
treatment.  
To determine circulating LH concentrations, samples (4 mL) were obtained from the 
jugular vein using a syringe attached to an indwelling jugular catheter. Samples were collected 
every 15 min from -15 min to 4 h after treatment and every 30 min from 4 to 6 h after treatment. 
Immediately after collection, samples were poured into tubes containing sodium heparin (10 µl 
of 6.7 IU/mL of heparin solution) and placed in crushed ice until centrifugation (within 2 h of 
collection) for 20 min at 2,000 x g in a refrigerated centrifuge set at 4°C. After centrifugation, 
plasma samples were harvested and stored at -20°C until assayed. 
Jugular catheters were placed 24 h before treatment. Briefly, cows were restrained in an 
individual cow chute and a halter was used to immobilize the head and neck. The area of the 
neck where the catheter was inserted was shaved using clippers followed by a first wash with 
povidone iodine solution and a second wash with 70% ethanol. A 13 gauge x 13 cm long 
polyurethane catheter over needle (Mila International, France, KY) was inserted into the jugular 
vein, the needle was removed and the catheter secured in place using a temporary suture. A 53 
cm extension tubing set (Baxter healthcare corporation, Deerfield, IL) was attached to the 
catheter to facilitate sample collection. Sterile saline solution containing 20 IU/mL of heparin 
was used to prevent clotting and maintain the catheter permeable until sampling began. 
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Determination of Circulating Concentrations of Progesterone  
  Progesterone concentrations were estimated in duplicate using a commercial solid-phase, 
no-extraction radio immunoassay (RIA; Experiment 1: Coat-a-count; Diagnostic Products Corp., 
Los Angeles, CA; Experiment 2: ImmuChem Coated Tube, MP Biomedicals, Costa Mesa, CA). 
To assess the precision of the assay, control samples with a high (7.5 and 6.0 ng/mL for 
experiments1 and 2 respectively) and low (0.5 and 0.3 ng/mL for experiments 1 and 2, 
respectively) concentrations of P4 were assayed. Average sensitivity for the P4 assay was 0.03 
ng/mL for Experiment 1 and 0.1 ng/mL for Experiment 2. The intra-assay CV for the high-
concentration sample was 10.6% in Experiment 1 and 7.9% in Experiment 2. The CV for the low 
concentration sample was 4.9% in Experiment 1 and 13.9% in Experiment 2.  
 
Determination of Circulating Concentrations of Estradiol 
 Circulating concentrations of estradiol were only determined for samples from 
Experiment 1 because the assay used for Experiment 1 was no longer available and no other 
assay with adequate sensitivity was available to run samples from Experiment 2 (collected at a 
later time). 
 Samples were assayed in duplicate for estimation of E2 concentrations using a double 
antibody RIA after benzene:toluene extraction. Analysis was performed as described in Beam 
and Butler (1997) using a commercially available kit (MaiaZen Estradiol R-FA-120, Zen Tech 
SA, Belgium). Average sensitivity for the assay was 0.3 pg/mL. A quality control sample (6.5 
pg/mL) was added in quadruplicate (2 x 100 μL and 2 x 200 μL) at the beginning and end of 
each assay to assess the precision of the assay. Intra-assay CV was 16%. 
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Determination of Circulating Concentrations of Luteinizing Hormone  
 Concentrations of LH in plasma samples (200 µL) from both experiments were 
determined using two different double antibody RIA. In Experiment 1, assays (n = 2) were 
conducted as in Price et al. (1987) with the modifications described in Butler et al. (2004). 
Samples containing known amounts of LH (2.5 ng/mL) were included at three different dilutions 
at the beginning and end of each assay. These control samples showed parallelism with the 
standard curve. Mean limit of detection, defined as 95% binding, was 0.2 ng/mL. Intra and inter-
assay CV were 10% and 8%, respectively.  
For LH assays used in Experiment 2 (n = 4), bovine LH (bLH AFP-11118B; National 
Hormone and Peptide Program, Harbor-UCLA Medical Center, Torrance, CA) was used to make 
iodinated tracer and standards. Rabbit anti-bovine LH antiserum was used as first antibody 
(AFP-192279; National Hormone and Peptide Program, Harbor-UCLA Medical Center, 
Torrance, CA). On Day 1, buffer, sample (200 µL) or standards, tracer, and first antibody were 
added to assay tubes and incubated at room temperature for 24 h. On Day 2, the secondary 
antibody was added and incubated at room temperature for 24 h. Thereafter, tubes were 
incubated at 4°C for an additional 24 h. Samples containing high (4.5 ng/mL) and low (2.5 
ng/mL) LH concentrations were included at the beginning and end of each assay at three 
different dilutions. Control samples showed parallelism with the standard curve. Mean limit of 
detection, defined as 95% binding, was 0.7 ng/mL for the four assays. The intra-assay CV was 
9% and 13% and the inter-assay CV was 9% and 26% for the high and low control sample, 
respectively.  
In both systems the standard curve range was 0.1 to 4 ng which is equivalent to 0.5 to 20 
ng/mL. 
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Statistical Analysis 
 Data from Experiment 1 and 2 were analyzed using the same methodology unless stated 
otherwise.  
A surge of LH after treatment (Time 0) was defined as an increase in mean LH 
concentrations from basal levels (i.e., mean for  -15 and 0 min after treatment) equal or greater to 
the mean increase to maximum concentration in ng/mL of LH observed for cows in the G100-IM 
treatment minus two SD. This calculation was conducted separately for Experiments 1 and 2. 
Area under the curve (AUC) for LH concentration from -15 to 360 min after treatment was 
approximated through the trapezoidal method as described in Giordano et al. (2012a). For 
continuous variables (concentrations of P4, E2, and LH, AUC, maximum LH concentration, time 
to maximum LH concentration, time to ovulation, DIM, BCS, and BW) normality of residuals 
and homoscedasticity of variance were verified using graphical methods (Q-Q plot and 
conditional studentized residual plot) generated with the residual option of the MIXED 
procedure of SAS (version 9.4, SAS Institute Inc., Cary, NC). In both experiments mean LH 
concentrations had a non-normal distribution and studentized residuals showed 
heteroscedasticity of variance. Because none of the data transformation methods used (natural 
logarithm, square root, and inverse transformation) eliminated the heteroscedasticity of variance, 
the natural logarithm of LH concentration was used for Experiment 1 and the inverse of LH 
concentration was used for Experiment 2. The final models were selected based on the lowest 
value for the AIC and BIC (Littell et al., 2006). Transformed mean LH concentration values 
were analyzed using ANOVA with repeated measures using the MIXED procedure of SAS 
including the Satterthwaite approximation. In order to adjust for varying intervals in blood 
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sample collection, a spatial power covariance structure was used. Treatment, time, and the 
treatment by time interaction were included as fixed effects. Cow nested within treatment was 
included as a random effect in the models.  
 Data for P4 concentration at Time 0, AUC, maximum LH concentration, and time to 
maximum LH concentration had a non-normal distribution and were transformed to natural 
logarithm for analysis. The aforementioned variables and BCS, DIM, BW, size of the largest 
follicle at the time of treatment and E2 concentration at Time 0 were analyzed using ANOVA 
with the MIXED procedure of SAS with a model that included treatment as fixed effect. The 
Tukey post-hoc mean separation test was used to determine differences between LSM. Due to 
lack of normality and heteroscedasticity of the data, time to ovulation was analyzed using the 
Kruskal-Wallis test with the NPAR1WAY procedure of SAS, using a model that included 
treatment as the classification variable. 
 Binomial outcomes (proportion of cows with a surge of LH and ovulatory response after 
treatment) were analyzed using Fisher’s exact test with the FREQ procedure of SAS because 
some treatments had either 0% or 100% of the cows with a positive outcome. Mean separation 
analysis was not conducted for binomial outcomes because there was an insufficient number of 
observations for a meaningful comparison. 
 All values for continuous variables are presented as arithmetical means and SE generated 
with the MEANS procedure of SAS. All proportions were generated using the FREQ procedure 
of SAS. All explanatory variables included as fixed effects in models were considered significant 
if P < 0.05, whereas 0.05 ≤ P ≤ 0.10 were considered a tendency.  
  
RESULTS 
  
225 
 
Experiment 1 
No signs of discomfort were observed after treatment in any of the cows. No urination or 
backflow of fluid from the vagina was observed for up to 45 min after treatment. One cow from 
the G100 treatment was removed from the data analysis because it presented elevated P4 (2.1 
ng/mL) concentration at the time of treatment. No statistical difference was observed between 
treatments for DIM (P = 0.94) and BCS (P = 0.46). 
Size of the largest follicle at the time of treatment.  Size of the largest follicle was not 
different (P = 0.63) among treatments (SAL = 17.5 ± 0.6 mm, G100-IM = 16.1 ± 1.9 mm, G100 
= 17.8 ± 0.3 mm, G500 = 18.3 ± 0.7 mm, and G1000 = 19.1 ± 2.0 mm). 
Circulating Concentrations of Progesterone and Estradiol at Time 0. Mean P4 and E2 
concentrations at the time of treatment were not different (P > 0.1) among treatments (Table 1). 
All cows had P4 concentrations below 0.5 ng/mL at Time 0 except one cow from the SAL and 
one cow from the G100 treatment which had P4 concentrations of 0.8 and 0.9 ng/mL, 
respectively.  
Circulating Concentrations of LH. Treatment affected (P < 0.001) AUC for LH. Cows 
in the G100-IM treatment had the greatest AUC whereas cows in the G1000 treatment had 
greater AUC than cows in the SAL and G500 treatments (Table 1).  
There was an effect of treatment (P < 0.001), time (P < 0.001), and treatment by time 
interaction (P < 0.001) for mean circulating LH concentrations (Figure 3.2).  
Treatment affected (P < 0.001) the maximum LH concentration reached during the 
sampling period. Cows in the G100-IM treatment had the greatest maximum LH concentration 
whereas cows in the G1000 treatment had greater maximum LH concentration than cows in the 
SAL and G500 treatments (Table 1). Treatment affected (P < 0.001) the proportion of cows with 
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a surge of LH within 6 h of treatment. None of the cows in the IVG treatments had an increase in 
LH concentrations consistent with a surge of LH as defined for this experiment (Table 1). Time 
to maximum LH concentration was not compared between treatments because only cows in the 
G100-IM treatment had a surge of LH.  
Ovulatory Response to Treatment. Although this study was not designed to validate 
treatment effects on binomial outcomes such as ovulatory response, this outcome was recorded 
and analyzed. Treatment did not affect the proportion of cows that ovulated within 48 h of 
treatment (P = 0.28) or mean time to ovulation (P = 0.17; Table 1). 
 
Experiment 2 
 No signs of discomfort or alteration of the vaginal mucosa detectable through visual 
inspection were observed after treatment in any of the cows. One cow from to the G1000 
treatment was removed from the data analysis because LH concentration at 15 min before 
treatment were 889% greater than the mean of the other cows in the G1000 treatment (6.67 vs 
0.75 ng/mL). No statistical difference was observed between treatments for DIM (P = 0.72), BW 
(P = 0.85), and BCS (P = 0.98). 
Circulating Concentrations of Progesterone at Time of Treatment.  No statistical 
analysis was performed for P4 concentration at Time 0 because mean P4 concentrations were at 
or below the assay detection limit (0.1 ng/mL) in all treatments (Table 2). None of the cows had 
P4 concentrations above 0.2 ng/mL. 
Size of the largest follicle at the time of treatment.  Size of the largest follicle was not 
different (P = 0.86) among treatments (SAL = 20.5 ± 1.5 mm, G100-IM = 18.5 ± 0.5 mm, G1000 
  
227 
 
= 18.6 ± 0.9 mm, G1000CA = 19.1 ± 1.0 mm, B80 = 18.9 ± 0.6 mm, and B80CA = 18.9 ± 1.9 
mm). 
Circulating LH Concentrations. Treatment affected (P < 0.001) the AUC for LH 
concentrations. The AUC was greater for cows in the G100-IM, G1000CA, and B80CA 
treatments than for the other IVG treatments (Table 2).  
Mean circulating LH concentrations during the experimental period were affected by 
treatment (P < 0.001), time (P < 0.001), and the treatment by time interaction (P < 0.001; Figure 
3.3).    
Treatment affected (P < 0.001) the proportion of cows that had a surge of LH within the 
sampling period (Table 3.2). Treatment affected (P < 0.001) maximum LH concentration during 
the experimental period because it was greater for the G100-IM, G1000CA, and B80CA 
treatments than for the rest of the IVG treatments (Table 3.2).  
Because no cows in the SAL treatment and only one cow in the G1000 and B80 
treatments had a surge of LH, these treatments were not included in the analysis of time to 
maximum LH concentration. Only cows in the G100-IM, G1000CA, and B80CA treatments with 
an evident LH surge were included in the analysis for time to maximum LH concentration. 
Treatment affected (P < 0.001) time to maximum LH concentration because the G100-IM 
treatment had the shortest interval from treatment to maximum LH concentration and the 
G1000CA had shorter time to maximum LH concentration than the B80CA treatment (Table 
3.2).  
Ovulatory Response to Treatment. Although this study was not designed to validly 
evaluate treatment effects on binomial outcomes such as ovulatory response, this outcome was 
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recorded and analyzed. Treatment did not affect (P = 0.11) the proportion of cows that ovulated 
within 48 h of treatment and tended (P = 0.07) to affect mean time to ovulation (Table 3.2).  
  
229 
 
Table 3.1. Steroid hormone concentration (progesterone and estradiol) at the time of treatment, LH secretion dynamics, and ovulation 
after treatment in Experiment 1. 
 
Treatment1 
P42 Time 
0 (ng/mL) 
E23 Time 
0 (pg/mL) 
AUC4 
Maximum 
LH 
(ng/mL) 
LH surge 
(%; n) 
Time to 
maximum 
LH (min)5 
Ovulation6 
(%; n) 
Time to 
ovulation7 (h) 
SAL (n = 6) 0.3 ± 0.1 4.2 ± 0.9 242 ± 63c 1.1 ± 0.2 c 0 (0) - 67 (4) 34 ± 5 
G100-IM (n = 
5) 
0.1 ± 0.1 4.6 ± 0.8 
1,149 ± 
69a 
6.9 ± 0.4 a 100 (5) 81 ± 4 100 (5) 28  
G100 (n = 6)8 0.2 ± 0.1 4.2 ± 0.4 286 ± 36bc 1.4 ± 0.2bc 0 (0) - 50 (3) 38 ± 3  
G500 (n = 8) 0.2 ± 0.1 4.7 ± 0.8 247 ± 55c 1.2 ± 0.1c 0 (0) - 75 (6) 36 ± 5 
G1000 (n = 7) 0.1 ± 0.1 5.4 ± 1.0 546 ± 58b 2.8 ± 0.6b 0 (0) - 86 (6) 37 ± 3 
P-value 0.25 0.82 < 0.001 < 0.001 < 0.001 - 0.45 0.17 
1Forty eight hours after the first of two PGF2α treatments given 12 h apart, cows were randomly assigned to receive the following treatments: 2 ml of saline 
intravaginal (SAL), 100 µg of Gonadorelin i.m. (G100-IM), 100 µg of Gonadorelin IVG (G100), 500 µg of Gonadorelin IVG (G500), or 1,000 µg of 
Gonadorelin IVG (G1000). Blood samples were collected every 15 min from -15 min to 4 h after treatment and every 30 min from 4 h until 6 h after treatment.  
2P4 = progesterone  
3E2 = estradiol  
4AUC = area under the curve 
5Only for cows that had a surge of LH.  
6Transrectal ultrasonography of the ovaries was performed every 8 h from Time 0 until 48 h after treatment to detect ovulation. 
7Standard error of the mean not reported because it was 0. 
8One cow was removed from the data analysis because it presented elevated P4 (2.1 ng/mL) concentration at the time of treatment. 
Different superscripts within a column differ statistically based on Tukey’s mean separation test.   
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Table 3.2. Concentration of progesterone at the time of treatment, LH secretion dynamics, and ovulation after treatment in Experiment 
2. 
 
Treatment1 
P42 Time 0 
(ng/mL) 
AUC3 
LH surge 
(%; n) 
Maximum 
LH (ng/mL) 
Time to 
maximum 
LH4 (min) 
Ovulation5 
(%; n) 
Time to 
Ovulation6 
(h) 
SAL (n = 8) 0.1 356 ± 36b 0 (0) 1.4 ± 0.4b - 50 (4) 38 ± 6 
G100-IM (n = 8) 0.1 1,781 ± 191a 100 (8) 9.7 ± 0.9a 101 ± 8c 100 (8) 28 ± 2 
G1000 (n = 7)7 0.1 615 ± 200b 14 (1) 3.1 ± 1.3b - 57 (4) 36 ± 5 
G1000CA (n = 8) 0.1 1,977 ± 309a 88 (7) 9.8 ± 1.5a 145 ± 5b 88 (7) 28 
B80 (n = 8) 0.1 466 ± 143b 13 (1) 1.7 ± 0.6b - 88 (7) 37 ± 5  
B80CA (n = 8) 0.1 1,946 ± 278a 100 (8) 9.3 ± 1.5a 185 ± 10a 88 (7) 28 
P-value - < 0.001 < 0.001 < 0.001 < 0.001 0.11 0.07 
1Forty eight hours after the first of two PGF2α treatments given 12 h apart, cows were randomly assigned to receive the following treatments: 2 ml 
of saline intravaginal (SAL), 100 µg of Gonadorelin i.m. (G100-IM), 1,000 µg of Gonadorelin IVG (G1000), 1,000 µg of Gonadorelin plus 10% 
citric acid IVG (G1000CA), 80 µg of Buserelin IVG (B80), 80 µg of Buserelin plus 10% citric acid IVG (B80CA). Blood samples were collected 
every 15 min from -15 min to 4 h after treatment and every 30 min from 4 h until 6 h after treatment.  
2P4 = progesterone  
3AUC = area under the curve  
4Only for cows with a surge of LH in the G100-IM, G100CA, and B80CA treatments. 
5Transrectal ultrasonography of the ovaries was performed every 8 h from Time 0 until 48 h after treatment to detect ovulation. 
6Standard error of the mean not reported because it was 0. 
7One cow was removed from the data analysis because LH concentration at 15 min before treatment were 889% greater than the mean of the other 
cows in the treatment (6.67 vs 0.75 ng/mL). 
Different superscripts within a column differ statistically based on Tukey’s mean separation test.   
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Figure 3.1. Graphical depiction of experimental procedures for Experiments 1 and 2. Cows were 
synchronized using a modified Ovsynch protocol with two PGF2α injections (GnRH-7 d-PGF2α 
-1 d-PGF2α -32 h-GnRH). Cows with at least one corpus luteum ≥15 mm and one follicle ≥15 
mm 7 d after the second GnRH injection of Ovsynch remained in the study to receive the 
treatments.  In Experiment 1, cows (n = 32) stratified by parity received: 2 mL of saline solution 
intravaginal (IVG; SAL, n = 6), an i.m. injection of 100 µg of Gonadorelin (G100-IM, n = 5), 
100 µg of Gonadorelin IVG (G100, n = 6), 500 µg of Gonadorelin IVG (G500, n = 8), and 1,000 
µg of Gonadorelin IVG (G1000, n = 7). In Experiment 2, cows (n = 47) stratified by parity 
received: 2 mL of saline solution IVG (SAL, n = 8), an i.m. injection of 100 µg of Gonadorelin 
(G100-IM, n = 8), 1,000 µg of Gonadorelin IVG (G1000, n = 7), 1,000 µg of Gonadorelin plus 
10% citric acid IVG (G1000CA, n = 8), 80 µg of Buserelin IVG (B80, n = 8,) and 80 µg of 
Buserelin plus 10% citric acid IVG (B80CA, n = 8). Blood was collected every 15 min from 15 
min pretreatment up to 4 h, and then every 30 min up to 6 h after treatment. PGF = PGF2α, TUS 
= transrectal ultrasonography, BC = blood collection. 
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Figure 3.2.  Mean circulating LH concentrations from -15 min to 6 h after treatment for 
Experiment 1. Seven days after the second GnRH injection of a modified Ovsynch protocol, 
cows received two PGF2α treatments 12 h apart. Forty-eight hours after the first PGF2α 
treatment, cows were randomly assigned to the following treatments: SAL = 2 ml of saline 
intravaginal (IVG), G100-IM = 100 µg of Gonadorelin i.m., G100 = 100 µg of Gonadorelin IVG, 
G500 = 500 µg of Gonadorelin IVG, G1000 = 1,000 µg of Gonadorelin IVG. Blood was 
collected every 15 min from 15 min pretreatment up to 4 h, and then every 30 min up to 6 h after 
treatment. There was an effect of treatment (P < 0.001), time (P < 0.001), and an interaction 
between treatment and time (P < 0.001) on circulating concentration of LH. 
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Figure 3.3.  Mean circulating concentration of LH from -15 min to 6 h after treatment for 
Experiment 2. Seven days after the second GnRH injection of a modified Ovsynch protocol, 
cows received two PGF2α treatments 12 h apart. Forty eight hours after the first PGF2α 
treatment, cows were randomly assigned to the following treatments: SAL = 2 ml of saline 
intravaginal (IVG), G100-IM = 100 µg Gonadorelin i.m., G1000 = 1,000 µg Gonadorelin IVG, 
G1000CA = 1,000 µg Gonadorelin plus 10% citric acid IVG, B80 = 80 µg Buserelin IVG, 
B80CA = 80 µg Buserelin plus 10% citric acid IVG. Blood was collected every 15 min from 15 
min pretreatment up to 4 h, and then every 30 min up to 6 h after treatment. There was an effect 
of treatment (P < 0.001), time (P < 0.001), and an interaction between treatment and time (P < 
0.001) on circulating concentration of LH.  
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DISCUSSION 
The main objective of this research was to test the feasibility of using intravaginal 
instillation of GnRH analogues for inducing a surge of LH in cattle. We aimed to induce a surge 
of LH similar to that induced after i.m. injection of the labeled dose of GnRH (100 µg of 
Gonadorelin) for synchronization of ovulation in cattle. In Experiment 1 three different doses of 
Gonadorelin equivalent to 1, 5, and 10 times the labeled i.m. dose of Gonadorelin were instilled 
in the vagina of lactating dairy cows. Results from this experiment indicated that IVG instillation 
of Gonadorelin did not elicit a surge of LH of the same magnitude and timing observed after i.m. 
injection of a 100 µg dose of Gonadorelin. The lack of response (i.e., no difference from basal 
LH concentrations up to 6 h after treatment) to the smaller doses of Gonadorelin suggests that 
either no Gonadorelin or less than the minimum amount required to cause a substantial increment 
in circulating LH concentrations reached the pituitary gland. Conversely, the low magnitude but 
detectable increment in circulating LH concentrations observed for cows in the G1000 treatment 
suggests that at least part of the Gonadorelin was absorbed and reached the pituitary gland. 
Although we cannot rule out the possibility that a surge of LH occurred after sampling 
concluded, the rate of absorption and/or the amount absorbed was inadequate to elicit release of 
large amounts of LH in a surge-like pattern up to the end of the sampling period.  
In two experiments Bas et al. (2012; 2014) compared intrauterine administration of 100 
or 200 µg of Gonadorelin with i.m. injection of 100 µg of Gonadorelin in lactating dairy cows. In 
both cases intrauterine administration of Gonadorelin failed to mimic the LH surge elicited by 
i.m. administration. The LH surge observed was of low magnitude and mean LH concentrations 
did not differ from that of cows that received intrauterine saline. Collectively, the results of our 
first experiment and others (Bas et al., 2012, 2014) suggest that absorption of Gonadorelin 
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through intact vaginal or uterine epithelium of lactating dairy cows is limited which, in turn, 
leads to insufficient absorption of Gonadorelin to induce a surge of LH of similar magnitude and 
timing than that observed after i.m. injection. 
By design the endocrine environment at the time of treatment in cows from Experiment 1 
was optimal for LH secretion (Giordano et al., 2012a; Lima et al., 2013; Pulley et al., 2015). All 
cows had sub luteal (< 1 ng/mL) concentrations of P4 and similar circulating concentrations of 
E2 than observed during estrus (Lucy and Stevenson, 1986) when the endogenous LH surge 
responsible for triggering ovulation is elicited by E2 (Moenter et al., 1990). It is also well known 
that cattle which receive i.m. GnRH when circulating concentrations of P4 are low (< 1 ng/mL) 
and circulating concentrations of E2 are high, have greater LH release than when circulating 
concentrations of P4 are high and E2 concentrations are low (Giordano et al., 2012a; Pulley et 
al., 2015; Stevenson and Pulley, 2016). In spite of the adequate endocrine environment at the 
time of treatment, IVG instillation of Gonadorelin either did not elicit LH release or the amount 
released was less than that observed for cows in the i.m. treatment. Only cows in the G1000 
treatment had a detectable increase in circulating LH (AUC and maximum LH concentration). 
Collectively, these observations support the notion that vaginal absorption was substantially less 
than after i.m. injection and the greater amount of Gonadorelin provided to cows in the G1000 
treatment only partially offset poor absorption. Because it is unlikely that the pharmacokinetics 
of a GnRH analogue is affected after it reaches the blood stream when given through different 
routes of administration, we speculated that major reasons for the poor response to IVG 
treatment with Gonadorelin were limited passage through the mucosa, degradation before 
absorption, or both. Reduced passage (or absorption) may have been the result of the physical 
barrier created by the inter-cellular tight junctions of the vaginal epithelium. Degradation of 
  
236 
 
GnRH analogues is possible because it has been shown that the vaginal mucus from various 
species (i.e., human, sheep, rat and rabbit) contains proteolytic enzymes which may be able to 
degrade GnRH analogues (Han et al., 1995; Acartürk et al., 2001). Although we cannot 
completely rule out the possibility of a poor response due to backflow of GnRH, we did not 
observe backflow from the vagina for up 45 min after treatment. 
Thus, our objective for Experiment 2 was to increase absorption of GnRH analogues 
through the vaginal mucosa by adding citric acid to the GnRH analogue solutions. Increasing 
absorption of GnRH analogues was expected to help induce a surge of LH of at least similar 
magnitude and timing than that observed after i.m. administration of Gonadorelin. In support of 
our hypothesis, results from this experiment provided evidence that including citric acid as an 
absorption enhancer was a feasible strategy to induce a surge of LH after IVG instillation of 
GnRH analogues in lactating dairy cows. The addition of citric acid to Gonadorelin and 
Buserelin facilitated the induction of a surge of LH in 88% and 100% of cows in the G1000CA 
and B80CA treatments, respectively. Based on the AUC and maximum LH concentration, the 
LH surge was of similar magnitude than that observed for cows that received Gonadorelin i.m. 
These findings are in agreement with experiments performed in rats where vaginal absorption of 
the GnRH analogue Leuprolide increased after addition of citric acid (Okada 1982, 1983). 
Addition of this acid facilitates intercellular transport of peptides as it loosens intercellular tight 
junctions by chelating Ca2+  (Cho et al., 1989). In addition, the reduction in pH may cause 
alterations to membrane and peptide charges that facilitate absorption of hydrophilic molecules 
(Okada et al., 1983). 
Addition of citric acid benefited absorption of the GnRH analogues; however, the similar 
magnitude of the LH surge in cows that received 100 µg of Gonadorelin i.m. and cows in the 
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G1000CA and B80CA treatments suggested that IVG absorption of Gonadorelin and Buserelin 
was less efficient than after an i.m. injection of Gonadorelin. The treatments that included citric 
acid also had a clear shift in the timing of LH release which resulted in greater intervals from 
treatment to maximum concentration of LH. This interval was at least 30 to 110 min longer than 
for cows which received Gonadorelin i.m. in ours and other experiments (Giordano et al., 2012a; 
Picard-Hagen et al., 2015; Pulley et al., 2015). This delay may have been the consequence of the 
additional time required for citric acid to exert its action on the vaginal epithelium. It also 
suggests that the greatest limitation to absorption of GnRH analogues was the inability to pass 
through the mucosa rather than degradation by proteolytic enzymes present in the vaginal mucus.  
We also explored the possibility that the potent GnRH analog Buserelin would elicit 
greater LH release than Gonadorelin. Our reasoning was that because of its greater potency [i.e., 
~50 times more potent; (Chenault et al., 1990; Picard-Hagen et al., 2015)], Buserelin would be 
less dependent on absorption of large quantities than Gonadorelin. We did not observe a 
substantial difference in LH concentrations between treatments that received Gonadorelin or 
Buserelin with or without citric acid. In fact, the greatest difference in LH profiles between the 
two analogues was the longer interval from treatment to maximum LH concentration in the 
B80CA treatment. Although this remains speculative, our observations suggest that vaginal 
absorption of Buserelin might have been less efficient than that of Gonadorelin. Modifications to 
the molecular structure of Buserelin to increase its potency (Millar, 2005) may have been 
responsible for the reduced absorption and/or a different response to the reduction in pH.  
 Our current experiments were not designed to and were underpowered to evaluate 
ovulatory response to treatment. Nevertheless, the observed incidence and timing of ovulation 
were intriguing. As expected all cows with a surge of LH ovulated within 48 h of treatment 
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except for one cow in the B80CA treatment (data not shown). Interestingly, 64% of cows that did 
not have a surge of LH (data combined from Experiments 1 and 2) during the sampling period 
ovulated within 48 h of treatment. Then, it is reasonable to speculate that we could have detected 
more cows with a surge of LH if the sampling period was extended. Whether these LH surges 
would have been spontaneous or induced by the IVG treatment with the GnRH analogues would 
have been difficult to determine. The fact that 57% of the cows in the SAL treatment ovulated 
suggests that at least in some cows a spontaneous and not an induced LH surge occurred after the 
end of the sampling period. Moreover, although it is rather unlikely, we cannot rule out the 
possibility that some of these cows had an endogenous LH surge before the time of treatment.  
As expected, cows that had a surge of LH during the sampling period tended to ovulate 
earlier and timing of ovulation for cows that ovulated in the G100-IM, G1000CA, and B80CA 
was within the expected time frame after GnRH treatment (Pursley et al., 1995; Rantala et al., 
2009; Giordano et al., 2012a). In spite of the fact that cows in the G1000CA and B80CA 
treatments had a longer interval until LH concentrations reached their peak, mean time to 
ovulation was the same in all treatments. Therefore, the delay in reaching maximum 
concentration of LH observed in our experiment may not substantially affect timing of ovulation 
in cows. Additional research with more cows is necessary to determine if IVG instillation of 
GnRH analogues leads to differences in ovulatory response and time to ovulation as compared 
with i.m. injection. 
 
CONCLUSION 
 Based on results from Experiment 1, we concluded that Gonadorelin absorption through 
intact vaginal epithelium was insufficient to elicit a surge of LH of similar magnitude and timing 
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than that observed after i.m. injection of Gonadorelin. Based on the results of Experiment 2, we 
concluded that citric acid can enhance absorption of Gonadorelin or Buserelin through the 
vaginal mucosa. A dose of Gonadorelin and Buserelin 10 times greater than the regularly used 
i.m. dose of these GnRH analogues plus 10% citric acid, induced a surge of LH of similar 
magnitude than that induced after i.m. injection of a 100 µg dose of Gonadorelin. More research 
is needed to elucidate differences in pharmacokinetics of GnRH and its analogues after IVG 
administration in order to establish the most appropriate dose, volume, and vehicle to effectively 
induce a surge of LH capable of triggering ovulation in cattle.  
 Results from the current experiments and previous research on IVG instillation of PGF2α 
in lactating dairy cows (Wijma et al., 2016) support the potential use of the vagina as a route of 
administration for reproductive hormones used in synchronization of estrus and/or ovulation 
protocols. Demonstrating the feasibility of IVG hormone administration is a necessary first step 
for facilitating the development of automated IVG hormone delivery devices which, in turn, 
might help improve the value of synchronization of estrus and ovulation protocols for cattle 
operations. 
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SECTION III 
 
OVERALL CONCLUSIONS AND FUTURE RESEARCH 
 
1. Strategies to maximize reproductive performance of non-pregnant previously 
inseminated lactating dairy cows based on ovarian status at nonpregnancy diagnosis 
1.1 Overall conclusions 
The objective of the first experiment described in Chapter II of Section I of this 
dissertation was to have a better understanding of ovarian dynamics in previously inseminated 
dairy cows. More specifically, a major interest was to elucidate the impact of embryo mortality 
on ovarian function because of the relevance of ovarian responses to the success of 
resynchronization of ovulation protocols for second and greater AI services. Embryo mortality 
was diagnosed using mRNA expression of interferon stimulated genes (ISG) on peripheral white 
blood cells and circulating concentration of pregnancy specific protein B (PSPB). Cows with 
circulating PSPB concentration similar to those of pregnant cows but with no embryo visualized 
through transrectal ultrasonography (TUS) from Day 14 to 42 after artificial insemination (AI) 
were considered to have undergone late embryo mortality (LEM; after Day 24 after AI). 
Conversely, cows that did not meet this criterion but had ISG mRNA expression fold changes 
indicative of the presence of an embryo from 18 to 22 days after AI were considered to have 
undergone early embryo mortality (EEM; before Day 24 after AI). This was the first time this 
methodology was used to diagnose embryo mortality in cattle. Most published research 
regarding the impact of embryo mortality on the estrous cycle was performed based on the 
assumption that cows undergoing EM had extended luteal phases. This diagnostic method is not 
  
246 
 
accurate, because the presence of a corpus luteum (CL) or elevated concentration of progesterone 
(P4) are not indicative of the presence of an embryo. Although we did not have a gold standard 
method to detect the presence of an embryo, using ISG mRNA expression as diagnostic method 
allowed us to indirectly detect embryos through an embryo-derived product like Interferon-τ. 
Thus, unlike previous research in which the outcome of embryo mortality (i.e., extended luteal 
phases) rather than evidence of the presence or absence of an embryo was used as diagnostic 
method, the methods used in our experiment provided a better indication of the actual incidence 
of embryo mortality and its consequences for ovarian dynamics. In contrast to what has been 
described in the literature, we observed delayed luteal regression in cows that underwent LEM 
but not in cows undergoing EEM. Therefore, we concluded that the embryo needs to survive 
beyond Day 22 after conception to cause significant alterations to the estrous cycle, in particular 
prevent luteolysis. Certainly, this hypothesis should be tested using a larger sample size as we 
had a limited number of cows in our experiment. Further, we did not observe significant 
alterations to follicular growth and regression patterns, or circulating concentration of estradiol 
(E2) around the onset of luteolysis and ovulation. Therefore, we concluded that embryo mortality 
had no major effect on ovarian function other than delaying luteal regression in cows that 
underwent LEM.  
In the same experiment, we also investigated follicular and luteal dynamics at the 
approximate time points when resynchronization of ovulation programs are commonly initiated 
in commercial dairy farms (i.e., 24, 32, and 38 days after AI; Appendix 1). Considering all 
inseminated cows that did not have an embryo present 32 days after AI (i.e., nonpregnant and 
embryo mortality cows) we observed that most cows had an active follicle (92%; ≥10 mm in 
diameter and in the growing or static phase of development) and an active CL (84%; P4 ≥1 
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ng/mL) 24, 32, and 38 days after AI. Only 30 and 57% of the cows, however, had a mature CL 
(>6 days old) 24 and 32 days after AI, respectively. Thus, we concluded that at those time points, 
most previously inseminated cows had similar ovarian structures, and to some extent at a similar 
stage of development than cows at the time of prostaglandin F2α (PGF2α) treatment of Ovsynch-
like protocols (i.e., presence of a putative ovulatory follicle and an active CL). Therefore, we 
hypothesized that these cows could be treated with PGF2α to induce luteolysis and then 
Gonadotropin Releasing Hormone (GnRH) to induce ovulation before TAI without receiving 
GnRH to induce a new follicular wave before induction of luteolysis. Our reasoning was that 
most cows 32 ± 3 d after AI would have a dominant follicle generated through spontaneous 
follicular wave turnover, capable of continuing to grow as well as a CL responsive to PGF2α. 
Removing the GnRH treatment to induce a new follicular wave before induction of luteolysis 
would eliminate one of the main inconveniences of treating cows with GnRH 25 ± 3 d after AI 
(around the time of expected estrus expression after a previous insemination) that is suppress 
estrus expression. Therefore, dairy farms that are successful detecting cows in estrus and observe 
reasonable P/AI to those AI services can benefit from both insemination of cows at detected 
estrus and a short interbreeding interval for most nonpregnant cows that need TAI. Another 
important benefit of the strategy without the initial GnRH treatment would be not treating 
pregnant cows with GnRH before their pregnancy status is determined. This is important for 
reducing not only treatment cost but also the burden of finding and treating cows which is both 
labor intensive and disrupts normal cow behavior.   
Based on the observations from this research, we designed a new management strategy 
for second and greater AI services in which cows were differentially treated based on the ovarian 
structures present at the time of NPD. Cows with an ovarian status similar than that observed at 
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the time of the PGF2α injection of Ovsynch-like protocols (i.e., had a functional CL responsive 
to PGF2α and an ovarian follicle capable of continuing to growth and ovulate in response to 
GnRH) received a short resynchronization of ovulation protocol consisting of: induction of 
luteolysis with PGF2α, 24 h later PGF2α, 32 h later GnRH, and 16 to 18 h later TAI. We named 
this protocol Short Resynch (SR) because cows were inseminated within 3 d of the beginning of 
the protocol. A reproductive management program that included SR as the main strategy to 
resynchronize cows was tested in the experiments described in Chapters III and VI from Section 
I of this dissertation. In the first experiment, our objectives were to test the impact of removing 
the GnRH treatment to induce a new follicular wave before induction of luteolysis in the SR 
protocol on estrus expression before NPD and pregnancy per AI (P/AI). We hypothesized that 
removing the GnRH 25 ± 3 d after AI would result in more cows inseminated at detected estrus 
than when GnRH is given to induce a new follicular wave. We also hypothesized that there 
would be no difference in the overall proportion of pregnant cows (cows inseminated at estrus + 
cows inseminated at TAI) because pregnancies generated through inseminations at detected 
estrus would compensate for the potential reduction in P/AI in cows that did not receive GnRH 
25 ± 3 d after AI. Therefore, we compared in a randomized controlled experiment the SR 
treatment to the same protocol but including GnRH treatment to induce a new follicular wave. In 
both treatments NPD was performed 32 ± 3 days after AI and cows bearing a CL and a putative 
ovulatory follicle received two PGF2α treatments 24 hours apart, GnRH 32 hours after the 
second PGF2α, and TAI 16 hours later. Cows with no CL and/or a putative ovulatory follicle 
(i.e. ≥10 mm) at NPD were not expected to respond to this treatment and therefore received the 
Ovsynch protocol with two PGF2α treatments and P4 supplementation. We decided to use two 
PGF2α treatments because in the experiment presented in Chapter II we observed that a large 
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proportion of cows did not have a mature CL at the time of NPD. We expected these cows to 
have a poor response to a single PGF2α treatment. As expected (Chapter III), we observed more 
cows inseminated at detected estrus before NPD in the group that did not receive GnRH 
treatment seven days before NPD. Conversely, conception risk for cows that had a CL and a 
putative ovulatory follicle at NPD was greater for cows that received GnRH 25 ± 3 d after AI. 
Our explanation for the reduced P/AI in cows in SR was that the putative ovulatory follicle at the 
time of NPD was on average 1.9 days older than in cows that received GnRH, most likely 
because of poor synchrony of follicular wave turnover. In these cows the extended period of 
dominance of the ovulatory follicle may have negatively affected oocyte and embryo quality. On 
the other hand, there was no difference in P/AI among cows inseminated at detected estrus, cows 
with no CL at NPD, or when considering all AI services (estrus AI + TAI) together. We 
concluded that the SR program was a valid alternative to reduce the interbreeding interval for 
TAI services and not reduce the proportion of cows inseminated upon estrus detection after a 
previous insemination. A limitation of this experiment was the re-randomization of cows to the 
experimental treatments after each AI service precluding evaluation of time to pregnancy during 
lactation. 
Therefore, the experiment described in Chapter IV of Section I of this dissertation was 
designed to test the hypothesis that the SR program would reduce time to pregnancy during 
lactation as compared to use of a program based on blanket enrollment in the Ovsynch protocol 
for resynchronization of ovulation 32 ± 3 d after AI (i.e., Day 32-Resynch). Another objective 
was to provide additional evidence that reasonable conception risk could be obtained with the SR 
program. We expected the SR program to reduce time to pregnancy due to: (1) no reduction in 
estrus expression after the previous AI service, (2) reduced interbreeding interval for cows with a 
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CL at nonpregnancy diagnosis, and (3) improved P/AI of cows with no CL at nonpregnancy 
diagnosis when compared with blanket use of the Day 32-Resynch protocol. We decided to use 
this protocol for the control group because it is the most widely used protocol for 
resynchronization of ovulation in the U.S. Cows were randomly assigned to treatments after the 
first service postpartum. Afterwards, cows were followed for 210 days or until cows left the 
herd. Although overall P/AI was not different among treatments, the fact that cows with a CL 
and a putative ovulatory follicle at NPD (~70%) had a seven day reduction in the interbreeding 
interval along with greater P/AI for cows with no CL at NPD, resulted in greater hazard of 
pregnancy. Although an economic analysis was not performed in this experiment, we speculate 
that the reduction in time to pregnancy (i.e., 16 d reduction in median days) and reduced 
proportion of nonpregnant cows at the end of lactation would have a greater positive impact on 
cow profitability than the potential additional cost of the SR program. As expected, P/AI was 
greater for the SR group among cows with no CL and/or a putative ovulatory follicle at NPD. In 
contrast to our observations from the previous experiment, P/AI was not different among cows 
with a CL at NPD. We speculate that the negative impact of not synchronizing the follicular 
wave with the first GnRH treatment did not affect P/AI because of two reasons. First, the initial 
GnRH treatment of the Day 32-Resynch protocol was given 32 and not 25 days after AI hence, a 
large proportion of cows expected to have high fertility were inseminated at estrus before NPD 
rather than through TAI as it may have happened if they received GnRH on Day 25. Second, the 
use of an additional PGF2α treatment to increase luteal regression before TAI in the SR 
treatment.  
In summary, the experiments presented in Section I of this dissertation showed that EEM 
does not cause major alterations to the ovarian dynamics of lactating dairy cows, whereas LEM 
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leads to extended luteal phases but not major alterations to the follicular wave dynamics. In 
addition, the great proportion of previously inseminated cows that present an active CL and a 
putative ovulatory follicle 32 ± 3 days after AI provides an opportunity to use resynchronization 
of ovulation programs such as the SR program which did not interfere with inseminations at 
detected estrus and reduced time to pregnancy after the first service. 
 
1.2 Future research 
In the experiment performed in Chapter I of Section I we tested a new method to detect 
the presence of an embryo around the period of maternal recognition of pregnancy and thereafter 
classified cows as undergoing EEM (18 to 23 days after AI) or LEM (≥ 24 days after AI). We 
observed that the occurrence of EEM did not have a major impact on ovarian dynamics, whereas 
LEM resulted in delayed luteolysis. After this experiment, many questions regarding ovarian 
dynamics in cows suffering embryo mortality remain unanswered. For example: (1) is luteolysis 
triggered by the same mechanism(s) in cows that undergo maternal recognition of pregnancy but 
later lose their pregnancy than in cows that do not undergo maternal recognition of pregnancy?, 
(2) up to how many days after fertilization is IFNT produced and for how many days is it 
required to, or capable of preventing luteolysis?, (3) is there a molecular signal or a set of 
molecular signals that prevent luteolysis beyond the period of maternal recognition of pregnancy 
in cattle?, and (4) is uterine receptivity to an embryo compromised after early and/or late embryo 
mortality in cattle? 
To determine whether (first question) luteolysis is triggered through the same 
mechanisms after maternal recognition of pregnancy or during the estrous cycle in cows with no 
exposure to an embryo around the period of maternal recognition of pregnancy, an experiment 
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could be performed to monitor ovarian dynamics, expression of hormone receptors in the 
endometrium, PGF2α secretion, and corpus luteum function in cows exposed or not exposed to a 
conceptus and/or IFNT. The experiment would include three groups: (1) non-inseminated cyclic 
cows, (2) pregnant cows with induced embryo loss after Day 25 of pregnancy, and (3) non-
inseminated cows with maternal recognition of pregnancy simulated by intrauterine infusion of 
recombinant IFNT from Day 14 to 25 after AI. In the cyclic group, blood samples, uterine 
biopsies, and CL biopsies would be collected at 48 h intervals from Day 12 to Day 20 after 
induction of ovulation. In the other two treatments the same samples would be collected every 48 
hours from Day 25 to Day 33 after induction of ovulation. At each sampling point transrectal 
ultrasonography (B-mode and color Doppler) would be performed to monitor size and blood 
flow of ovarian structures and uterine content. Circulating concentrations of estradiol and 
progesterone would be measured in blood samples to monitor follicular and luteal function. 
Analysis of both protein and mRNA abundance for E2, oxytocin, and P4 receptors would be 
performed in endometrial tissue samples. In CL biopsy samples, both protein and mRNA 
abundance analysis would be performed for oxytocin and markers of steroidogenic function 
(steroidogenic acute regulatory protein and 3β-hydroxysteroid dehydrogenase), apoptosis (BAX 
and BCL2), inflammation (tumor necrosis factor-α), and vascular remodeling (vascular 
endothelial growth factor). Moreover, on the days of the first, third, and fifth biopsy, blood 
samples would be collected every 30 minutes during four hours prior to biopsy collection to 
measure circulating concentrations of PGFM (a PGF2α metabolite). As described in Chapter I of 
Section I, the onset and inhibition of luteolysis are regulated through interactions among the 
ovary, CL, endometrium, and embryo. The regulation of this process is governed by the 
abundance of E2, oxytocin, and P4 receptors in the endometrium, which are regulated by E2, P4, 
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oxytocin, and IFNT. Pulsatile secretion of PGF2α is required for luteolysis to occur. This 
pulsatile release is triggered by oxytocin, therefore there must be a down regulation of the P4 
receptor and an upregulation of the oxytocin receptor in the endometrium for luteolysis to occur. 
During maternal recognition of pregnancy, the oxytocin receptor is downregulated in the 
endometrium due to the action of IFNT. Whether the mechanism that leads to luteolysis after 
embryo mortality during or after the period of maternal recognition of pregnancy follows the 
same pathways and timing as in a normal estrous cycle is unknown. I hypothesize that the 
presence of an embryo along with embryonic membranes and secretions will alter the way in 
which the luteolytic mechanism is established as compared with a normal estrous cycle. This 
experiment would allow to elucidate the physiological and molecular mechanisms that lead to 
delayed luteolysis in cows that suffer late embryonic mortality. 
A simple experiment can also be conducted to determine the relationship between 
duration of IFNT exposure and luteal lifespan. Cows would be randomly assigned to receive 
intrauterine infusions of recombinant IFNT or saline solution from Day 14 to 35 after induction 
of ovulation or the time of CL regression, whatever occurs first. Daily blood sampling would be 
performed to determine P4 and E2 concentrations. At the same time peripheral white blood cells 
would be harvested to analyze mRNA expression of ISG to monitor the systemic response to 
IFNT. Moreover, uterine biopsies would be obtained from a subgroup of cows to measure 
protein and mRNA expression of E2, P4, and oxytocin receptors in the endometrium because 
these are the key regulators of luteolysis. The main objectives would be to determine if there is a 
maximum number of days after ovulation that IFNT can block the luteolytic mechanism. Further, 
to explore the potential influence of other molecules on maternal recognition of pregnancy, a 
third group of cows may be included to receive intrauterine infusions of embryo lysates in which 
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IFNT has been removed or blocked using antibodies. Inclusion of a treatment with lysates from 
embryos at different stages of development may also help elucidate the effect of time on 
production and/or secretion of other molecules that may be involved in the prevention of 
luteolysis in pregnant cows. 
Determining the impact of embryo mortality on subsequent fertility would be important 
because of the substantial proportion of cows that suffer embryo mortality and are re-
inseminated immediately after NPD. Many of these cows do not undergo luteolysis before the 
time of NPD, and therefore it is fair to expect that the endometrium had been exposed to 
embryonic tissues for a prolonged period of time and a different endocrine environment than a 
cow which already had CL regression. If these cows receive a resynchronization of ovulation 
treatment that results in immediate re-insemination (e.g., Short-Resynch protocol described in 
Chapters III and IV) it is reasonable to speculate that the uterine environment might be different 
from a cow that did not have delayed luteal regression because of lack of fertilization or early 
embryo mortality. An experimental design to address the question of uterine receptivity after 
embryo loss would include two treatments. One of the treatments would consist of non-
inseminated cyclic cows whereas the other group would consist of cows with induced embryo 
mortality. In the embryo mortality treatment, pregnancy would be diagnosed using circulating 
concentration of pregnancy associated glycoproteins (PAG) and transrectal ultrasonography. 
Thereafter, embryo mortality would be induced on Day 27 after AI. On Day 32 after 
synchronized ovulation cows from both groups with a CL and an active follicle would receive 
PGF2α, a second PGF2α treatment 24 h later, GnRH 32 hours after and timed AI 16 hours later. 
Any cow observed in estrus after induction of embryo mortality would be inseminated 
immediately. After re-insemination, pregnancy diagnosis would be performed starting at 24 days 
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after AI using circulating PAG concentration and by transrectal ultrasonography 32 days after 
AI. This pregnancy testing scheme will allow detecting pregnancy loss at an early stage of 
gestation. This experiment would help to elucidate, at least in part, if the presence and later death 
of an embryo causes alterations in uterine receptivity and further embryo survival. The main 
limitation of this experiment would be the large number of cows needed per treatment because 
the main outcome would be P/AI.  
Regarding the second part of Section I, composed by Chapters III and IV, further 
research would be directed toward validation of the SR program. The first question that arises is 
how the SR program would compare to the Day 25-Resynch program (first GnRH given 25 ± 3 
days after AI) for time to pregnancy and differences on the proportion of cows that receive AI at 
detected estrus. Although the experiment described in Chapter III showed a greater proportion of 
cows detected in estrus before NPD and no difference was observed in overall P/AI, 
experimental design limitations prevented us from testing the hypothesis that cows in the SR 
program would have greater insemination risk thereby, result in greater hazard of pregnancy. 
Therefore, an experiment similar to the one presented in Chapter IV is being conducted to test 
this hypothesis. Briefly, after the first service postpartum cows are randomly assigned to receive 
the SR program or the Day 25-Resynch protocol. For both treatments, cows with no CL ≥15 mm 
and follicle ≥10 mm at the time of NPD receive the Ovsynch protocol with two PGF2α 
treatments and P4 supplementation. Our objectives are: (1) to evaluate the effect of removing the 
GnRH treatment 25 ± 3 d after AI on the hazard of pregnancy after the first AI postpartum, and 
(2) validate results from the experiment presented in Chapter IV. Of particular interest are the 
effect of GnRH or no GnRH treatment on the re-insemination dynamics before NPD, and P/AI 
for cows with a CL ≥15 mm and follicle ≥10 mm at NPD. 
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In the experiments presented in Chapters III and IV we showed that the SR program 
generated a similar proportion of pregnant cows after NPD when compared with the Day 25 (i.e., 
for cows with CL at NPD) and Day 32-Resynch protocols, but greater hazard of pregnancy 
during lactation than the latter. However, an economic analysis is needed to determine the 
profitability of cows managed with these programs. Therefore, in future experiments data for 
milk yield, feed cost, reproductive cost, and replacements cost would be needed to conduct such 
analysis and determine the true impact of the reducing time to pregnancy and inseminating more 
cows at detected estrus on dairy herd profitability. 
More questions were also generated during analysis of data from the experiment 
presented in Chapter III. For example, what is the fate of the dominant follicle in cows that 
receive GnRH seven days prior to NPD and do not ovulate? The notion that follicular turnover 
only happens in cows that ovulate in response to GnRH treatment in resynchronization of 
ovulation protocols does not necessarily match the pattern of estrus expression observed in the 
experiment presented in Chapter III. Even though only 50% of the cows ovulated in response to 
this GnRH treatment, there was a clear difference in the pattern of estrus expression after Day 25 
compared to cows that did not receive GnRH treatment. Therefore, one of my hypothesis is that 
in cows that do not ovulate, the LH surge elicited by the GnRH treatment suppresses E2 
production in the dominant follicle. As a consequence, this would suppress estrus expression and 
allow a rise in circulating concentration of follicle stimulating hormone (FSH) which may lead to 
the emergence of a new follicular wave. An observational study to monitor ovarian function, and 
FSH and LH concentrations after GnRH treatment in cows that do not ovulate would be 
performed. Cows in diestrus (seven days after ovulation) would be used rather than cows 25 days 
after a previous ovulation because of the great variability expected for stage of follicle and CL 
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development as well as P4 and E2 concentrations. Thus, cows would be synchronized with the 
Ovsynch protocol and receive GnRH seven days later. Only cows that ovulate to this GnRH 
would be eligible to receive another GnRH treatment seven days later. Transrectal 
ultrasonography and ovarian mapping of all structures ≥3 mm would be performed at 12 hour 
intervals starting one day before the last GnRH treatment until seven days after GnRH. Blood 
samples to measure E2, P4, LH, and FSH concentrations would be collected every two hours 
from -2 to 12 hours after treatment, every 6 hours until 24 hours after treatment, and then every 
12 hours until 7 days after treatment. My hypothesis is that in cows that fail to ovulate after the 
GnRH treatment, the GnRH-induced LH surge will cause the dominant follicle to stop producing 
E2, hence allowing an increase in circulating concentration of FSH which will lead to the 
emergence of a new follicular wave. This experiment would allow description of follicular wave 
dynamics and hormonal profiles in cows that have a dominant follicle but fail to ovulate after 
GnRH treatment. In addition, because there would be cows that do ovulate, we would be able to 
compare differences in the response variables between cows that do and do not ovulate. 
 
2. The vagina as a route of hormone delivery for synchronization of ovulation in cattle 
2.1 Overall conclusions 
The objectives of the experiments presented in Section II of this dissertation were to test 
the feasibility of inducing an LH surge and luteal regression through intravaginal (IVG) delivery 
of GnRH and PGF2α, respectively. The long-term objective of this line of research is to develop 
electronically controlled automated IVG drug delivery devices. Such devices could be 
programed to release the required type and dose of hormones at predefined time points to 
synchronize ovulation and be removed immediately before TAI. These devices would allow to: 
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(1) maximize compliance in timing and dosage of drug administration, (2) minimize labor 
requirements for treatments, (3) minimize cow time budget disruption and number of injections, 
(4) better mimic physiological patterns of hormone release, and (5) tailor treatments to individual 
cows.  
In Chapter II of Section II, two experiments were performed to test the feasibility of 
inducing luteal regression through IVG administration of PGF2α to lactating dairy cows. 
Progesterone concentration dynamics after IVG administration of different doses of PGF2α (25, 
50, and 100 mg of Dinoprost) were compared to a negative control (IVG saline solution) and a 
positive control group [25 mg Dinoprost administered intramuscular (i.m.)]. All IVG treatments 
induced an initial decline in circulating P4 concentration. Nevertheless, we observed that a 
substantial proportion of cows had an initial decline in P4 concentration followed by return to 
pretreatment levels. Therefore, our conclusion from this first experiment was that although 
luteolysis was triggered in the treatments receiving PGF2α through IVG delivery, the stimulus 
was insufficient to cause complete luteal regression. Thus, we performed a second experiment in 
which we added a treatment that received two IVG treatments (25 mg Dinoprost) 12 hours apart. 
As observed in the first experiment, cows that received a single IVG treatment of PGF2α had an 
initial decline in P4 concentration followed by a rebound. Conversely, cows that received two 
IVG treatments 12 hours apart had a P4 concentration pattern very similar to cows in the positive 
control group. In these cows, P4 concentration dropped below 0.5 ng/mL by 36 hours after 
treatment and remained at these levels until 96 h after treatment. Results from these experiments 
supported the hypothesis that it is feasible to induce luteal regression in lactating dairy cows 
through IVG administration of PGF2α, and that two PGF2α treatments 12 hours apart are 
required to prevent a rebound in P4 concentration after the initial treatment.  
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The experiments described in Chapter III of Section II, had the objective of testing the 
feasibility of inducing an LH surge through IVG administration of GnRH. We aimed to trigger a 
surge of LH of similar magnitude and timing than observed after i.m. treatment with GnRH. In 
the first experiment circulating concentration of LH was measured after IVG administration of 
three different doses (100, 500, and 1,000 µg of Gonadorelin) of GnRH. A negative control (IVG 
saline) and a positive control (100 µg Gonadorelin i.m.) group were also included. None of the 
IVG treatments elicited a surge of LH, and only the highest dose caused a slight increase in 
circulating LH concentration. We concluded that GnRH was either not absorbed or degraded 
before absorption, and therefore did not reach the blood stream and the pituitary gland. The fact 
that there was a discrete response to the 1,000 µg dose suggested that at least a portion of the 
dose delivered was absorbed. Therefore, we performed a second experiment to test the 
hypothesis that adding an absorption enhancer would increase vaginal absorption of GnRH. In 
this experiment, we also included a more potent GnRH analogue (Buserelin) to test the 
hypothesis that a more potent analogue may be more effective to induce a surge of LH because 
inefficient absorption could be offset by greater potency (i.e., less amount needed to trigger the 
desired response). Therefore, using the same positive and negative controls as in the previous 
experiment, we measured circulating LH concentration after IVG administration of 1,000 µg of 
Gonadorelin and 80 µg of Buserelin with and without the inclusion of citric acid as an absorption 
enhancer. As in the first experiment, IVG administration of GnRH alone failed to elicit an LH 
surge. On the other hand, treatments including citric acid elicited an LH surge of similar 
magnitude as the i.m. treatment. Although there was no difference in area under the curve or 
peak LH concentration between the positive control and treatments including citric acid, there 
was a delay of 40 (Gonadorelin) to 80 (Buserelin) minutes in time to peak LH concentration. 
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This, and the fact that GnRH doses 10 fold greater did not cause an LH surge of greater 
magnitude after IVG than i.m. delivery suggest that either IVG absorption was less efficient 
and/or that GnRH was degraded by enzymes present in the vagina. Because we did not test the 
lower doses with the inclusion of citric acid, we can only speculate that these would not have had 
a similar response. We concluded that it is feasible to induce an LH surge through IVG 
administration of GnRH when citric acid is included as an absorption enhancer. We also 
concluded that using more potent analogues does not necessarily overcome poor absorption.  
The experiments presented in Chapters II and III of Section II supported the hypotheses 
that both luteal regression and an LH surge can be triggered through IVG administration of 
PGF2α and GnRH, respectively. Despite this, the experimental design of these experiments was 
inadequate to test potential differences between the IVG and i.m. treatments on: (1) risk of 
complete luteal regression, (2) risk of ovulation, and (3) time to ovulation after treatment. Thus, 
further research is needed to determine the best time, dose, and number of treatments needed to 
achieve the same or better results than those observed when cows receive i.m. GnRH and 
PGF2α. 
2.2 Future research 
 Further research related to this line of investigation should be directed towards: (1) 
evaluating efficacy of IVG administration of PGF2α to induce complete luteal regression with a 
larger number of cows, (2) evaluate efficacy of IVG administration of GnRH to induce ovulation 
with a larger number of cows and potential differences on time to ovulation compared to i.m. 
administration, (3) identify the best PGF2α and GnRH analogues, doses, and vehicles to 
effectively induce luteal regression and ovulation after IVG delivery, and (4) develop and test 
electronically controlled automated IVG drug delivery devices. 
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 We are currently performing an experiment to compare the risk of undergoing complete 
luteolysis after a single i.m. treatment of PGF2α or two IVG treatments 12 hours apart. Briefly, 
non-inseminated lactating dairy cows are randomly assigned to receive the i.m. or IVG PGF2α 
(500 µg of Cloprostenol) treatments seven days after a GnRH treatment. Transrectal 
ultrasonography of ovarian structures and blood sampling to measure P4 concentration are 
performed at the time of: GnRH treatment, PGF2α treatment, 24, 48 and 72 hours (at this time 
cows receive a second GnRH treatment) after treatment. Our main objective is to test the 
hypothesis that there is no difference in the proportion of cows undergoing complete luteal 
regression after i.m. or IVG administration of PGF2α. Further, we will also monitor physical 
activity patterns to compare estrous behavior between cows that receive PGF2α through the IVG 
and i.m. route of administration.  
 Another experiment should be performed to test the efficacy of IVG administration of 
GnRH to induce ovulation and describe time to ovulation after treatment. A possible 
experimental design would include five treatments: a positive control (100 µg Gonadorelin i.m.), 
a negative control (saline IVG), and an IVG treatment with 100, 500 and 1,000 µg Gonadorelin 
and 10% citric. Lactating dairy cows would be synchronized with the Ovsynch protocol and 
treated with PGF2α seven days later, at this time, cows would be randomly assigned to receive 
treatments. Transrectal ultrasonography and ovarian mapping would be performed 24 hours 
before treatment, and every 4 hours from the time of treatment until 48 hours after to determine 
the time of ovulation, which would be confirmed seven days after treatment through transrectal 
ultrasonography and circulating P4 concentration. This experiment would allow to identify any 
difference in risk and timing of ovulation after IVG instillation of different doses of GnRH 
compared to i.m. administration. The large number of cows needed to compare ovulation risk 
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would not allow to perform the frequent blood sampling needed to detect the presence and 
magnitude of an LH surge. 
 The development of electronically controlled automatic drug delivery device is beyond 
my area of expertise and was not attempted during my PhD program.  
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APPENDIX 
 
 
Appendix 1. Proportion of cows bearing an active corpus luteum, a mature corpus luteum, an 
active follicle, and largest active follicle diameter 24, 32, and 38 days after AI for cows that 
received Sham insemination and cows nonpregnant cows inseminated with semen. 
Days after AI Item Cyclic1 Nonpregnant1  P value 
  ACL2 (%; n/n) 33 (5/15) 74 (14/37) 0.76 
24 MCL3 (%; n/n) 0 (0/15) 30 (11/37) <0.001 
  AFOL4 (%; n/n) 73 (11/15) 81(30/37) 0.54 
  AFOL5 diam. (mm) 15.7 ± 1.1 15.4 ± 0.6 0.78 
  ACL (%; n/n) 93 (14/15) 84 (31/37) 0.38 
32 MCL (%; n/n) 80 (12/15) 57 (21/37) 0.13 
  AFOL (%; n/n) 100 (15/15) 92 (34/37) 0.97 
  AFOL diam. (mm) 20.4 ± 0.9 15.7 ± 0.6 <0.001 
  ACL (%; n/n) 87 (13/15) 86 (32/37) 0.98 
38 MCL (%; n/n) 87 (13/15) 86 (32/37) 0.99 
  AFOL (%; n/n) 93 (14/15) 100 (37/37) 0.97 
  AFOL diam. (mm) 14.6 ± 0.7 15.3 ± 0.4 0.35 
1Lactating Holstein cows were synchronized using the Presynch-Ovsynch protocol and at the time of AI (Day = 0) 
randomly assigned to receive AI with extender only (Cyclic) or regular semen in a ratio of approximately 1 to 5. 
Transrectal ovarian ultrasonography was conducted and blood samples were collected at the time of AI and then 2 
and 7 days after AI to verify ovulation and formation of a functional corpus luteum (progesterone ≥ 1 ng/mL) based 
on circulating concentrations of progesterone and estradiol. From Day 14 to 42, transrectal ultrasonography was 
conducted every 24 h to record the presence and size (diameter) of all ovarian structures and evaluate uterine 
content. In addition, blood samples were collected every 48 h for determination of circulating concentrations of 
progesterone. Cows where no embryo was visualized through transrectal ultrasonography were considered as 
nonpregnant. 
2ACL: active corpus luteum (progesterone ≥ 1). 
3MCL: mature corpus luteum (≥ 6 days after ovulation). 
4AFOL: active follicle (diameter ≥ 10 mm and in growing or static phase).  
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Appendix 2. 
 
 
 
 
 
 
Appendix 2. Distribution of cows in the G25 treatment (Section I, Chapter III) by days after first 
or second and greater AI services when cows received GnRH treatment 25 ± 3 d after AI. 
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Appendix 3. 
 
 
 
 
 
Appendix 3. Progesterone concentration dynamics from enrollment until the time of the GnRH 
treatment before TAI in cows from the G25 and NoG25 treatments (Section I, Chapter III) 
combined. Cows were grouped according to the approximate day of complete luteal regression 
(CLR; P4 ≤0.5 ng/mL) after AI: CLR before 18 d after AI, CLR from 20 to 25 d after AI, CLR 
from 27 to 32 d after AI, no CLR by 32 d after AI. 
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